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The evolution of modules 
The appearance of multicellular organisms called for a multitude of novel proteins to 
allow communication among different cells, tissues and organs. Recent studies have 
shown that numerous proteins invented by multicellular organisms were assembled 
from modules (Blake, 1983; Patthy, 1990). Of the proteins unique to multicellular 
organisms, those involved with blood coagulation, and the fibrinolytic and 
complement cascades provided the first clear examples of this evolutionary strategy 
(Patthy, 1985; 1990). Analysis of the evolutionary history of these proteins has 
shown that their assembly was facilitated by some unique features of the genes 
encoding the modules. 
The proteases that participate in these cascades are most homologous to trypsin, 
and, since trypsin-like proteases are also found in bacteria, it follows that the 
proteases of higher organisms evolved from such an ancestor (Patthy, 1985; 1991). 
The plasma proteases, however, differ markedly from the proteases of bacteria and 
simple digestive enzymes, such as trypsin. These differences lie not in the catalytic 
regions of the plasma proteases, but in the large, non-protease, amino-terminal 
extensions that are primarily responsible for the regulation of the protease activity 
(Banyai et al., 1983; Patthy, 1990; Kitamoto et al., 1994; 1995; Matsushima et al., 
1994). These amino-terminal extensions contain distinct structural domains that 
interact with substrates, cofactors, and phospholipid membranes. The remarkable 
structural-functional autonomy of these nonprotease domains raised the possibility 
that their independence is a relic of their evolutionary autonomy (Blake, 1979; 
Stoltzfus, 1994). This suspicion has been supported by the observation that the 
amino-terminal, nonprotease regions (kringle, finger and growth factor modules) of 
plasma proteases are found in a number of proteins that are otherwise unrelated to 
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these enzymes (Banyai et al., 1983; Patthy et al., 1984; Rogers, 1985). Comparison 
of the evolutionary history of individual modules with the genealogy of the protease 
domains has confirmed this assumption and showed that modules existed previously 
as independent miniproteins, or were borrowed from other proteins (Patthy, 1985). 
Intron classes 
In the genes of plasma proteases and other mosaic proteins, introns are found at the 
boundaries separating the modules, suggesting that they play a role in the assembly 
process (Blake, 1978; Rogers, 1985). Introns can be classified according to the 
position at which they interrupt the reading frame: Phase 0 introns lie between two 
codons, phase 1 introns occur between the first and second nucleotides of a codon, 
and phase 2 introns are found between the second and third nucleotides of a coding 
triplet; the family of mosaic proteins comprised of a particular class of modules are 
referred to collectively as a clan. Although the position and number of introns can 
change as a result of splice-junction sliding, or through the insertion or omission of 
exons, the intron phase is highly conserved during evolution (Patthy, 1987; 
Lambowitz, 1993). 
Symmetric modules 
A remarkable feature of modules is that they display an unusual mobility: they 
undergo repeated insertions, tandem duplications, exchanges and deletions. Analysis 
of modules in a large number of proteins has revealed that nearly all are flanked by 
introns of the same phase. The significance of this finding is that only symmetric 
modules (exons with intron-exon boundaries of identical phase) can participate in 
exon-shuffling phenomenon of the type observed for modules without disruption of 
the reading frame (Fig. 1). Structural analysis of modules has revealed that they are 
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Fig. 1. Intron phase and modular exchange. Only exons that have introns of the same phase class at their 
5' and 3' ends can be inserted, duplicated or deleted by intronic recombination without disrupting the 
reading frame. Numbers refer to the phase class of splice junctions. Adapted from Patthy, 1987 
virtually all class 1-1 (Patthy, 1987; Dujon, 1989). The reason behind this 
preference for class 1-1 modules is not clear, but one theory suggests that the 
translation of nucleotides found in consensus splice sites (AG/GT) in phase 1 gives 
glycine, a residue common in the random coiled structures flanking modules (Patthy, 
1991). Should the splice site occur in phase-0 or phase-2, the resulting translation 
products might be more difficult to accommodate while maintaining the structural 
requirements of the recipient protein. In addition to being flanked by symmetric 
introns, modules have several other common characteristics: they are most often 
small, cysteine-rich domains, they are found only in extracellular proteins, or the 
extracellular domains of transmembrane proteins, and modules occur, with few 
exceptions, only in 'young' proteins unique to eukaryotes, such as extracellular matrix 
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components, muscle proteins, proteins involved in cellular adhesion, and molecules 
regulating cell growth and differentiation (reviewed by Patthy, 1995). 
Domains and modules 
The distinction between a module and a domain is that the former is flanked by 
introns and the latter is not (Patthy, 1991). A module may be created from a domain 
by the insertion of splice site-containing transposable elements at its boundaries 
(Fridell et al., 1990; Menssen et al., 1990; Patthy, 1991). It is assumed that insertion 
of introns at the boundaries of protein domains is the first step to mobilizing the 
domain. If the inserted introns are symmetric, a 'protomodule' is created from the 
domain, allowing it to undergo tandem duplication, deletion and exchange. A 
consequence of intron insertion is that amino acids encoded by the nucleotides 
comprising the transposable element are inserted into the recipient protein. To be 
tolerated, these additional amino acids must not disrupt the structure of the recipient 
protein to the extent that it is functionally impaired. Non-essential regions of target 
proteins, such as those serving to connect structural motifs, are therefore favored for 
intron insertion. 
The ontogeny offollistatin modules 
Protease inhibitors are one of the few examples of modules that still exist as 
independent proteins, an observation attributed to the efficiency with which these 
small molecules fulfill their functions without the assistance of additional modules 
(Patthy, 1991). The secretory trypsin inhibitor is one such example of the 
modularization process because, although it is the parent protein of the INH module, 
it remains present in contemporary eukaryotes. The gene of secretory trypsin 
inhibitor contains a single INH protomodule, bounded by phase-1 introns. This makes 
the INH module susceptible to the modular exchange events outlined above, and this 
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module has been discovered inserted into a phase-1 intron of the gene encoding the 
precursor of ß-amyloid (Schilling et al., 1991). There are also three INH modules in 
lipoprotein-associated coagulation inhibitor, and two IHN modules in inter-a-trypsin 
inhibitor (Diarra-Mehrpour et al., 1990). The secretory trypsin inhibitor is closely 
related to the pancreatic secretory trypsin inhibitor (PSTI) which contains an 
ovomucoid module, named after the abundant glycoproteins in avian eggwhites that 
contain three such tandemly repeated modules (Laskowski et al., 1987, 1990; 
Apóstol et al., 1993). PSTI, however, is particularly interesting in that this parent 
protein apparently underwent modularization on two separate occasions, giving rise 
to the class 0-0 ovomucoid module, found in multiple copies in various Kazal-type 
protease inhibitors, as well as to the class 1-1 follistatin module (Fig. 2), found in 
follistatin (Esch et al., 1987), hevin (Girard and Springer, 1995), osteonectin 
(Findlay et al., 1988), TSC-36/FRP (Shibanuma et al., 1993; Zwijsen et al., 1993), 
SCI (Johnston et al., 1990), agrin (Rupp et al., 1991), and testican (Alliel et al., 
1993). In agreement with modular exchange theory, a notable difference exists 
PSTI -О- AKCYNELN GCTKI-- -YDPvCGTDGH-YPNECVLCFENRKP. QTSILIOKSGPC · 
ovomucoid 1 - 0 - VDCSHFPNRTOKEGKDVLVCNKD---LRPICOTDCVTYTNI>CLLCAYSIEP GTNISKEHDGBCKETVP - 0 -
ovomucoid 2 - 0 - KNCSSYANTTSEDGKVWVLCNRA---FNPVCGTDOVTYTNDCLLCAYSIEF GTHISKEKDGECKETVP - 0 -
ovomucoid Э - 0 - VDCSEYPK PDCTAE---DRPLCGSDNXTYGMXCNFaiAWES NGTLTLSHFGKC * 
f o l l i s t a t i n 1. - 1 - FTCTNVDCGPGWiCWWKiQJKP-RCV-CAP--DCSNI-TWKGPVCGIÄ5KTYRNECALLKARCKB QPELEVgYQGRCKX - 1 -
f o l l i e t a t l n 2 - 1 - ErTCT^VFCPGSSTCVVDQTNNA-YCVTCHR--rCPEPASSEQYLCaNDGVTYSSAC3ILRJUlTCLL GRSIGLAYEGKCXK - 1 -
f o l l i s t a t i n J - 1 - KAKSCEDTQCTGGKXCLWDFKVGRGRCSLCDE--LCPDS-KSDEPVCASDNATYASECAMKEAACSS GVIXEVKHSGSCNS - 1 -
o a c e o n e c t i n . - 1 - NTÏQNHHCKHGRVCELOESNTP-HCV-CQDPTSCPAPIGEFEKVCSNDNKTFDSSCHFFATXCTLEGTKKGHXLHLDYTGPCKY - 1 -
Fig. 2. Alignment of class 0-0 ovomucoid modules from human ovomucoid and PSTI, and class 1-1 
follistatin modules fian follistatin, osteonectin (also known as BM-40 and SPARC), agra and SCI. 
Numbers indicate the phase of the introns found at the boundary of the modules. Asterisks indicate the 
carboxy-tennini. Adapted from Patthy and Nikolics, 1991. 
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between the apparent relative mobilities of these PSTI-derived modules. Class 1 -1 
follistatin modules are distributed among a wide variety of seemingly unrelated mosaic 
proteins while class 0-0 ovomucoid modules are found only in Kazal-type protease 
inhibitors. The amino terminal of follistatin modules, in addition to displaying 
homology to ovomucoid modules, is also closely related structurally to the epidermal 
growth factor (EGF) modules (Campbell and Bork, 1993; Bork et al., 1996; 
Hohenester et al., 1997), suggesting that an evolutionary relationship exists between 
the two module types. 
EGF modules 
Class 1-1 EGF modules are named after the eight repeated structures in the 
extracellular domain of the transmembrane EGF precursor. These modules contain 
three or, in some cases, four disulfide bridges stabilizing a tightly folded structure, 
which in some variations binds calcium (Rees et al., 1988; Handford et al., 1991; 
Selander-Sunnerhagen et al., 1992). EGF modules, which typically occur in large 
numbers in a single protein (up to 36), form rod-like structures that serve as 
scaffolding or spacing elements (Pan et al., 1993). In addition to the extracellular 
domain of the EGF precursor, EGF modules are found in a number of mosaic proteins 
involved with cellular adhesion and the blood clotting cascade. They also occur in 
many extracellular matrix proteins, such as the glycoprotein fibrillin whose EGF 
modules are structurally disrupted in individuals affected by Marfans syndrome, a 
heritable disease of the connective tissue (Dietz et al., 1991). EGF modules are also 
found in the extracellular domain of a variety of transmembrane signaling molecules 
important in development such as notch, serrate and spitz (Fig. 3), where they 
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Fig. 3. Membrane-anchored proteins containing EGF modules. The figure represents the general domain 
structure of the protein indicated on the right The shaded vertical line represents the plasma membrane. 
The juxtamembrane EGF module is mitogenic in EGF, TGF-a, AR, HRG and gurken. The EGF module of 
gurken is not known to be released. Notch is cleaved only in its cytoplasmic domain. 
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Mitogenic EGF modules 
In addition to the eight distal EGF modules, the EGF precursor contains a ninth, 
juxtamembrane EGF module that is encoded by two exons and contains an interaal 
intron-exon boundary (reviewed by Carpenter and Wahl, 1991). Following 
extracellular processing, this repeat gives rise to mature, soluble EGF (Bell et al., 
1986; reviewed by Prigent and Lemoine, 1992), which binds to and stimulates the 
EGF receptor (EGFR/erbB-1). Homologous mitogenic repeats have been found in a 
number of transmembrane precursors for erbB-family ligands, which, besides the 
EGFR, includes erbB-2 (neu), егЬВ-3, and егЬВ-4. Transforming growth factor-α 
(TGF-a), amphiregulin (AR), betacellulin (BTC) and heparin-binding EGF (HB-EGF) 
all contain a single mitogenic EGF module, proximal to the plasmamembrane, with 
an internal intron-exon boundary. Like EGF itself, these precursors are all processed 
extracellularly to release the soluble EGF domain (Plowman et al., 1990; Texido et 
al., 1990; Shing et al., 1993; Thompson et al., 1994), although the intact precursors 
of some ligands can stimulate receptors on adjacent cells (Wong et al., 1989). The 
precursors of TGF-a, AR, BTC and HB-EGF all have much shorter amino-terminal 
extensions than proEGF, without homology to known modules, suggesting that the 
EGF-precursor gene arose form one of these less complex genes through insertion of 
exons encoding the more distal EGF modules. The precursor of heregulin, a ligand for 
erbB-3 and erbB-4 (Sliwkowski et al., 1994; Carraway et al., 1994; Riese et al., 1996), 
contains a class 1-1 immunoglobulin module distal to its mitogenic EGF module, 
indicating that it was inserted into a TGF-a/AR-like precursor (Bork and Campbell, 
1993). These mitogenic EGF modules are more highly conserved than EGF modules, 
although they have a similar structure. They always occur in a position directly 
proximal to the transmembrane domain of the precursor, have never been observed 
in multiples in a single protein, and for mitogenic EGF modules for which the 
genomic sequence is known, all contain an intron-exon boundary at this location 
13 
(Bell et al., 1986; Blasband et al., 1990; Plowman et al., 1990). Although still 
technically modules because they are flanked by exons of the same phase, the cells 
need the to tightly regulate the potent bioactivity of these mitogenic EGF modules 
has apparently hindered their participation in modular exchange events, as is 
reflected by their presence in comparatively few proteins, all of which bear very 
similar structural organization. The EGF transmembrane precursor is, by defmition, a 
clan 1-1 mosaic protein, making it susceptible to modular exchange events. As might 
be expected, several mosaic proteins exist bearing resemblance to the EGF precursor, 
but with various insertions and deletions. The low-density lipoprotein (LDL) receptor 
and the EGF precursor show a striking conservation of the positions at which the 
introns interrupt both genes (Südhof et al., 1985a; 1985b). The exons encoding the 
LDL receptor exodomain also encode EGF modules homologous to those found distal 
to the mitogenic, juxtamembrane EGF repeat in the EGF precursor. Other 
transmembrane proteins with an intron-exon structure reminiscent of the EGF 
precursor include LRP (LDL related protein; Raychowdhury et al., 1989) and megalin 
(Herz et al., 1988). 
A universal function for modules? 
The functional consequences of a modules presence in a mosaic protein are disputed. 
Modules typically encode discrete structural units of fifty amino acids or less, 
prompting some workers to hypothesize that modules have a universal function, 
which they convey to recipient mosaic proteins (Patthy, 1991). Others believe that 
modules acquire different functions based on their structural setting (Bork et al., 
1996). FoUistatin itself consists of a small amino-terminal domain, followed by three 
follistatin modules. FoUistatin binds activin, a TGF-ß superfamily member, and this 
interaction is directly responsible for the inhibition of follicle-stimulating hormone 
release (reviewed by Michel et al., 1993). The activin binding epitope of follistatin 
14 
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has not been mapped to a specific domain. It has been suggested that follistatin 
modules may cany a structural fold with affinity for TGF-ß superfamily members in 
general (Patthy and Nikolics, 1993). Despite a growing number of mosaic proteins 
containing follistatin modules, to date, this property has been demonstrated for only 
osteonectin, which contains a single follistatin module and binds platelet derived 
growth factor (PDGF), preventing it from binding to its receptor (Raines et al., 
1992). Regions of some follistatin modules are also known to bind heparan sulfate 
proteoglycans on cell surfaces and in the extracellular matrix ECM (Sugino et al., 
1993) and the osteonectin follistatin module stimulates angiogenesis (Lane and Sage, 
1994; Sage, 1997). Agrin is currently the only example of a mosaic protein with both 
EGF and follistatin modules, the former occurring in its amino-terminal and the latter 
in its carboxy terminal. Agrin is synthesized in cell bodies of motor neurons and is 
transported along axons to neuromuscular junctions where it induces aggregation of 
nicotinic acetylcholine receptors on myotubes. Besides aggregation of these 
receptors, agrin also binds to heparan sulfate proteoglycans and binds the neural cell 
adhesion molecule, and these properties have been attributed to opposite ends of the 
agrin protein (Ruegg et al., 1992), consistent with the hypothesis that modules are 
functionally autonomous units, and that this function is conveyed to mosaic proteins 
in which they are found (Patthy and Nikolics, 1993). Further support for this theory 
is provided by the observation that both the receptor aggregating and heparan sulfate 
binding properties of agrin are regulated by alternative splicing that results in 
¡soforms containing graded numbers of modules in either end of the protein (Ferns et 
al., 1993; O'Toole et al., 1996; Campanelli et al., 1996). 
7365, a novel mosaic protein 
This dissertation introduces 7365, the first transmembrane protein with EGF and 
follistatin modules. Like agrin, the amino terminal of 7365 contains multiple 
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follistatin modules, however the EGF domain of 7365 bears far more likeness to the 
mitogenic EGF modules found in the precursors of EGF-family hormones than to the 
EGF modules found in agrin or in transmembrane signaling proteins such as notch. 
The structural organization of 7365 is also highly reminiscent of the precursors of 
EGF family hormones in that it has a short, cytoplasmic domain, a transmembrane 
domain, and the single EGF domain occupies a juxtamembrane position. Although its 
genomic structure is unknown, 7365 appears to be a clan 1-1 mosaic protein, that has 
undergone insertion by a follistatin module, probably followed by tandem duplication. 
The cDNA encoding the Xenopus 7365 homolog (X7365) was discovered 
serendipitously in a preliminary phase of a screening program (Fig. 4) designed to 
isolate cDNAs that are coordinately upregulated with the proopiomelanocortin 
(POMC) gene in the hypophysis of Xenopus laevis during the process of black-
background adaptation (Holthuis et al., 1995). One of the first steps in this screening 
approach was to remove cDNAs encoding POMC. To characterize the population of 
cDNAs remaining after removal of POMC cDNAs, 110 clones from an estimated 
12,600, were randomly chosen and partially sequenced. Those with open reading 
frames of 100 or more amino acids were used to conduct homology searches of the 
EMBL/GenBank databases. The partial-length X7365 cDNA, encoding the EGF 
module, transmembrane and cytoplasmic domains, and the З'-untranslated region, was 
among this group of 110 randomly picked clones and was identified by virtue of its 
homology to (pro) TGF-ct, AR, BTC and EGF. The primary objective of the 
screening program that resulted in the indentification of X7365 was to isolate cDNAs 
that were coordinately expressed with POMC. However, because X7365 was 
discovered in an intermediate step of the program, there was no assurance that it 
would meet this objective, and indeed, expression studies at both the protein and RNA 
levels failed to show that X7365 is induced in response to black-background 
adaptation in Xenopus. Nevertheless, because of the striking homology of X7365 to 
16 
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100 NIL'S from black-background adapted Xenopus 




Hybridization with POMC probe 
^-»•positives removed 
Hybridization with liver probe 
^*· positi ves removed 
Analyze expression profile of remaining cDNAs 
in black background 
adapted animals 
Sequence analysis and database searching 
Fig 4 Schematic diagram of the screening approach designed to uncover novel regulated secretory 
pathway proteins that led to the discovery of X736S Asterisk indicates the point at which X7365 was 
detected. NIL, neurointermediate lobe 
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the precursors of EGF-family hormones, it was decided to conduct further studies on 
this novel protein. These endeavors are the subject of this dissertation. 
Outline of the dissertation 
This dissertation describes the cloning, expression and functional analysis of the 
novel 7365 protein. Chapter 2 relates the discovery of the partial length X7365 
cDNA from a Xenopus neurointermediate pituitary lobe screening program, and the 
subsequent cloning of the full-length Xenopus cDNA from a hypothalamus library. 
The putative protein sequence predicted by the full-length cDNA showed for the first 
time that, in addition to the unique EGF module already known from the partial-
length cDNA, the extracellular domain of 7365 contained two follistatin modules. 
Futhermore, this chapter describes the distribution of X7365 gene products in the 
organs of adult Xenopus, focusing on the brain and in particular, the hypothalamic-
hypophysial axis which is responsible for regulating hypophysial secretion. Chapter 3 
details the cloning of the mouse 7365 ortholog (M7365) from a brain cDNA library. 
The deduced protein encoded by this cDNA provided the first glimpse of a 
mammalian 7365 protein, and showed that this protein is highly conserved in the 
evolutionary period that elapsed between Xenopus and mouse. The expression of 
gene products encoded by this homolog is analyzed in adult mouse tissues, and 
particularly in the brain, where they are expressed in two areas where neurogenesis 
continues postnatally. The pattern of expression of M7365 protein and transcripts is 
compared with that observed for the Xenopus homolog as well as with several other 
recently discovered precursors encoding ligands for erbB family receptors. Chapter 4 
delves further into the expression of M7365, concentrating on the developing and 
adult mouse pancreas. The M7365 protein is found to be colocalized with glucagon, 
and to some extent peptide YY, from very early in pancreogenesis onward, 
suggesting that it may have a role in the development of this organ, and hinting that 
18 
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it may itself be a pancreatic hormone. Chapter S describes the cloning of the human 
7365 ortholog (H7365) from both human fetal brain and small cell lung cancer 
cDNA libraries. This chapter reports the discovery that in man, multiple isoforms of 
the protein are encoded by splicing variants of the gene, and that the expression of 
these gene products is differentially regulated in the progression of human lung cancer 
from treatment-responsive small cell lung carcinomas to non-responsive non-small 
cell lung carcinomas. Chapter 6 presents the results of somatic cell hybrid analysis 
and fluorescent in situ hybridization studies that led to the assignment of the 
chromosomal location of H7365 to 9q31. Chapter 7 gives an account of the 
production of the recombinant H7365 EGF module, as well as an important mutant, 
and studies conducted with these peptides designed to evaluate their potential to 
stimulate receptors belonging to the erbB family. This chapter also makes structural 
comparisons of the H7365 EGF module and TGF-a, and evaluates differences in the 
hydrophobic properties between the EGF modules of H7365 and EGFR ligands. These 
analyses show that, although at the primary structural level considerable homology 
exists between the EGF modules of 7365 and EGFR ligands, significant differences 
exist in their relative hydrophobic properties and three-dimensional structure. 
Finally, in Chapter 8, the results of the preceding chapters are discussed. 
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A novel transmembrane protein with epidermal growth 
factor and follistatin domains expressed in the 
hypothalamo-hypophysial axis of Xenopus laevis 
Chapter 1 
ABSTRACT 
Through the use of a screening strategy designed to isolate novel cDNAs encoding 
proteins concerned with pituitary secretion in Xenopus laevis, we discovered clone 
X7365 which encodes a transmembrane protein with a signal peptide, two follistatin 
modules, a unique epidermal growth factor (EGF) domain, and a short cytoplasmic 
region. RNA expression analyses indicated that X7365 transcripts are enriched in 
neuroendocrine tissues. Immunohistochemical studies demonstrated that, in addition 
to being expressed in the optic tectum and in astrocytes in the optic nerve, the 
X7365 protein is concentrated in a discrete population of magnocellular neurons. 
Axons projecting to the median eminence and the neurointermediate lobe of the 
pituitary were also immunopositive, suggesting that X7365 functions in the 
regulation of magnocellular neurosecretion. 
D.W. Eib and G.J.M. Martens 
Department of Molecular Animal Physiology, University of Nijmegen. Toemooiveld 1, 6525 ED 
Nijmegen, The Netherlands 
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INTRODUCTION 
Endocrine secretion from the pars intermedia and pars distalis of the hypophysis in 
Xenopus laevis is regulated by messengers synthesized in higher brain nuclei and 
delivered to the pituitary by two main routes. Inhibitory messengers, such as 
neuropeptide Y (NPY), GABA and dopamine (DA), are synthesized in neurons of the 
suprachiasmatic nucleus (Tuinhof et al., 1994), transported within axons projecting 
to the hypohysis, and released from nerve terminals which form direct synaptic 
contacts with melanotropes in the pars intermedia (Van Strien et al., 1991; De Rijk 
et al., 1992). Secretagogues, like corticotropin-releasing hormone (CRH) and 
thyrotropin releasing-hormone (TRH), are synthesized in the magnocellular nucleus 
of the hypothalamus (Tuinhof et al., 1994), transported along nerve fibers projecting 
to the median eminance and pars nervosa, where they are secreted, arriving at the 
pars intermedia and pars distalis via a portal system, or by diffusion (Jenks et al., 
1993). In addition to stimulatory messengers for pituitary secretion, vasotocin and 
mesotocin are also synthesized in the magnocellular nucleus and released from axon 
terminals in the pars nervosa and median eminance (González and Smeets, 1992). 
Dose-dependent release of CRH from rat hypothalamus occurs following 
intraventricular injections of the inhibin ßA-subunit (Plotsky et al., 1991). The 
inhibin ßA-subunit is one of three monomers found in the dimeric activins and 
inhibins, which are structurally related to transforming growth factor-ß (TGF-ß; Vale 
et al., 1990). Activins also stimulate oxytocin release from supraoptic and 
paraventricular nuclei in rats (Sawchenko et al., 1988), which are homologous to the 
hypothalamic magnocellular nucleus in Xenopus (Goos et al., 1978). Furthermore, 
inhibin ßA-subunits have been localized in nerve terminals connected to oxytocin-
containing neurons, and in nerve terminals of the CRH-rich region of the 
paraventricular nucleus in rats (Plotsky et al., 1991). 
AU forms of activin are bound by follistatin, resulting in their inactivation (Fukui et 
al., 1993). Follistatin is a monomelic, glycosylated protein occurring in at least three 
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forms (Robertson et al., 1987), originally isolated from ovary (Ueno et al., 1987). 
Follistatin has more recently been found in a variety of tissues, including brain and 
pituitary (reviewed by Michel et al., 1993). The N-terminal of follistatin contains a 
conserved motif which occurs three times. Each of these three repeats is encoded by 
a separate exon and is therefore classified as a module (Patthy 1991). Modules are 
subject to exchange phenomena and follistatin modules have been described in a 
number of important mosaic proteins such as agrin (Rupp et al., 1991), 
osteonectin/SPARC (Lankat-Buttgereit et al., 1988), and the brain-specific extra-
cellular matrix glycoprotein, SCI (Johnston et al, 1990). It has been proposed that 
modules donated to mosaic proteins retain the function they had in the donor 
protein. Follistatin modules are therefore believed to convey binding affinity for 
members of the TGF-ß or platelet derived growth factor (PDGF) families to mosaic 
proteins (Patthy and Nikolics, 1993). 
In this paper we describe the cloning and expression of the first transmembrane 
protein to contain follistatin modules. In addition, the X7365 protein is structurally 
similar to precursors of epidermal growth factor (EGF) receptor ligands and contains 
a novel EGF-like domain. 
MATERIALS AND METHODS 
Animals 
Xenopus laevis were bred and housed ш the Department of Animal Physiology aquanum facility at the 
University of Nijmegen Toads were maintained under constant illumination at 22°C and weighed 40 to 
60 g when killed 
Construction and Screening of Xenopus cDNA libraries 
Construction and screening of the neurointermediate lobe (NIL) cDNA library was as described 
previously (Holthuis et al, 1995) Briefly, the cDNA library was constructed with RNA isolated from 
100 Xenopus laevis NILs usmg the NP-40 method, followed by ohgo(dT) chromatography (Sambrook 
et al, 1989) Roughly 50,000 primary plaques were hybridized overnight on duplicate nitrocellulose 
filters (Schleicher and Schuell, Dassel, Germany) with a 0 8-kb proopiomelanocortin (ЮМС) cDNA 
fragment labeled by random oligonucleotide pruning with a[32P] dATP according to standard 
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procedures (Sambrook et al, 1989) Hybridization was at 63°C m 6X SSC, 0 5% sodium dodecyl sulfate 
(SDS), 0 1% pyrophosphate, 40 mM sodium phosphate pH 7 0, 1 mM EDTA, 3X Denhardts, and 0 1 
mg/ml denatured salmon sperm DNA Filters were washed at 63°C to a final stringency of 0 2X SSC, 
0 1% SDS and 1 mM EDTA and exposed to X-ray film for two days at -70°C with two intensifying 
screens From the pBluescript phagemids that faded to hybridize with the POMC probe, 110 were 
randomly selected, excised m v/vo from bacteriophage λ ZAP clones, and rescued as single-stranded 
DNA, according to the manufacturers instructions (Stratagene, La Jolla, CA) After sequencing, clones 
with an open reading frame of 100 or more ammo acids were subjected to a FASTA search Following 
identification of X7365, a random-pruned, double-stranded DNA probe was made from a 350-bp 
fragment of the partial cDNA and used to screen a Xenopus laevis hypothalamic cDNA library in λ ZAP 
XR, made as described previously (Van Riel et al, 1993) Ultimately, two overlapping, full length 
clones were isolated Labeling of the probe, hybridization procedures, and in vivo excision were con­
ducted as described above Sequencmg was performed on single-stranded DNA using Ъ DNA 
polymerase and the dideoxy cham termination method (Sanger et al, 1977) Sequences were determined 
in both directions with the aid of subclones and synthetic internal primers Nucleotide sequences and 
deduced ammo acid sequences were compared with EMBL/GenBank and Swissprot/PIR databases 
using the FASTA program and the University of Nijmegen CAOS/CAMM computer system 
Northern Blot Analysis 
Poly(A)+ RNA for Northern blot analysis (-7 5 μg per sample) was prepared by oligo(dT) 
chromatography from total RNA isolated with Tn-Pure reagent, according to the manufacturer's 
instructions (Boerhinger, Mannhein, Germany), from Xenopus liver, lung, heart, kidney and bram RNA 
was electrophoresed on a 2 2 M formaldehyde-containing agarose gel in 3-[N-Morpholino] 
propanesulfonie acid and blotted onto nitrocellulose After baking for 2 h at 80°C, the filter was prehy-
bndized m 6X SSC, 50% formamide, 5X Denhardt's, 0 5% SDS and 0 1 mg/ml denatured hemng sperm 
The filter was then hybridized overnight m the same solution containing 106 cpm/ml of random primed 
probe prepared as described under cDNA library screening procedures The following day, filters were 
washed to a final stringency of 0 25X SSC, 0 1% SDS, 65°C and autoradiographed at -70°C with two 
intensifying screens To check loading, the blot was subsequently stripped and rehybndized with a 
Xenopus type 3 cytoskeletal actm probe 
RNase Protection Assay 
A 450-bp fragment of the protein-coding region of clone X7365 (nucleotides 738-1,188, Fig 1) was 
subcloned into pBluescript SK', and the resultmg construct was linearized by digesting at an internal 
Stul site Approximately 100 ng of linearized construct was used to generate antisense RNA run-off 
transcripts The probe was synthesized at 37°C for 30 nun m 12 5 μΐ transcription buffer (Promega, 
Madison, WI) containing 34 units of Ъ RNA polymerase, 10 mM DTT, 50 mCi [32P]UTP (800 Ci/mM), 
17 5 units RNasin (Promega) and 1 mM each of rATP, rCTP, and rGTP After treatment with 9 units of 
DNase I at 37°C for 10 mm, the probe was separated from unincorporated label on a 4% 
27 
Chapter 1 
polyacrylamide/6M urea gel A Xenopus type 3 cytoskeletal actin probe, used as a loading control and 
generated in the same manner, was 210 nucleotides Roughly 106 ерш of probe was hybridized with 
total RNA samples in 25 μΐ of buffer (80% formamide, 0 4 M NaCl, 40 mM Piperazine-N,N'-bis[2-
ethanesulfomc acid] pH 6 4, and 1 mM EDTA) Samples were heated to 80°C for S mm before 
incubating overnight at 42°C The following day, hybridization mixtures were diluted with 0 3 ml 
digestion buffer (10 mM Tris pH 7 S, 0 3 M NaCl, and 5 mM EDTA) containing 25 mg/ml RNase A and 
500 units/ml Tl RNase, and digested at 37°C for 30 min. Digested hybridization mixtures were then 
proteinase-K. treated and phenol/chloroform/isoamylalcohol extracted After adding 10 μg yeast tRNA 
and precipitating with ethanol, samples were run on a 4% sequencing gel Gels were dried and 
autoradiographed at -70°C using two intensifying screens 
Reverse transcription-polymerase chain reaction (RT-PCR) 
Total RNA was isolated from Xenopus brain, anterior and intermediate pituitary lobes, optic nerve, 
heart, lung, spleen, ovary, and skeletal muscle, as described under the northern blotting procedure, and 
1 μg was processed for first strand cDNA in the presence or absence of reverse transcriptase (GIBCO, 
Breda, The Netherlands) using random hexanucleotide primers Four percent of the resulting cDNA was 
then used for each set of primer reactions Pnmer sequences for X7365 were 5'-TAGAAACAGATGAAA 
CAAGCA-3' (X7365-5') and 5'-CATCCGGGAAGTATCTGA-3' (X7365-3') Pnmer sequences for 
Xenopus ornithine decarboxylase (XODC) were 5'-GTCAATGATGGAGTGTATGGATC-3' (XODC-5') 
and 5'-TCCATTCCGCTCTCCTGAGCAC-3' (XODC-3·) The PCR reaction consisted of 30 cycles of 1 
mm each at 94°C (melting), 55°C (annealing), and 72°C (elongation) Each reaction contained 5 μΐ of 
10X Taq buffer, 250 nM S' and 3' primers, 2 μΐ of the 50 μΐ reverse transcriptase reaction, 8 μΐ of 1 25 mM 
NTT's and 0 5 units of Taq polymerase (Pharmacia, Uppsala, Sweden) diluted to 50 μΐ with distilled 
water PCR products were analyzed on a 1% agarose gel, loading was standardized according to the 
ornithine decarboxylase content of each sample 
Generation of Antiserum 
For use as an antigen, a fragment of the clone corresponding to the EGF-domain of Human 7365 was 
expressed in Escherichia coll as a fusion protein with 6 histidines using the QIAexpress system 
(Diagen, Hilden, Germany) and punned to near homogeneity with Ni2+-mtnlotriacetic acid resm The 
purified antigen was dissolved in Freunds adjuvant prior to immunization Characterization of the 
resulting anbsera with ELISA showed no cross reactivity with EGF or a variety of other proteins 
expressed as a fusion protein with the 6 histidine tag (data not shown) 
Immunohlstochemical Staining of Xenopus Brain 
For lmmunohistochemistry Xenopus laevis were transcardially perfused with phosphate buffered saline 
(PBS. 101 mM NaCl, 2 7 mM KCl, 4 3 mM Na2HP04 and 1 4 mM KH2P04) for 10 mm followed by 
Bourn's fixative for 20 mm. Brains were dissected and post fixed for 2 h In some cases perfusion was 
omitted and brains were only fixed by immersion Paraplast sections (5-7 μιη) were cut on a rotary 
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microtome and mounted on poly-L-lysine coated slides After deparaffinization and rehydration, 
sections were blocked with 20% normal goat serum (NGS) in 0 S M Tns containing 0 9% NaCl (TBS) 
for 20 mm This and all subsequent incubations were at room temperature The blocking solution was 
replaced with primary antisera diluted 1 200 in TBS and sections were incubated overnight The next 
day, following three 5-min nnses in TBS, sections were incubated for 1 h with goat antirabbit IgG 
(Nordic Immunology, Tilburg, The Netherlands) diluted 1 150 in TBS Sections were rmsed as before m 
TBS and incubated for 1 h with rabbit peroxidase-antiperoxidase (Nordic Immunology) at a dilution of 
1 1000, and again rinsed in TBS Finally, sections were treated with 0 025% 3,3-diaminobenzidine, 
0 25% mckle ammonium sulphate and 0 01% hydrogen peroxide in 0 05 M Tns-HCl, pH 7 6 To check 
the specificity of staining, primary antiserum was incubated overnight at 4°C with an excess of antigen 
prior to incubating with sections The pre-immune serum was also used in control experiments to check 
the specificity of staining Nomenclature of Xenopus bram was accordmg to Neary and Northcutt 
(1983) 
RESULTS 
We have developed a screening approach to identify cDNAs in a Xenopus laevis 
pituitary library which encode novel proteins concerned with peptide hormone 
synthesis and release (Holthuis et al., 1995). Because of the nearly complete 
dedication of the NIL to production of the prohormone POMC, an early step in this 
strategy was to remove POMC cDNAs. To characterize the cDNAs remaining after 
this step, 110 cDNAs failing to hybridize with a POMC probe were randomly 
selected, sequenced, and subjected to homology searches of the GenBank/EMBL 
databases. During this evaluation, clone X7365 was identified by its homology to 
members of the EGF family. To isolate a full-length X7365 cDNA, a Xenopus laevis 
hypothalamus cDNA library was screened using the partial cDNA as a probe. This 
resulted in the identification of two full-length, overlapping cDNAs, which both 
encoded the complete X7365 protein (Fig. la). The cDNAs contained two in-frame 
stop codons preceding the starting methionine (Kozack, 1987) and an open reading 
frame of 1,110 nucleotides encoding a protein of 370 amino acids. The 3'-
untranslated region of 1,073 nucleotides ended with a poly(A) tail preceded by a 
polyadenylation signal. This region also contained five destabilizing ATTTA motifs, 
which are known to expedite degradation of lymphokine, cytokine and proto-
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S CGA 3 
OGOlTCCTCOGTSSCTOeJlCTCGJUWCGACTGCCTGCTTTTCCCTCTCCTTArr^ 134 
A*p Thr S e r S e r Arg « e t Vel « · * ЭТО 
GAT ACT TCT rCC CGC АТС CTG TAG СТТААСТтССССССП ТСТ[ГАтьі11П'АТАСТГАСАТПа^САТСТатет 1346 
TTTCAGAGGCCTTAITl l U 1 lATTATCAl 111311 lCtóC14A;iUUGCCAACAAAGAATOAOCACA<y^UraWTAGJa^l^-[ATAGAii;iTrt^l 11 IUI 1 ΓΙ Ι M 11 ΓΙ lAAATTCCTGTATTGGGAGCA 1477 
аиТГССТССАГ111Ш1^ЦГГТЦС17ГГАСАТАаТТОТААТСААААТАСААТ^^ 1«0β 
CTGACAlTriTrAATGOTACATAAACATOGAIIAATA'l Γ1 ІЪТТССАСТСССААТСТССАСАЛСіиі ТЬШІТТАТАССАТТАСАТтСТАСАСТАІПАППТМгаТАМ^ 1719 
ATTTAGTATAAACATCAAAACATAACATGGGACGGJtfHMTGAAATGATCACACACATTOgTGQATAAM 1870 
CATTAAACJUUlCACCTAAAGATAAATGGGAATAAaAAAACecraCAAA^ 2 0 0 1 
ATATCTCAATOTTITATAaAAATTAGTTJlCCJU^TTrTATT^ 21ЭЗ 
TGTOCCll11 ll^CATTTTATCAAgrAATGATCAATCAAGCAGAAGCAri-rriGOl'GlTAAACrAAGACairnTOTAA Г Π I'lAAGCACCTCCTAAA 2 2 6 3 
AAAATCCATATTTTAGCAAA^A^CTTGGCACCATGAAAAAAAAAAAAAAAA Ì 2 3 1 7 
Fig la. Nucleotide and deduced ammo acid sequence of X7365 In frame stop codons preceding the 
starting methionine are overlined Destabilizing ATTTA motifs are singly underlined The box indicates 
the potential transmembrane region A potential polyadenylation signal is doubly underlined 
Residue Posición 
Fig lb Hydropathy plot (K.yte and Doohttle, 1982) of the deduced X7365 protein 
SP, signal peptide, TM, transmembrane region 
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Fig le Schematic drawing of X7365 Numbers indicate amino acids beginning with starting 
methionine SP, signal peptide, TM, transmembrane region 
oncogene mRNAs (Shaw and Kamen, 1986). The deduced protein, with a calculated 
mass of 40,430 Da and a pi of 6.38, contained a predicted signal peptide (von Heijne, 
1986) and a transmembrane region, both of which are apparent in a hydropathy plot 
(Fig. lb). Salient features of the deduced protein are shown in a schematic diagram 
(Fig. lc). Alignment of X7365 with the mature forms of EGF, transforming growth 
factor-α (TGF-ct), amphiregulin (AR), betacellulin (BTC) and heparin-binding EGF 
(HB-EGF) clearly shows the similarity between X7365 and the transmembrane 
precursors that give rise to the EGF receptor ligands (Fig. 2). The overall levels of 
identity (36%-47%) and similarity (53%-64%) between the deduced X7365 protein 
and members of the EGF family over this domain are in the same range as established 
EGF receptor ligands. Furthermore, the six cysteines defining the mature EGF ligands 
are spaced identically in X736S and all members of this family. However, the 
substitution of arginine 41 in mature EGF by tyrosine 299 in X7365 excludes it from 
the group of EGF receptor ligands. Database searches also uncovered homology 
between two N-terminal domains in X7365 with three similar N-terminal domains in 
follistatin. A sequence alignment of these two modules in follistatin, agrin, 
osteonectin, TSC-36, SCI, and testican (Fig. 3) gives identity and similarity levels of 
30-37% and 43-50%, respectively. In addition, the 10 cysteines within the follistatin 
modules of these proteins have virtually the same spacing as those in the two N-
terminal domains of X7365. The tissue distribution of X7365 transcripts, assessed by 
northern blot analysis of poly(A)+ RNA isolated from Xenopus heart, lung, kidney, 
spleen, and brain showed a signal in only brain (Fig. 4). RNase protection assays on 
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Fig. 2. Comparison of the X7365 protein with EGF-family precursors. Alignments are based on the 
cysteines of the mature (i.e. cleaved) forms. For each protein, the number of the first amino acid in the 
figure, relative to the starting methionine, is given in parentheses after the name. Numbers in 
parentheses following the sequences of EGF and TGF-ot indicate the distance in amino acids to the 
carboxy-terminal. Numbers below the sequences correspond to the residues of mature EGF. The shaded 
box indicates transmembrane regions. Boxed residues are those identical to X7365 at a given position. 
Arrows inside ellipses indicate precursor cleavage sites. The amino-terminal cleavage site for 
amphiregulin lies outside the figure. Sequences were taken from GenBank accession numbers 
P01133(EGF), P01135(TGF-a), P15514(AR), Q05928(BTC) and Q99075(HB-EGF). 
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Fig. 3. Alignment of the X7365 protein with follistatin module-containing proteins based on cysteine 
residues within the follistatin modules. For each protein, numbers of the first and last amino acids in the 
figure, relative to the starting methionine, are given in parentheses. Boxed residues are those identical 
to the corresponding residue in either the first or second follistatin module of X7365. Sequences were 
taken from GenBank accession numbers P19883(follistatin), P25304(agrin), P07214(osteonectin), 
S51362(TSC-36), P24054(SC1) and X73608(testican). 
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Fig. 4. Northern blot analysis of X7365 
transcripts in 7.5 μg poly(A)+ RNA iso-lated 
from Xenopus lung (a), brain (b), heart (c), 
kidney (d), and liver (e). Following 
hybridization with a 451-bp double stranded 
random-primed X7365 cDNA probe and a l · 
wk exposure at -70°C, the blot was stripped 
and rehybridized with a Xenopus 
cytoskeletal actin RNA probe (lower panel) 
and autoradiographed for one week at -70°C. 
total RNA isolated from Xenopus liver, spleen, heart, skeletal muscle, ovary, NIL, 
PD and brain also indicated that expression was brain specific (data not shown). 
However, neither of these methods gave a clear signal in the NIL, from which X7365 
was cloned, leading us to employ RT-PCR because of its higher sensitivity. This 
technique revealed signals in brain, PD, NIL and optic nerve (Fig. 5). RT-PCR gave 
very low or no signal in heart, lung, spleen, ovary, and skeletal muscle, indicating 
that X7365 is enriched in neuroendocrine tissues. 
To evaluate the distribution of X7365 protein, antiserum was raised against a 
recombinant X7365 protein fragment expressed in E.coli. Staining of sagittal 
Xenopus brain sections showed immunopositive neurons almost exclusively in the 
diencephalon. In the preoptic area of the hypothalamus immunoreactivity was found 
in a discrete group of neurons in the magnocellular nucleus, visible in both coronal 
(Fig. 6a and b) and sagittal (Fig. 6d) sections. Specificity of the antiserum was verified 
by preabsorption with antigen before incubation with sections (Fig. 6c). From these 
immunopositive hypothalamic magnocellular neurons, fibers were seen running in a 
ventrocaudal direction, crossing the optic chiasm (Fig. 6h) and continuing their 
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Fig. 5. RT-PCR analysis of X7365 tissue distribution. cDNA was made from 1 μg of total RNA isolated 
from brain (lane a), PD (lane b), NIL (lane c), optic nerve (lane d), heart (lane e), lung (lane f), spleen 
(lane g), ovary (lane h), and skeletal muscle (lane i), and subjected to PCR amplification, as described in 
Materials and Methods. Loading was standardized according to the XODC content of each tissue. The 
X7365 signal was obtained with one-half the reaction volume used to generate the XODC signal. This 
analysis is valid only for relative comparisons. 
Fig. 6. Immunohistochemistry of X7365 in Xenopus brain and pituitary. 
a. Coronal section showing X7365 immunostaining in the magnocellular nucleus (Mg) and in axons 
projecting to the median eminance (me). Scale bar = 1 mm 
b. Higher magnification of section shown in a, which demonstrates that positive staining for X7365 
occurs only in selected magnocellular neurons. Scale bar = 100 μπι. 
c. Section adjacent to that shown in a and b and stained under identical conditions except for 
preincubation of the X7365 antiserum with antigen. Scale bar = 100 μηι. 
d. Sagittal section of brain showing immunostaining of X7365 in the magnocellular nucleus (Mg) and 
in axons projecting to the median eminence (me). Scale bar = 200 μηι. 
e. Sagittal pituitary section. Note the positive staining for X7365 in nerve terminals in the pars nervosa 
(pn). pi, pars intermedia Scale bar = 100 μηι. 
f. Higher magnification of an immunostained sagittal section proximal to that shown in e, demonstrating 
X7365 in the vicinity of only selected melanotropes in the pars intermedia. Scale bar = 20 μπι. 
g. Higher magnification of an immunostained section proximal to those shown in e and f, demonstrating 
X7365 in the PD. Scale bar = 20 μιη. 
h. Transverse section of optic nerve (on) showing positive staining for X7365 in the cytoplasm of 
astrocytes surrounding fascicles (arrows) in the optic nerve bundle, and in nerve fibers crossing the 
optic chiasma (oc). Scale bar = 50 μπι. 
i. Sagittal section showing X7365 immunostaining in the rostral-dorsal optic tectum. Scale bar = 50 μηι 
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course underneath the ventral infundibular nucleus and terminating in the median 
eminence and pars nervosa (Figs 6d and e). In addition to the staining in the 
perikarya and axons of the hypothalamic magnocellular nucleus, in some sagittal 
sections staining was visible in the NIL (Fig. 6f) and PD (Fig. 6g). It is unclear from 
the immunostaining in the NIL whether the signal occurs in nerve fibers projecting 
into the NIL or in melanotropes. Immunostaining was also present in the rostral 
optic tectum (Fig. 6i). In transverse sections through the optic nerve, staining was 
localized in astrocytes, projecting radially from the center of the nerve, surrounding 
fascicles (Fig. 6h). 
DISCUSSION 
We have cloned a new transmembrane protein from Xenopus NIL that is novel in 
two chief aspects: the first is the presence of a unique EGF-domain, and the second is 
the occurrence of follistatin domains in a transmembrane protein. 
EGF-domain ofX736S 
All EGF receptor ligands possess a consensus sequence of 36-40 amino acids that is 
defined as CX7CX4_5CX10.13CXCX8GXRC (where X is a residue other than C, G, or R; 
Carpenter and Wahl, 1990). When the arginine specified in the consensus sequence 
for EGF ligands (arginine 41) was mutated to histidine in human EGF, receptor 
affinity was reduced to 0.2% of wild-type EGF (Engler et al., 1990). The absence of 
the corresponding arginine in X7365 indicates that EGF receptor activation is 
probably not the primary function of this domain. X7365 may function as a 
receptor. The C-terminus of TGF-a was shown recently to be associated with three 
different kinases, suggesting that the precursor acts as a receptor (Shum et al., 1994). 
Similarly, the HB-EGF precursor is a receptor for the diptheria toxin (Naglich et al., 
1992). Comparison of the transmembrane and cytoplasmic domains of X7365 with 
its human homologue shows 98% amino acid sequence identity (D.W. Eib and G.J.M. 
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Martens, unpublished results), indicating that a more important function for this 
portion of the protein than simply anchorage. The alignment of X7365 with EGF 
family transmembrane precursors suggests that 
X7365 is cleaved extracellularly. In proEGF and proAR, cleavage occurs at peptide 
bonds following a single basic amino acid or at an alanine within a cluster of small, 
apolar residues in proTGF-oc (Massagué and Pandiella, 1993). A site closely 
resembling the C-terminal cleavage site in proAR (EK/S) is present at a similar 
position in X7365 (DK/T; see Fig. 2). Extracellular cleavage sites N-terminal from 
the mature EGF receptor ligand are less well defined among EGF family precursors, 
and no clear candidates are apparent in X7365. 
Follistatin modules ofX7365 
In follistatin, three highly conserved domains, each encoded by individual exons, 
occur in the N-terminal. At the intron-exon boundaries of the exons encoding these 
domains, the reading frame is interrupted after the first codon of the coding triplet. 
This allows these domains to be classified as class 1-1 modules (Patthy, 1991), which 
are susceptible to recombination with other class 1-1 modules, resulting in the 
formation of mosaic proteins. As predicted by modular exchange theory, follistatin 
modules have recently been described in several mosaic proteins, including agrin, 
osteonectin/SPARC, and SCI (Patthy and Nikolics, 1993). For unknown reasons, 
class 1-1 modules are also prone to tandem duplication (Patthy, 1991), as may be the 
case with X7365. Although the genomic sequence of X7365 remains to be 
determined, we believe the similarity of the follistatin motifs in X7365 to known 
follistatin modules is sufficient to warrant their designation as modules. 
The presence of follistatin modules in a mosaic protein is indicative of a role in the 
binding of molecules structurally related to TGF-ß. Follistatin itself binds the TGF-ß 
family members activin A and inhibin through the common ßA subunit (Shimanoka et 
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al., 1991). Osteonectin, which contains a single follistatin module, binds platelet 
derived growth factor (PDGF), which is structurally similar to TGF-ß, preventing 
PDGF receptor activation (Raines et al., 1992). The follistatin modules in agrin may 
also act in binding and thus creating local concentrations of TGF-ß family members 
in motor neurons and muscle (Patthy and Nikolics, 1993). In addition to binding 
activin-A, follistatin also has high affinity for heparin sulfate side chains of 
membrane proteoglycans (Nakamura et al., 1991). Through the combination of 
affinity for both components of the extracellular matrix and activin, follistatin is 
believed to immobilize activin to create concentrations or gradients for purposes of 
localized growth promotion. The functional characteristics of these follistatin 
module-containing proteins seem likely to be present ОТ some extent in X7365. 
Whether or not X7365 is cleaved to yield soluble follistatin domain(s), it may also 
act in the immobilization of TGF-ß-like factors in a process similar to that described 
for follistatin itself. As mentioned previously, X7365 may also function in 
transmembrane signal transduction. This could involve the follistatin modules as well 
as the EGF domain. 
Expression ofX736S 
The expression of X7365 in the hypothalamic-pituitary axis is largely consistent 
with that of messengers stimulating secretion from the anterior lobe of the pituitary, 
such as CRH and TRH, or from peripheral organs, as is the case with mesotocin and 
vasotocin. The presence of X7365 immunostaining in a discrete group of neurons in 
the magnocellular nucleus, together with its absence in nuclei known to inhibit 
pituitary secretion, suggests that X7365 is involved with the modulation of a specific 
group of stimulatory messengers. In addition to its presence in the hypothalamus and 
its projections to the pituitary, immunohistological studies and RT-PCR showed that 
X7365 is present in the PD, where it probably has a function similar that in the 
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magnocellular neurons. X7365 was also detected in the optic nerve, suggesting that it 
may have other roles, possibly in axonal growth or survival. Magnocellular neurons 
convert the stimulatory signal of activins in the ventricular liquor into increased 
neuroendocrine secretion (Sawchenko et al., 1988; Plotsky et al., 1991). The 
transmembrane structure and the follistatin modules of X7365, together with its 
expression in the hypothalamic magnocellular nucleus, make it an enticing candidate 
for a participant in this process. Activins also influence the secretion of several 
hormones from the PD (Kitaoka et al., 1988), making it possible that X7365 serves 
a similar function in this lobe of the pituitary. The contribution that the X7365 EGF 
domain might make to a role in the regulation of neuroendocrine secretion from 
either of these two locations is difficult to estimate. Although probably not a ligand 
for the EGF receptor, the similarity of X7365 EGF domain to established mitogens, 
together with the expression of X7365 in non-endocrine tissues, such as optic nerve, 
suggests instead that X7365 may have additional functions, possibly in axonal growth 
or maintenance. 
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Cloning and expression of M7365, a novel type I transmembrane 
protein with EGF and follistatin modules, in mouse brain 
Chapter 2 
ABSTRACT 
We recently described the cloning and expression of the novel X7365 protein in the 
hypothalamo-hypophysial axis of Xenopus Iaevis. This protein, enriched in Xenopus 
neuroendocrine tissues, is similar to precursors of epidermal growth factor (EGF) 
receptor ligands, and is the first transmembrane protein with follistatin modules. The 
EGF-like domain is unique in that it differs from the consensus sequence for EGF-
receptor ligands solely by the presence of a tyrosine in place of the crucial arginine 
41. Here we report the cloning of the mouse 7365 homolog (M7365) and analysis of 
M7365 expression in mouse brain and hypophysis. M7365 is highly conserved 
relative to X7365, is expressed in the hypothalamic pre- and supraoptic nuclei and 
their projections to the neural lobe, and is enriched in neuroendocrine tissues. 
M736S, however, is also present in the olfactory lobe, hippocampus and cerebellum, 
a partem of expression that overlaps with that of the erbB-family receptor ligands 
neuregulin-1, -2 and Don-l. The presence of M7365 in hippocampus and olfactory 
lobe of 6-wk-old mice suggests that it may participate in neurogenesis, which is 
largely confined to these areas in the postnatal rodent brain. 
D W Eib1, N Dewulf\ D Huylebroeck2 and G J M Martens' 
'Department of Molecular Animal Physiology, University of Nijmegen, Toemooiveld 1, 6525 ED 
Nijmegen, The Netherlands 
2CELGEN, University of Leuven and Flanders Interumversity Institute for Biotechnology, Herestraat 
49, 3000 Leuven, Belgium 
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INTRODUCTION 
We recently described the cloning of a novel, type I transmembrane protein from 
Xenopus hypophysis, currently designated X7365 (Eib and Martens, 1996). The 
function of X7365 is unknown but its primary structure resembles precursors of 
ligands for the erbB-family of receptors, which include the epidermal growth factor 
receptor (EGFR/erbB-1), neu (erbB-2/HERl), erbB-3 (HER-3) and erbB-4 (HER-4). 
Although similar to the precursors of EGF-family hormones, X7365 is unique in two 
respects: it is the first transmembrane protein with follistatin modules, and it has an 
EGF-like domain that meets all criteria specified by the consensus sequence for 
binding and activation of the EGFR (reviewed by Carpenter and Wahl, 1990) except 
for the presence of a tyrosine in place of the arginine specified at position 41 
(numbering refers to mature EGF; Eib and Martens, 1996). Follistatin modules have 
been described in a number of secreted proteins, such as osteonectin, agrin, SCI, and 
follistatin itself (Patthy and Nikolics, 1993; Hemmanti-Brivanlou et al., 1994) that 
have been implicated in adhesion (Sugino et al., 1993) and anti-adhesion (Sage et al., 
1989) of cells to the extracellular matrix (ECM). Follistatin, as well as follistatin-
module containing proteins, also bind certain transforming growth factor-ß (TGF-ß) 
superfamily members (Nakamura et al., 1990; Raines et al., 1992; Yamashita et al., 
1995), a property attributed to a structural fold contained within follistatin modules 
(Patthy and Nikolics, 1993). The inhibition of receptor binding, and the creation of 
local concentrations resulting from these interactions, represent one of the 
mechanisms contributing to the regulation of the TGF-ß superfamily activity 
(Patthy and Nikolics, 1993; Sugino et al., 1993; de Winter et al., 1996; Hashimoto et 
al., 1997). In Xenopus, X7365 is expressed predominantly in neuroendocrine tissues; 
in Xenopus brain, it is largely confined to a discrete group of hypothalamic 
magnocellular neurons and their axonal projections to the hypophysial neural lobe 
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(Eib and Martens, 1996). Studies of erbB-family receptors and their ligands have 
shown that they are often expressed in areas of the mammalian brain that are poorly 
developed in amphibians, such as the cerebellum and hippocampus (Marchionni et al., 
1993; Chang et al., 1997; Busfieldet al., 1997). To characterize the expression of 
7365 in mammalian brain, we cloned the mouse homolog of 7365 (M7365) from a 
mouse brain cDNA library, compared its primary structure with the Xenopus 
homolog, and examined expression of M7365 transcripts and protein in mouse brain 
and hypophysis. 
MATERIALS AND METHODS 
cDNA Probes 
A 918 bp, EcoRA-EcoRl fragment (nucleotides 118-1031) of the protein coding region ofH7365 was 
used to generate the probe used for screening the mouse brain cDNA library and for Southern blot 
analysis of positively hybridizing clones For m situ hybridization analysis of mouse bram and 
hypophysis, two different M736S probes were used Probe A was synthesized from an 800 bp EcoKl-
EcoJti fragment of M736S, encompassing the entire protein coding region, and probe В was 
synthesized from an 800 bp Xba\-Xho\ fragment of the З'-untranslated region (UTR) Radiolabeled [cc-
3ÎS]UTP (Amersham) RNA probes were prepared by m vitro translation using T7 RNA polymerase and 
linearized templates RNA probes were subjected to limited hydrolysis, such that an average length of 
350 nucleotides was obtained, as estimated by denaturing agarose gel electrophoresis (Sambrook et al, 
1989) For Northern blot analysis, probe A was labeled by random oligonucleotide pruning with [o> 
'2P]ATP (Amersham), according to standard procedures (Sambrook et al, 1989) 
Antisera 
For immunohistochemistry, two polyclonal antisera were raised in rabbits the antisera recognizing the 
EGF-like domain of human 7365 (A59) has been described previously (Eib and Martens, 1996) 
Antiserum B73, which recognizes the cytoplasmic region of 7365, was raised agamst a synthetic 
peptide (CLGHFTSDTSSRM) comprised of the penultimate twelve C-terminal ammo acids of H7365, 
with a cysteine placed at the N-terminus of the peptide to allow coupling to hemocyanin, which was 
used as a earner during immunization 
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Isolation of Mouse 7365 cDNA Clones 
Approximately 3 χ 10s plaques of an ohgo(dT)-pnmed, C57 adult mouse bram cDNA library, 
constructed m λ ZAP XR (Stratagene, La Jolla, CA) on duplicate filters, were hybridized with a random 
pruned, [a-32P]dATP labeled H7365 probe (see above) according to standard procedures (Sambrook et 
al, 1989) Hybridization was performed overnight at 42°C m 6X saline-sodium citrate (SSC, IX SSC is 
15 mM sodium citrate and 150 mM NaCl), 0 5% sodium dodecyl sulfate (SDS), 0 1% pyrophosphate, 40 
mM sodium phosphate, pH 7 0, 1 mM EDTA, 25% formarmele and 0 1 mg/ml denatured herring sperm 
DNA Filters were washed to a final stringency of 60°C, 0 1 X SSC, 0 1% SDS, 1 mM EDTA and were 
autoradiographed 2 days at -70°C with two intensifying screens 
Northern Blot Analysis 
Total RNA was isolated from brains of 6-wk-old mice using Tnzol reagent (Gibco, Breda, The 
Netherlands), according to the manufacturers instructions, and 15 μg was fractionated on a 1 2% 
agarose MOPS-formaldehyde gel and transferred to a nitrocellulose filter (Schleicher and Schuell, 
Dassel, Germany) After baking for 2 h at 80°C, the blot was prehybndized in 6 X SSPE, 50% 
formamide, 5 X Denhardt's solution, 0 5% SDS and 0 1 mg/ml denatured herring sperm at 42°C for 2 h 
The filter was subsequently hybridized overnight in the same solution containing approximately 1 X 
10s cpm/ml of random pruned [ct-32P]ATP labeled probe A (see above) The following day, the filter was 
washed to a final stringency of 0 25 X SSPE, 0 1% SDS, 65°C, and autoradiographed for 1 wk at -70°C 
with two intensifying screens 
Reverse Transcription-Polymerase Chain Reaction 
Total RNA was isolated from bram, neurointermediate lobe (NIL), pars distahs (PD), heart, liver, 
kidney, pancreas, spleen, ovary, testis and skeletal muscle of 8-wk-old mice usmg Tnzol reagent, 
according to the manufacturer's instructions, and 1 μg was processed for cDNA in the presence or 
absence of reverse transcriptase (Gibco), using random hexanucleotide primers Four percent of the 
resulting cDNA was then used m each set of primer reactions Primer sequences were 5'-CTAAGATCT 
ATCGGAAGCCACATGCCTTGC-3' (M7365-5'), 5'-ACCCTCGAGCTAGAGAATACTAAAGTCCGT 
CTT-3' (M7365-3'), 5'-TACTCCTGCTTGCTGATCCACAT-3' (mouse ß-actin-5'), and 5'-CGGGACCTG 
ACWGACTACCTCATG-3' (mouse ß-actin-Э') The reaction consisted of 30 cycles of 1 mm each at 
94°C (melting), 52CC (annealing), and 72CC (elongation) Each reaction contained 5 μΐ of 10X Taq 
buffer, 250 nM 5' and 3' primers, 2 μΐ of the reverse transcriptase reaction, 8 μΐ of 1 25 mM NTPs, and 0 5 
units of Taq polymerase (Pharmacia, Uppsala, Sweden) diluted to 50 μΐ with double distilled water 
Reaction products were visualized on 1 2 % ethidium bromide-stained agarose gels 
DNA Sequence Analysis 
Positively hybridizing pBluescnpt phagemids from the mouse bram cDNA library were excised in 
vivo according to the manufacturers instructions (Stratagene) and used to prepare double stranded 
DNA Insert size was determined by PvuU digests, and approximately 0 5 μ§ of plasmid DNA was 
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fractionated on 1 2% agarose gels Gels were fixed in 0 4 M NaOH, 0 8 M NaCl for 30 mm at room 
temperature and then neutralized for 30 min at 0°C in 0 5 M Tns-HCl (pH 7 5), 1 5 M NaCl After drying 
under vacuum at 60°C for 2 h, gels were prehybndized in 0 5 M pyrophosphate, 7% SDS and 0 1 mg/ml 
hemng sperm DNA The dried gels were then hybridized overnight at 65°C m the same solution 
containing approximately 1 X 106 cpm of a random pruned, [a-32P]ATP H7365 probe (see above) The 
following day, the gel was washed to a final stringency of 0 OS M pyrophosphate, 0 5% SDS, 50°C, and 
autoradiographed for 2-6 h Clones with the largest inserts were sequenced in both directions with an 
ABI PRISM 310 automatic sequencer (Perlon Elmer, Philadelphia, PA) using T7 and internal primers 
Sequences were analyzed using the University of Nijmegen CAOS/CAMM computer system 
In Situ Hybridization Analysis 
Brains of6-wk-old mice were exsanguinated by transcardial perfusion with 0 9% saline for IS mm, 
followed by 4% paraformaldehyde in PBS for 30 nun Following dissection, both brains and 
hypophyses were immersion fixed in the same solution for 12 h and washed for 24 h in three changes of 
PBS After dehydration and embedding, S μπι sections were cut on a rotary microtome and mounted on 
superfrost slides (Pharmacia) treated with 3-aminopropyltnethosyxilane The remainder of the procedure 
has been described previously (Wilkinson and Green, 1990) Briefly, after treatment with 30 mg/ml 
proteinase-K and 0 25% (vol/vol) acetic anhydride, sections were mcubated with probe dissolved in 
50% formamide, SX SSC for 16 h at SS°C in a moist chamber Slides were sequentially washed in S X 
SSC, 10 mM dithiothreitol (DTT) until coverslips detached, 50% formamide, 2 X SSC, 10 mM DTT for 35 
mm, followed by 5 washes, each 10 mm, m 10 mM Tns-HCl, 0 5 M NaCl, 5 mM EDTA (TNE), 37°C, and 
treated with 20 mg nbonuclease-A/ml (in TNE) at 37°C for 35 nun Ribonuclease was removed with a 
TNE nnse and the high stringency wash (50% formamide-2 X SSC, 65°C) was repeated, followed by 15 
mm washes m 2 X SSC, 50°C, and 0 1 X SSC, 25°C Sections were then dehydrated through a graded 
ethanol senes containing 300 mM ammonium acetate, and air dried Sections were autoradiographed 
with Ilford K5 photo emulsion (Ilford, Moberly, UK) diluted 1 1 with 2% glycerol After drying, 
sections were exposed at 4°C for 2-3 wk in a light-safe box containing silica gel Development was with 
Kodak D19 developer (Kodak, Rochester, NY) and thereafter, sections were fixed with UNIFIX 
(Kodak), counterstained with hematoxylin and photographed with a Leica Vano Orthomat camera 
system (Leica, Wetzlar, Germany) mounted on a Leica DM RB/E microscope equipped with bright- and 
dark-field illumination and Leica Fluotar objectives Unrelated probes hybndized under identical 
conditions were used as controls (data not shown) 
Immun о his toe he mis try 
For lmmunohistochemistry, perfusion, fixation and embedding were as desenbed above, except that 
Bourn's solution was substituted for 4% paraformaldehyde Tissue was sectioned as desenbed above, 
but sections were mounted on gelatm coated slides Following deparaffinization and rehydration, non­
specific staining was blocked with 20% normal goat serum, 3% BSA (Serva, Heidelberg, Germany) in 
50 mM Tns-HCl, pH 7 4, 0 9% NaCl, 0 1% Tnton X-100 (TBS-T) for 1 h This and all subsequent 
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incubations were earned out at room temperature in a moist chamber Incubations with primary antisera 
diluted 1 200 in blocking solution were overnight The following day, sections were washed three 
tunes, 5 mm each, in TBS-T, and biotinylated goat anti-rabbit (Kirkegaard and Perry, Gaithersburg, 
MD) diluted 1 200 in TBS-T was applied for 1 h Following three, 5-min TBS-T washes, horseradish 
peroxidase conjugated streptavidin (Kirkegaard and Perry) diluted 1 1000 m TBS-T was applied, again 
for 1 h After the TBS-T washes, sections were nnsed twice in ТВ (50 mM Tns-HCl, pH 7 4, 0 9% NaCl) 
for S mm each Finally, sections were treated with 0 025% 3,3-diaminobenzidine, 0 025% nickle 
ammonium sulfate 0 01% hydrogen peroxide m 0 05 M Tns-HCl, pH 7 6 To check the specificity of 
staining, immune serum (both Л59 and B73) was replaced with preimmune serum and antiserum (A59 
only) was incubated overnight at 4°C with an excess of antigen prior to application to sections 
RESULTS 
Cloning and Sequence Analysis of an M7365 cDNA 
Of the approximately 3 X 106 plaques that were screened from the mouse brain 
cDNA library, 18 were positive on duplicate sets of filters. These were subjected to in 
vivo excision and Pvull restriction digests to determine insert size. Southern blot 
analysis was performed on Pvull as well as Rsal digests (data not shown) and clones 
with the largest, positively-hybridizing inserts were sequenced. Clone Ml-2a was 
found to be nearly full-length, and, as our primary motive in obtaining a M7365 
clone was analysis of the predicted amino acid sequence and determination of tissue 
distribution by Northern blot and in situ hybridization analyses, we elected not to 
search further for a cDNA containing additional amino-terminal coding sequence. 
Clone Ml-2a, approximately 2.2 kb in length, contained a 1056 bp open reading 
frame encoding a protein of 352 amino acids. Alignment of the deduced protein 
encoded by Ml-2a with the deduced H7365 and X7365 proteins shows that this is the 
mouse 7365 homolog (Fig. 1). All of the characteristic features of 7365 are present 
in the deduced protein, including the two follistatin modules, the EGF-like and 
transmembrane domains, and the short cytoplasmic region. Cysteine residues are 
conserved throughout the entire protein, and overall, M7365 shows a remarkable 
degree of conservation with H7365 (92% identity and 94% similarity). The EGF-like 
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Fig. 1. Sequence alignment of the deduced human, mouse and Xenopus 7365 proteins. SP, presumptive 
signal peptide; FS, follistatin module; EGF, EGF-like domain; TM, transmembrane region. Asterisk 
indicates the residue equivalent to arginine 41 in mature EGF. Sequences were taken fiom GenBank 
accession numbers U19879 (X7365) and U19878 (H7365). 
domain of M7365 is identical to that of H7365, and contains a histidine residue at 
the position equivalent to arginine 41 in mature EGF. The second follistatin module 
is also identical between the mouse and human homologs, while the first follistatin 
module has two conservative substitutions. As expected, the homology between 
M7365 and X7365 (71% identity and 82% similarity) is lower than between the 
mouse and human 7365 homologs. Comparison of M7365 with X7365 shows that 
the EGF-like domains are 80% identical and 91% similar, the first follistatin module 
is 88% identical and 93% similar, and the second follistatin module is 76% identical 
and 88% similar. There are also two pairs of basic amino acid residues, conserved 
among all three homologs, that may be potential processing sites: Arg97-Arg98, 
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located between the eighth and ninth cysteine residues of the first follistatin module 
and Lys218-Lys219, situated between the EGF-like domain and second follistatin 
module. A third dibasic pair, Arg334-Arg335, present in the cytoplasmic region, is also 
conserved, but unlikely to be a cleavage site for any known prohormone convertase. 
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) 
RT-PCR analysis of a variety of tissues from 6-wk-old mice revealed that brain, pars 
distalis (PD), neurointermediate lobe (NIL), pancreas, ovary, and testis expressed 
detectable levels of M7365 (Fig. 2). Heart, kidney, liver, spleen and skeletal muscle 
were negative for M7365 RNA. As with X7365, M7365 is enriched in 
neuroendocrine tissues, and brain from both Xenopus and mouse was the richest 
source of 7365. In mouse, the PD gave a stronger signal than the NIL, while in 
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Fig. 2. RT-PCR analysis of M7365 tissue distribution. cDNA made from 1 μξ of total RNA, isolated 
from the designated tissue, was subjected to PCR amplification with M7365 and mouse ß-actin primer 
sets, as described in Materials and Methods. This analysis is valid only for relative comparisons. 
51 
Chapter 2 
Northern Blot Analysis 
Northern blot analysis of total RNA from mouse brain revealed a single band of 
approximately 2.3 kb (Fig. 3) that is close to the estimated size of cDNA clone Ml-
2a. This is somewhat smaller than the X7365 transcript seen in Northern blots of 
Xenopus brain (Eib and Martens, 1996). No evidence of multiple transcripts was 
found, even when blots were autoradiographed for 6 wk (data not shown). In contrast 
to Northern blots of Xenopus brain, where the X7365 transcript is just visible in a 
lane containing 7.5 μg of poly(A)+ RNA (Eib and Martens, 1996), the M7365 
transcript was clearly visible in a 15 μg sample of total mouse brain RNA, indicating 
that 7365 expression is substantially higher in mouse brain. 
Fig. 3. Northern blot analysis of M7365 in 
IS Hg of total RNA isolated from mouse 
brain. Following hybridization with a 800-
bp double stranded, random primed probe 
encompassing nearly the entire exodomain of 
M736S, the blot was autoradiographed for 1 
wk at -70°C. 
In Situ Hybridization Analysis 
Using probes encompassing the protein coding (probe A) and З'-untranslated region 
(probe B) of M7365, expression of M7365 RNA was analyzed in sections of mouse 
brain and pituitary by in situ hybridization analysis. The distribution of signals 
obtained with both probes was identical, but probe A gave a stronger signal. In 
agreement with the expression of X7365 observed in Xenopus brain (Eib and 
Martens, 1996), in situ hybridization of mouse brain and hypophysis showed high 
concentrations of silver grains over the supraoptic, lateral preoptic and 
magnocellular preoptic nuclei (Fig. 4a, and data not shown), which are homologous to 
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Fig. 4. In situ hybridization analysis of M7365 expression in mouse brain. 
a: Sagittal section through medial forebrain. so, supraoptic nucleus; lpo, lateral preoptic nucleus; oc, 
optic chiasma. Scale bar = 100 μπι. 
b: Coronal section of hypophysis, pn, pars nervosa; pi, pars intermedia; pd, pars distalis. 
Scale bar = 50 μπι. 
с: Sagittal section of cerebellum, pel, Purkinje cell layer; gel, granular cell layer. Scale bar = 50 μπι. 
d: Sagittal section through mesencephalic trigeminal nucleus. 4v, fourth ventricle; MeTg, mesen­
cephalic trigeminal nucleus. Scale bar = 50 μπι. 
e: Sagittal section through hippocampus. CA1-CA4, CA1-CA4 fields of Amnion's horn; DG, dentate 
gyrus. Scale bar = 100 μπι 
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the hypothalamic magnocellular nucleus in Xenopus (Goos, 1978). The hypophysis 
gave the most intense signal around the dorsal-lateral periphery of the PD (Fig. 4b). 
The extreme ventral portions of the pars intermedia (PI) were also positive, while 
the pars nervosa (PN) showed virtually no silver grains above background levels. 
Outside the hypothalamo-hypophysial axis, silver grains were concentrated over the 
glial matter and Purkinje cell layers in the lobules of the cerebellum (Fig. 4c). The 
trigeminal area, adjacent to the cerebellum, was also positive (Fig. 4d). In the 
hippocampus, all areas of Ammon's Horn and the dentate gyrus hybridized with the 
probe, with more intense signals in regions of the CAI and CA4 fields (Fig. 4e). 
Immunohistocltemlstry 
The distribution of M7365 protein was investigated with antiserum A59, directed 
against the EGF-like domain of H7365, and antiserum B73, raised against a peptide 
corresponding to the cytoplasmic domain of H7365. As mentioned above, the EGF-
like domain of M7365 is identical to that of H7365, eliminating concerns of species-
specificity with antiserum A59. Similarly, the cytoplasmic domains of M7365 differs 
Fig S Immunohistocbemical staining of M7365 in mouse brain and hypophysis 
a Sagittal section corresponding to Fig 4a stained with antiserum B73 so, supraoptic nucleus, oc, 
optic chiasma. Scale bar = 100 ц т 
b Coronal section through hypophysis corresponding to Fig 5b stained with antiserum A59 pn, pars 
nervosa, pi, pars intermedia, pd, pars distahs Scale bar = 100 ц т 
с Coronal section through hypophysis corresponding to Figs 4b and Sb, stained with antiserum B73 
pn, pars nervosa, pi, pars intermedia, pd, pars distahs Scale bar = 100 ц т 
d Sagittal section through cerebellum stained with antiserum B73 pel, Purkinje cell layer, gel, 
granular cell layer Scale bar = 100 ц т 
e Sagittal section through cerebellum corresponding to Fig 5d, stained with antiserum AS9 pel, 
Purkinje cell layer, gel, granular cell layer Scale bar = 100 ц т 
f Higher magnification of section depicted m Fig 5d Scale bar - 50 ц т 
g Higher magnification of section depicted m Fig 5e Scale bar = 50 ц т 
h Section adjacent to that depicted m Fig 5e stained with preabsorbed antiserum A59 
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Fig. 5. Immunohistochemical staining of M7365 in mouse brain and hypophysis (continued). 
i: Sagittal section through hippocampus corresponding to Fig. 4e, stained with antiserum A59. CA 1 -
CA4, CA1-CA4 fields of Amnion's Horn; DG, dentate gyrus. Scale bar - 100 μπι. 
j : Section similar to that depicted in Fig. 5i stained with preimmune serum. Scale bar = 100 μηι. 
к: Sagittal section through the mesencephalic trigeminal nucleus (MeTg), coresponding to Fig. 4d, 
stained with A59. Scale bar = 50 μηι. 
1: Sagittal section through the pyramidal tract stained with antiserum B73. py, pyramidal tract; tz, 
trapezoid body. Scale bar = 100 μηι. 
m; Sagittal section through the olfactory bulb stained with antiserum B73. mcl, mitral cell layer; eel, 
external plexiform layer; gel, granule cell layer. Scale bar = 50 μηι. 
η: Sagittal section through the olfactory bulb stained with antiserum A59. mcl, mitral cell layer; eel, 
external plexiform layer; gel, granule cell layer. Scale bar = 50 μηι. 
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by only a single conservative amino acid substitution from H736S, making it unlikely 
that antiserum B73 is species specific. Both antisera recognized their corresponding 
recombinant antigen on immunoblots and in ELISA analyses, and specifically labeled 
COS-1 cells transiently transfected with a construct encoding full-length X7365, or 
immunoprecipitated a reticulocyte-translation product of approximately 42 kDa, in 
agreement with the mass of the deduced protein (data not shown). We are currently 
conducting metabolic labeling studies with 7365-producing cells to clarify its 
biosynthesis and processing. In the hypothalamo-hypophysial axis, staining was 
observed with A59 and B73 in the pre-, supra- and lateral preoptic nuclei, the 
magnocellular preoptic nucleus, and their projections into the median eminence (Fig. 
5a and data not shown). Using A59, a discrete population of cells in the PD, 
generally located more towards the periphery of the lobe, were immunopositive (Fig. 
5b). The PN was negative with A59 and the PI showed only a weak, diffuse staining 
except for discrete regions along the extreme ventral margin. This staining pattern is 
in good agreement with the in situ hybridization signal seen in PD. B73 gave a 
pattern of staining in the PD that was similar to, but more extensive than, that 
obtained with A59 (Fig. 5c), with the exception that nerve terminals in the PN were 
strongly stained. No staining was apparent in the PI with B73. In the cerebellum, glial 
matter in the lobules was immunopositive for B73 (Fig. 5d) but stained very weakly 
with A59 (Fig. 5e). In Purkinje cells, B73 gave a punctate, perinuclear staining (Fig. 
5f) while A59 stained both the Purkinje cell dendrites and the perinuclear region (Fig. 
5g). Preabsorption of A59 with antigen largely ablated staining in the cerebellum 
(Fig. 5f) and throughout the brain (data not shown). A59 stained nerve fibers in the 
CA1-CA4 and regions of Amnion's hom, and the dentate gyrus of the hippocampus 
(Fig. 5i). Although the CAI field gave a strong signal with in situ hybridization, 
immunostaining in this field was weak, indicating that M7365 protein has been 
transported to the dendrites of the CAI neurons. Substitution of the A59 antiserum 
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with preimmune serum virtually eliminated this staining (Fig. 5j), as well as staining 
throughout the brain (data not shown). No staining was detected in the hippocampus 
using B73 (data not shown). A59 gave staining in the perinuclear cytoplasm and 
axons of neurons in the mesencephalic trigeminal nucleus (Fig. 5k), but B73 was 
negative in this area (data not shown), and the pyramidal tract showed intense 
staining only with B73 (Fig. 51). The external plexiform layer of the olfactory lobe 
gave a signal with only A59 (Fig. 5m), while B73 stained only the granule cell layer 
(Fig. 5n). 
DISCUSSION 
Sequence Analysis ofM7365 cDNA 
The cloning of M7365 and comparison of the deduced protein with the Xenopus and 
human homologs illustrates the high degree of conservation that exists among 7365 
from various species. As expected, M7365 is clearly more similar to H7365 than to 
X7365; the EGF-like domain is identical in the mouse and human homologs, and the 
cytoplasmic, transmembrane and region have only a single conserved amino acid 
substitution. Within the EGF-like domain, the residue at the position equivalent to 
arginine 41 in mature EGF is a histidine in M7365, as it is in H7365. The significance 
of this replacement, which in human EGF results in an EGFR ligand with less than 
0.2% of wild type affinity for the EGFR (Hommel et al., 1991), remains unclear. 
Preliminary studies with recombinant H7365 EGF-like domain have failed to show 
that it stimulates phosphorylation of any of the erbB-family receptors (D.W. Eib and 
DJ. Riese II, unpublished results), suggesting that 7365 may act in concert with other 
erbB ligands, or that it is a ligand for an unknown receptor. 
The follistatin modules are also well conserved among the 7365 homologs; of the 67 
amino acids in the first follistatin module there are only two conservative 
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substitutions between M7365 and H7365, and two conservative and six 
nonconservative substitutions between M7365 and X7365. The 66 amino acids 
comprising the second follistatin module are identical in the two mammalian 
homologs, while the same region has undergone seven conservative and nine 
nonconservative substitutions between Xenopus and mouse. It has been proposed that 
these modules bind growth factors of the TGF-ß family (Patthy and Nikolics, 1993), 
however, with the exception of osteonectin (Raines et al., 1992), among proteins 
containing follistatin modules, this property has been demonstrated only for 
follistatin itself (Nakamura et al., 1990; Yamashita et al., 1995; de Winter et al., 
1996; Hashimoto et al., 1997). An alternative function for the follistatin modules in 
7365 may be related to the affinity of follistatin for heparan sulfate proteoglycan 
(HSPG) in the extracellular matrix (ECM) and on the surface of cells (Sugino et al., 
1992). The combination of an EGF-like domain with an heparan sulfate 
proteoglycan binding domain in the same protein has been observed previously in 
ARIA (acetylcholine receptor-inducing activity), a splicing variant of the 
neuregulins, known also as gp30, heregulin, glial growth factor, and neu 
differentiation factor (Corfas et al., 1995). The exodomain of the transmembrane 
ARIA precursor is cleaved to release a soluble polypeptide containing the 
immunoglobulin module, responsible for the HSPG affinity of ARIA, and an EGF-like 
domain that activates erbB2 (Loeb and Fischbach, 1995). The released fragment 
binds to HSPGs in the ECM, from where the mature ligand is released by an 
unspecified protease. A similar model can be envisioned for the extracellular domain 
of 7365, with the substitution of the immunoglobulin by the follistatin modules. A 
third conserved feature of all 7365 homologs are the two pairs of basic amino acids 
that may be proteolytic processing sites. Processing of the transmembrane precursors 
of erbB-family ligands at a Lys-Arg site between the EGF-like and transmembrane 
domain of neuregulin-2ß has recently been suggested (Chang et al., 1997). A Lys-Arg 
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site is present at the identical position in several of the neuregulins and analysis of 
neu differentiation factor has shown that its precursor is cleaved intracellularly, prior 
to arrival at the plasma membrane (Burgess et al., 1995). Together, these 
observations indicate that proteolytic processing of ligands for erbB-family 
hormones occurs at sites besides those recognized by elastase-like enzymes (reviewed 
by Massagué, 1990), and hints that the conserved dibasic residues in the heregulins, as 
well as 7365, may be recognition sites for intracellular cleavage. 
Expression ofM7365 
The tissue distribution of M7365 in mouse reflects that of X7365 in Xenopus; 
expression is enriched in neuroendocrine tissues with brain being the richest source of 
M7365 RNA. The observation of M7365 expression in mouse pancreas and, to a 
lesser extent, ovary and testis, further illustrates the link between 7365 and a 
neuroendocrine phenotype. The level of expression of M7365 in mouse ovary 
exceeds that of X7365 in Xenopus ovary, which is just detectable with RT-PCR, and 
may reflect the more intimate relationship of the ovary and oocyte or embryo in 
mammals. In mouse brain, the presence of M7365 in the pre-, medial and supraoptic, 
as well as the magnocellular nuclei in the hypothalamus, together with its expression 
in the median eminence and hypophysis, correlates directly with the distribution of 
X7365 in the hypothalamo-hypophysial axis of Xenopus. An exception is the higher 
expression of M7365 in mouse pars distalis than of X7365 in pars distalis of 
Xenopus. Again, this may result from differences in the role of this lobe in mammals 
and amphibians. Results of Northern blots of Xenopus and mouse brain show that 
expression of 7365 is substantially higher in the mouse brain. This likely reflects the 
more highly evolved state of the rodent brain, particularly of structures such as the 
cerebellum, which we have shown to contain high levels of 7365. Immunostaining 
results obtained with antisera directed against the cytoplasmic and exodomains of 
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7365 are in good agreement with results of in situ hybridization analysis. This is 
obvious in the hypothalamo-hypophysial axis and in the cerebellum. Comparison of 
staining with A59 and B73 in the same regions of the brain suggests that either the 
epitopes recognized by these antibodies are in some cases either blocked, possibly by 
interactions with other proteins, or that following proteolytic processing, the 
extracellular, transmembrane and cytoplasmic domains of M736S are differentially 
located. The best example of this is the presence of B73 immunoreactivity in the 
pars nervosa, where A59 gives no staining (Figs. 5b and 5c), suggesting that the 
extracellular domain of M7365 is released after the protein arrives at nerve terminals 
in the pars nervosa following transport from the hypothalamic supraoptic nucleus. 
The immunoreactivity of the supraoptic nucleus and median eminence for both A59 
and B73 indicate that M7365 is intact while in transit from the hypothalamus, 
further supporting this theory. Interaction of M7365 with an epitope-blocking 
protein is suggested by the differential immunostaining observed in the cerebellum. 
The punctate, perinuclear staining obtained with B73 in Purkinje cells in the 
cerebellum is also found with A59, however A59 gives strong staining in Purkinje cell 
dendrites that is not found with B73. This hints that the C-terminal of M7365 
expressed on the cell surface of Purkinje cell dendrites may be bound to other 
proteins. Alternatively, cleavage of the cytoplasmic region could also explain this 
observation. 
The expression of M7365 gene products in the cerebellum and hippocampus overlaps 
with that of two recently isolated genes that encode hormones for erbB-family 
receptors. Don-] (Divergent of neuregulin-1), which stimulates erbB-2, erbB-3 and 
erbB-4 (Busfield et al., 1997), and neuregulin-2, a ligand interacting with erbB-3 and 
erbB-4 receptors (Chang et al., 1997), are both expressed in the cerebellar Purkinje 
cell- and granular layer, the dentate gyrus of the hippocampus, and the olfactory bulb. 
This contrasts the distribution of neuregulin-1 in the cerebellum, which is found 
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mainly in Golgi II cells (Carraway et al., 1997). Neuregulin-1, however, together with 
TGF-ct and EGF are the only erbB-family receptor ligands known to be expressed in 
the hypothalamo-hypophysial axis (Chaidarun et al., 1994; Fan and Childs, 1995; 
Fan et al., 1995; Carraway et al., 1997). 
The distribution of M7365 in mouse brain indicates that its chief function is less 
restricted than only regulating hypophysial endocrine secretion, as was surmised from 
its expression in Xenopus (Eib and Martens, 1996). The presence of M7365 in the 
hippocampus and the olfactory lobe in the 6-wk-old mouse brain suggests that it 
fulfills a role in neurogenesis since these are both sites where this process continues 
postnatally in the rodent brain (reviewed by Farbman, 1990; Kuhn et al., 1996). 
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M7365 is coexpressed with glucagon and PYY 
in developing and adult mouse pancreas 
Chapter 3 
ABSTRACT 
We recently cloned the novel X7365 protein from a Xenopus hypophysial cDNA 
library. This protein is structurally similar to the transmembrane precursors giving 
rise to ligands for erbB-family receptors and contains a unique EGF-like domain that 
complies with all the criteria imposed by the consensus sequence for EGFR ligands 
except for the substitution of a single arginine. 7365 is also the only example of a 
transmembrane protein with follistatin modules. Subsequent to cloning X7365, we 
isolated both the human and mouse (M7365) homologs, and found that 7365 is 
highly conserved throughout evolution, indicating that it has an important, yet 
currently unknown function. During expression analyses in adult mouse organs we 
found that pancreas is one of the richest M7365 sources. Here we report that M7365 
can be detected as early as E9.5 in rudimentary pancreas, when it is colocalized with 
glucagon and PYY. Coexpression of M7365 and glucagon was observed up to 6 wks 
post partum, while expression of M7365 was seen in a discrete population of PYY 
producing cells whose number decreased with age. Its early expression in developing 
pancreas hints that M7365 may have a role in pancreogenesis, in addition to a role 
in the mature organ. 
D.W. Eib and G.J.M. Martens 
Department of Molecular Animal Physiology, University of Nijmegen, Toemooiveld 1, 6525 ED 
Nijmegen, The Netherlands 
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INTRODUCTION 
Embryonic pancreatic ducts arise in primitive gut endoderm and contain the 
endocrine precursor cells from which pancreatic islets develop (Pictet and Rutter, 
1972). The mature islets of Langerhans contain four distinct endocrine cell types 
producing the hormones glucagon, insulin, somatostatin and pancreatic peptide (PP). 
These cell lineages are thought to arise from a common, multipotential precursor 
(Alpert et al., 1988), whose identity has not been firmly established. The mouse 
pancreas develops by the fusion of ventral and dorsal primordia that first appear as 
evaginations of the gut. The primitive dorsal and ventral glands develop 
independently, forming both endocrine and exocrine tissues, and merge at E10.5 in 
mouse (Teitelman et al., 1993). Cells coexpressing glucagon, insulin, and peptide YY 
(PYY) immunoreactivity first appear at approximately embryonic day 9.5 (E9.5) in 
mice (Upchurch et al., 1994), roughly equivalent to the 20-somite stage. Although 
glucagon, insulin and PYY are coexpressed in these progenitor cells, their regulation 
during development differs (Krasinski et al., 1991) and hormone gene expression is 
selectively repressed as the various islet cell lineages differentiate from this 
multipotential progenitor cell. By E 12.5, PYY is produced by only a few β cells, 
however these Ins+/PYY+ cells remain present until birth. Glucagon expression in β-
cells is repressed early in development, and no Ins+/Glu+ cells are present after E12. 
A subpopulation of Ins+/Glu+ cells show repressed PYY expression by E15.5, and in 
adult mouse pancreas, only half of all a cells express PYY (Upchurch et al., 1994). 
Somatostatin-producing δ- and PP-producing cells also arise from PYY+ cells, but in 
these lineages PYY expression is not inhibited. Postnatally, PYY expression is 
markedly reduced relative to its developmental levels (Krasinski et al., 1995). We 
recently cloned a novel transmembrane protein from Xenopus pituitary whose 
primary structure resembles precursors of erbB-family ligands (Eib and Martens, 
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1996). This protein, currently designated as X7365, is unique in two respects: It is 
the first transmembrane protein with follistatin modules, and it contains an EGF-like 
domain that deviates from the consensus sequence derived from established epidermal 
growth factor receptor (EGFR) ligands by a single amino acid (Eib and Martens, 
1996). Subsequent cloning of the mouse (M7365) and human (H7365) homologs (Eib 
et al, 1997) revealed that 7365 is highly conserved throughout evolution, indicating 
that it had an important, albeit unknown, function. During studies to determine the 
tissue distribution of M7365 transcripts, we found that its expression was enriched in 
neuroendocrine tissues, and that after brain, pancreas was one of the richest sources 
of M7365 RNA. Of the established ligands for erbB-family receptors, expression of 
only transforming growth factor-α (TGF-oc), EGF, betacellulin and the EGFR has 
been reported previously in normal pancreas, and we know of no reports concerning 
the expression of members of this family of receptors and ligands during normal 
pancreatic development. This prompted us to examine the pre- and postnatal 
expression of M7365 in mouse pancreas. We report here that M7365 
immunoreactivity colocalizes with gucagon and PYY in the developing pancreas, and 
in the mantle of adult pancreatic islets. 
MATERIALS AND METHODS 
Experimental animals 
CD-I mice were bred and reared in the Department of Animal Physiology, University of Nijmegen The 
appearance of the vaginal plug was considered as day OS of gestation (EOS) in the staging of mouse 
embryos 
Antisera 
Monoclonal antibodies against porcine insulin and glucagon were purchased from Sigma Chemical Co 
(St Louis, MO) Chicken anti-PYY immunoglobulin Y was raised against canine PYY and isolated 
from eggs according to the method of Alata and Nakai (1993) The AS9 antiserum, raised against the 
EGF-like domain ofH7365, andtheB73 antiserum, raised against the C-terminal ofH7365, have been 
described previously (Eib and Martens, 1996, Eib et al, 1997) Antiserum C29 was raised against a 
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recombinant polypeptide corresponding to the follistatin domains ofH7365 (ammo acids 114-218) 
expressed in E coli as a fusion with a hexahistidine tag (Diagen, Hilden, Germany) 
Isolation of Islets of Langerhans 
Islets were isolated from the pancreata of 6-wk-old mice using the method of Lacy and Kostianovsky 
(1967), modified according to Lemmark (1974) Following cervical dislocation the abdomen was 
opened and the pancreas was removed and minced in a petn dish containing 2 ml of Kxebs-Ringers 
solution (115 mM NaCl, 4 7 mM KCl, 2 56 mM CaCI2, 1 2 mM KH2POi, 1 2 mM MgS07H 20, 20 mM 
NaHCCh, and 16 mM Hepes) The Krebs-Ringers solution, containing the minced tissue was transferred 
to a glass vial and 1 mg collagenase Ρ was added for each pancreas The vial was then incubated for Π ­
Ι 5 mm at 37°C with vigorous shaking, followed by manual shaking until the solution appeared 
homogenous Ten ml of Krebs-nngers solution was added and the vial was again shaken vigorously by 
hand for 1 mm The islets were then allowed to settle for 3 mm and the supernatant was removed The 
islets were resuspended in 5 ml of fresh Krebs-Ringers solution and were again allowed to settle The 
supernatant was then removed and the pellet was resuspended m 3 ml of 25% Ficoll, and transferred to a 
centrifuge tube On top of the 25% Ficoll suspension a step gradient was layered consistmg of 3 ml of 
23% Ficoll, 3 ml of 20% Ficoll and 2 ml of 11% Ficoll, and the tube containing the gradient was spun at 
800 χ g for 10 mm The islets were recovered from the interface between the 11% and 20% Ficoll and 
washed three tunes m Krebs-Ringers before beginning with RNA isolation 
Immun ohistoch emlstry 
Pregnant female mice were sacrificed by cervical dislocation, and the uterus was removed and immersed 
m Bourn's fixative After 15 mm, embryos were dissected while tissues remained submersed in fixative, 
and were postfixed for 2 h m the same solution Pancreata of adult mice were dissected and placed 
directly in Bourn's fixative for 2 h Following fixation, embryos and pancreata were washed once for 1 h 
m 50% ethanol, followed by three changes of 70% ethanol over 24 h All fixation and deydration steps 
were performed with gentle agitation After the last 70% ethanol wash, tissues were dehydrated through 
a graded ethanol series, cleared in xylene, and embedded in paraffin Sections (5 mm) were cut with a 
rotary microtome and mounted on gelatin coated slides Following deparaffimzation and rehydration, 
non-specific staining was blocked with 20% normal goat serum, 3% BSA (Serva, Heidelberg, Germany) 
m 50 mM Tns-HCl, pH 7 4, 0 9% NaCl, 0 1% Triton X-100 (TBS-T) for 1 h This and all subsequent 
incubations were earned out at room temperature m a humid chamber Incubations with primary antisera 
diluted 1 200 m blocking solution were overnight The following day, sections were washed three 
times, 5 mm each, in TBS-T, and biotinylated goat anti-rabbit (Kirkegaard and Perry, Gaithersburg, 
MD) diluted 1 200 in TBS-T was applied for 1 h Following three, 5-min TBS-T washes, horseradish 
peroxidase conjugated streptavidm (Kirkegaard and Perry) diluted 1 1000 in TBS-T was applied, again 
for 1 h After the TBS-T washes, sections were nnsed twice in ТВ (50 mM Tns-HCl, pH 7 4, 0 9% NaCl) 
for 5 mm each Finally, sections were treated with 0 025% 3,3-diaminobenzidine (DAB), 0 0 1 % 
hydrogen peroxide in 0 05 M Tns-HCl, pH 7 6 For colocalizations, DAB stained sections were 
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subjected to the same blocking regimen described above, and were incubated with monoclonal 
anibodies recognizing insulin or glucagon, or polyclonal chicken antiserum raised against canine 
PYY. Sections were washed in the same manner described above, and were incubated for 1 h with either 
fluorescein isothiocyanate (FITC) labeled goat-anti-mouse serum (Nordic, Tilburg, The Netherlands) or 
FITC labeled goat anti-chicken serum (Kirkegaard and Perry, Gaithersburg, MD). Sections were rinsed 
as described above and mounted in citifluor (Van Loenen Instruments, Amsterdam, The Netherlands). To 
check the specificity of staining, immune serum was replaced with preimmune serum and antisera were 
incubated overnight with an excess of antigen prior to application to sections. Immunostained sections 
were photographed with a Leica Vario Orthomat camera system mounted on a Leica DM RB/E 
microscope equipped with bright-field and fluorescence illumination, and Leica Fluotar objectives. 
Reverse Transcription-Potymerase Chain Reaction (RT-PCR) 
Total RNA was isolated from pancreatic islets and exocrine pancreas from 6-wk-old mice using Trizol 
(Gioco) reagent, according to the manufacturer's instructions, and 1 μg was processed for cDNA in the 
presence or absence of reverse transcriptase (Gibco), using random hexanucleotide primers. Four percent 
of the resulting cDNA was then used in each set of primer reactions. Primer sequences were: 
5'-CTAAGATCTATCGGAAGCCACATGCCTTGC-3' (M7365-5'); 5'-ACCCTCGAGCTAGAGAATA 
CTAAAGTCCGTCTT-3' (M7365-3'); 5'-TACTCCTGCTTGCTGATCCACAT-3' (ß-actin-5'); and 5'-CG 
GGACCTGACWGACTACCTCATG-3' (ß-actin-3'). The reaction consisted of 30 cycles of 1 min each at 
94°C (melting), 52°C (annealing), and 72°C (elongation). Each reaction contained 5 μΐ of 10X Tag 
buffer, 250 nM S' and 3' primers, 2 μΐ of the reverse transcriptase reaction, 8 μΐ of 1.25 mM NTPs, and 0.5 
units of Taq polymerase (Pharmacia, Uppsala, Sweden) diluted to 50 μΐ with double distilled water. 
Reaction products were visualized on 1.2% ethidium bromide-stained agarose gels. 
RESULTS 
RT-PCR 
Analysis of M7365 transcript distribution was previously analyzed in a variety of 
adult mouse tissues to assess its primary sites of expression (Eib et al, 1997). Results 
of RT-PCR analysis of total RNA isolated from brain, pars distalis, neurointermediate 
lobe, heart, liver, spleen, kidney, ovary, testis and skeletal muscle demonstrated that 
brain and hypophysis were the richest sources of M7365, followed by ovary and 
pancreas. RT-PCR analysis of preparations of isolated islets and the remaining 
exocrine material in 6-wk-old mice revealed that M7365 expression was highly 
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enriched in the endocrine relative to exocrine pancreas (Fig. 1). The weak signal 
obtained with exocrine pancreas is most likely the result of contaminating endocrine 
material, but may reflect the presence of low levels of M7365 expression outside the 
islets of Langerhans. 
Immunohistochemistry 
The observation of M7365 transcripts in the endocrine pancreas of 6-wk-old mice 
lead us to employ immunohistochemistry to evaluate expression of M7365 immuno-
reactivity in this organ. Results with all three 7365 antisera, A59, C29 and B73, 
confirmed results obtained with RT-PCR, and showed that M7365 was expressed 
Fig. 1. RT-PCR analysis of M7365 
expression in pancreatic islets and exocrine 
pancreas of 6-wk-old mice. cDNA made from 
1 \i% of total RNA, isolated from pancreatic 
islets (endo), or the remaining exocrine 
material (exo), was subjected to PCR amp-
lification with M7365 and mouse ß-actin 
primer sets, as described in the Materials and 
Methods section. This analysis is valid only 
for relative comparisons. 
primarily in the mantle of pancreatic islets from 6-wk-old mice (data not shown). All 
three antisera recognized M7365 immunoreactivity in the same cells, however 
staining was most intense with A59, which was used for further studies of M7365 
expression in developing pancreata. 
We next performed immunohistochemical colocalization studies of M7365, using 
rabbit polyclonal antiserum A59, and either monoclonal insulin or glucagon 








E12.5, E14.5, E16.5, E18.5, and pancreas of 6-wk-old mice. In E9.5 mice, M7365, 
glucagon and PYY immunoreactivity colocalized in progenitor cells of the endocrine 
pancreas (Fig. 2a and 2b). No signal was detected in the primitive gut endoderm of 
E8.5 embryos, indicating that M7365 expression in primordial pancreas begins 
between these two time points. An exhaustive analysis, however, such as 
immunohistochemical staining of serial sections through the primitive gut region 
from which the pancreas buds off, was not conducted. It is therefore possible that 
pockets of M7365 immunoreactivity were missed in embryos younger than E9.5. 
M7365 and glucagon immunoreactivity continued to be coexpressed at E12.5 
(Figs.4a and 4b), E14.5 (Figs. 5a and 5b), E16.5 (Figs. 6a and 6b), E.18.5 (Figs. 7a 
Fig. 2. Immunohistochemical colocalization 
of M7365 and glucagon in pancreatic 
primordia of E9.5 mice, (a) Micrograph 
showing FITC labeling of glucagon, (b) 
Brightfield micrograph of DAB reaction 
product in the same section following 
M7365 immunostaining. Arrows indicate the 
same cell under the two types of illumination. 
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and 7b), and in pancreatic islets of 6-wk-old mice (Figs. 8a and 8b). To further 
characterize the expression of M7365 in developing pancreas, we next looked for 
coexpression of M7365 and PYY immunoreactivity in developmental stages later 
than E9.5. At E 12.5, PYY producing cells also expressed M7365 (data not 
shown),but at E14.5 (Figs. 5e and 5f) and E 16.5 (Figs 6e and 6f), although some 
PYY-expressing cells also stained for M7365, there was no longer the nearly 
complete overlap of PYY and M7365 immunoreactivity seen in younger embryos. 
At El8.5 we observed no coexpression of PYY and M7365, but by 6 wk post partum 
there was again a discrete population of PYY-positive cells that also expressed 
M7365 (Figs. 8e and 8f). 
Fig. 3. Immunohistochemical colocalization 
of M7365 and glucagon in pancreatic 
primordia of E12.5 mice, (a) Micrograph 
showing FITC labeling of glucagon, (b) 
Brightfield micrograph of DAB reaction 
product in the same section following 
M7365 immunostaining. Arrows indicate the 
same cell under the two types of illumination. 
7 3 
Chapter 3 
Studies with antibodies against insulin failed to demonstrate coexpression of this 
hormone with M7365 either during development, or at 6 wks post partum. Attempts 
to colocalize somatostatin and M7365 were also unsuccessful (data not shown), 
indicating that M7365 is expressed only by a, a ' and PP cells in matureislets. 
Experiments with insulin failed to demonstrate coexpression of this hormone with 
M7365 either during development, or at 6 wks post partum. M7365 and insulin were 
not observed in the same cell at any stage of development, or in 6-wk-old pancreata 
(Figs. 5c-8c and 5d-8d). The distribution of M7365 in the mantle of the pancreatic 
islets of 6-wk-old mice suggested that it could be coexpressed withsomatostatin in δ 
cells. Attempts to colocalize somatostatin and M7365 were also unsuccessful (data 
not shown), indicating that M7365 is expressed only by a, a' and PP cells in mature 
islets. 
DISCUSSION 
Although 7365 is most highly expressed in the hypothalamus (Eib and Martens, 
1996) it has been noted previously that there are elements common to the genetic 
regulation of brain and pancreas (reviewed by Slack, 1995), evidenced by islet cells in 
culture, which express a variety of typically neural markers and extend long, 
neurofilament-containing processes (Teitelman, 1990). The relationship between 
neuronal cells and the endocrine hormone-producing cells of the gut and pancreas was 
first noticed by Feyrter (1938) and has more recently been expanded into the 
concept of a diffuse neuroendocrine system (DNES), comprised of cells of the amine 
precursor uptake and decarboxylation (APUD) series (Pearse, 1968; 1969; 1977). 
The DNES is further split into the central division, comprised of the hypothalamus 
and pineal gland, and the peripheral division, which includes the endocrine hormone 
producing cells of the gut and pancreas. The common trait of all APUD cells is their 
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Fig. 4. Expression ofM7365, glucagon, insulin and PYY in developing pancreas of E14.5 mice, (a) 
FITC labeling of glucagon and (b) bright-field illumination of M7365 DAB staining in the same 
section, (c) FITC labeling of insulin and (d) bright-field illumination of M7365 DAB staining in the 
same section. Note lack of coexpression. (e) FITC labeling of PYY and (f) bright-field illumination of 







Fig. 5. Expression of M7365, glucagon, insulin, and PYY in the developing pancreas of E 16.5 mice, (a) 
FITC labeling of glucagon and (b) bright-field illumination of M7365 DAB staining in the same sect­
ion, (c) FITC labeling of insulin and (d) bright-field illumination of M7365 DAB staining in the same 
section. Note lack of coexpression. (e) FITC labeling of PYY and (f) bright-field illumination of M7365 
DAB staining in the same section. Arrows indicate the same cell under the two illumination conditions. 
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Fig. 6. Expression of M7365, glucagon, insulin, and PYY in the developing pancreas of E18.5 mice, (a) 
FITC labeling of glucagon and (b) bright-field illumination of M7365 DAB staining in the same 
section, (c) FITC labeling of insulin and (d) bright-field illumination ofM7365 DAB staining in the 
same section. Note lack of coexpression. (e) FITC labeling of PYY and (f) bright-field illumination of 
M7365 DAB staining in the same section. Note lack of coexpression. Arrows indicate the same cell 
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Fig. 7. Colocalization of M7365, glucagon, insulin, and PYY in pancreatic islets of 6-wk-old mice, (a) 
FITC labeling of glucagon and (b) bright-field illumination of M7365 DAB staining in the same 
section, (c) FITC labeling of insulin and (d) bright-field illumination ofM7365 DAB staining in the 
same section. Note lack of coexpression. (e) FITC labeling of PYY and (f) bright-field illumination of 
M7365 DAB staining in the same section. Arrows indicate the same cell under the two illumination 
conditions. 
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expression of neuron-specific enolase (Schmechel, 1978), leading to speculation that 
they are all derived from a neuroendocrine-programmed ectoblast (Pearse, 1975; 
1977). Glucagon has been previously reported to be present, together with PYY, in 
the earliest endocrine progenitor cells (Upchurch et al., 1994). The coexpression of 
M7365 with glucagon in the primitive gut endoderm of E9.5 mice suggests that 7365 
is also expressed by these endocrine progenitor cells. Although we did not search for 
colocalization of M7365 and PP, PYY and PP are coexpressed both during 
development and in cells of the mature islet (Upchurch et al., 1994), indicating that 
results would have been similar to those obtained from M7365 and PYY 
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Fig 8 Proposed model of the origin and differentiation of islet cell lineages from a 01υ+/ΡΥΥ+/Μ7365* 
producing progenitor, adapted from Upchurch et al (1994) to include data from the present study An 
early progenitor cell, appearing at E9 S, expresses glucagon, insulin, PYY and M736S As development 
progresses, PYY is expressed in each of the four islet cell types when they first appear M7365 is coex­
pressed with glucagon and is produced by a discrete population of PYY* cells M736S is not coex­
pressed with insulin, but PYY+/PP*/M7365+ and PYY+/Som+/M7365+ cells may exist In the mature 
islet, PYY expression is restricted to 6 and PP cells, and a subpopulation of a cells (a') M736S is co-
expressed with glucagon, and to a lesser extent, PYY Therefore, the possible combinations (sites) of 
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colocalization studies. We also did not look for colocalization of somatostatin and, 
M7365 during development, but somatostatin, which is first expressed at about 
El 5.5, is also coexpressed with PYY during the remainder of development, and in the 
mature islet (Upchurch et al., 1994). Therefore, the partial coexpression of M7365 
with PYY in the later developmental stages and adult pancreata is likely to reflect 
the situation with M7365 and PP as well. Taking these observations into consider­
ation, we propose the model depicted in Fig. 8, expanded from that submitted by 
Upchurch et al. (1994) to include M7365. In addition to its endocrine componentthe 
pancreas in also innervated by the sympathetic nervous system (Woods and Porte, 
1974). As reported previously, 7365 has been characterized as having a 
neuroendocrine expression profile (Eib and Martens, 1996; Eib et al., 1997) the 
highest expression of 7365 occurs in and, given that nervous tissue, its presencein 
pancreas could be concerned with the innervation of this organ. The expression of 
M7365 immunoreactivity so early in pancreatic development, however, argues 
against such a role, as innervation of the pancreas does not occur until the 50-somite 
stage or about E 12.5 (reviewed by Slack, 1995). 
The expression of M7365 early in pancreatic development, suggests that it may be 
involved with the differentiation of the five established cell lineages (Glu+, 
PYŶ VGlu*, Ins+, PYY+/Som+, PYY+/PP+ from progenitor cells (Upchurch et al., 
1994), rather than in the morphogenesis of the organ. Until E10.5, the Glu+/M7365+ 
and PYY7M7365 + progenitor cells are located in the wall of the embryonic foregut, 
meaning that cell-specific gene expression of glucagon and PYY begins in a 
premorphogenic phase in the developing endocrine pancreas (Gittes and Rutter, 
1992). Therefore, the concomitant expression of M7365 with glucagon at E9.5 
argues against a role for M7365 in establishing the structural organization of the 
pancreas. 
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The expression of M7365 in mature islets could mean that it acts as a pancreatic 
hormone. The microcirculation in pancreatic islets follows a strict β-α-δ order 
(Samols et al., 1988), meaning that, should M7365 be cleaved to release a soluble 
product, its action in the endocrine pancreas would be confined to the somatostatin 
producing cells. As with the other pancreatic endocrine hormones, potential targets 
for released M7365 peptides might also be found in the liver or adipose tissue. 
The exodomain of 7365 contains two follistatin modules, which have been proposed 
to reversibly bind TGF-ß growth factors such as the activins and PDGF (Patthy and 
Nikolics, 1993). Interestingly, in pancreas, activin-A is expressed by α and δ cells 
(Yasuda et al., 1993) and follistatin is expressed in β cells (Ogawa et al., 1993) of 
mature pancreatic islets. Using a monoclonal antibody directed against the amino 
terminal of the activin subunit, immunostaining was reported only in β cells, while 
antisera directed against the carboxy terminal stained only α cells, suggesting that 
follistatin was binding the βΑ subunit (Ogawa et al., 1993). The observation that 
M7365 immunoreactivity is expressed by α cells in pancreatic islets, together with 
the reported expression of activin A in these same cells, suggests that coexpression 
of M7365 and activin A should be demonstrable. In our hands, however, the anti-
activin βΑ antibody used by Yasuda et al. (1993) gave no signal, even at one fifth the 
dilution used by these workers. This negative result is most likely the consequence of 
differences in the fixative and fixation protocols employed in the two sudies: M7365 
staining requires fixation in Bouin's solution for relatively short periods. Other 
fixatives, such as 4% paraformaldehyde, or longer fixation periods, commonly used 
in light-level immunohistochemical staining, gave negative or clearly inferior results 
compared to short periods of fixation in Bouin's fluid. Yasuda et al. (1993) used 
extended fixations in Bouin-Holland fixative which deviates significantly from 
Bouin's fixative. Although interaction of the M7365 follistatin modules with activin 
A may occur in older embryos, activin-A immunoreactivity has only been observed 
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as early as E12.5 in embryonic mouse pancreas (Furukawa et al., 1995). This 
indicates that in embryos younger than E12.5 the follistatin modules of M7365 are 
not occupied with activin binding. 
Interpretation of our results in relation to the expression of other erbB receptors and 
ligands during (pancreatic) development is hampered by the paucity of available data. 
Transforming growth factor-α (TGF-a) and the EGFR are expressed in pancreatic 
ducts, acini and islets of human fetuses at 10-12 gestation weeks (Miettinen and 
Heikinheimo, 1992). This is roughly comparable to ЕЮ mouse embryos, as this is 
the point in human pancreatic development where glucagon expression begins (Go et 
al., 1986). The majority of work in humans has centered around the upregulation of 
erbB-2 and erbB-3 occurring in adenomas and carcinomas (Muller et al., 1992; 
Lemoine et al., 1992). Of the few erbB receptors and ligands whose expression has 
been studied in pancreas, all have been found at roughly equal levels in both endocrine 
and exocrine tissue of the pancreas (Miettinen and Heikinheimo, 1992). Transgenic 
-/- neuregulin (Meyer and Birchmeier, 1995), erbB-2 (Gassmann et al, 1995), and 
егЬВ-4 (Lee et al., 1995) mice fail to survive past El 1.5. Analysis of these embryos 
at E 10.5, uncovered no defects in pancreas, the majority of abnormalities occurring 
in heart and various nervous system components. Defects in pancreas, however, 
could have easily been missed by these workers, owing to the lack of structure and 
very small size of this organ at E10.5. 
Realization of the full significance of M7365 expression so early in development of 
the pancreas will be possible only when the receptor of M7365 is discovered, and 
knowledge of the molecular events surrounding pancreatic development are more 
thoroughly understood. Given the extensive signaling networks resulting from erbB-
family receptor transmodulation, and the large number of ligands for erbB receptors, 
it seems unlikely that M7365 will act alone, whatever its role in pancreatic 
organogenesis. 
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H7365 spicing variants are differentially expressed in lung cancer cells 
Chapter 4 
ABSTRACT 
We recently cloned X7365, a novel protein of unknown function, which is enriched 
in Xenopus neuroendocrine tissues. This protein contains a unique EGF domain 
differing from the consensus sequence for EGFR ligands solely by having a tyrosine at 
the position corresponding to arginine41 in EGF. To obtain the human 7365 homolog 
(H7365), we screened a fetal brain library and isolated cDNAs encoding two H7365 
transcripts, different in only their N-terminal regions. H7365 is highly conserved 
relative to X7365, with nearly complete identity in the transmembrane and 
cytoplasmic domains. Northern blot analysis of a variety of tumors and tumor-
derived cell lines showed highest H736S levels in small cell lung cancer (SCLC) cell 
lines. In GLC-19 cells, derived from a treatment-resistant SCLC patient, 1.8 kb and 
3.0 kb H7365 transcripts were strongly induced relative to GLC-14 cells, initiated 
from the same patient before starting therapy. Nearly all non-SCLC cell lines were 
negative for H7365. Several cDNAs were isolated from a GLC-1 SCLC library that 
corresponded to the H7365 brain clones, while others encoded a C-terminally 
truncated protein. These observations indicate that H7365 transcripts may be useful 
markers for the onset of treatment resistance in SCLC, and suggest that H7365 may 
itself be involved in SCLC progression. 
D W Eib', Anton J M Roebroek2, W J M v d Ven2 and G J M Martens1 
'Department of Molecular Animal Physiology, University of Nijmegen, Toemooiveld 1, 6525 ED 
Nijmegen, The Netherlands 
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Interuniversity for Biotechnology, Herestraat 49, 3000 Leuven, Belgium 
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INTRODUCTION 
The four main types of lung neoplasms - small-cell, large-cell undifferentiated, 
adeno-, and squamous-cell carcinomas - each bear differentiation features of one or 
more types of normal bronchial epithelial cells, or cells appearing following bronchial 
injury (Mabry et al., 1991). Small cell lung cancer (SCLC) can be characterized as 
having an immature neuroendocrine phenotype, marked by high expression of, 
among others, gastrin releasing peptide (GRP), bombesin, neuron specific enolase 
(NSE; Carney et al., 1985; Gazdar et al., 1985), aromatic amino acid decarboxylase 
(AADC), peptidylglycine ct-amidating monooxygenase (PAM; Vos et al., 1996), 
proopiomelanocortin (POMC; Ray et al., 1994), and the prohormone convertase 
PCI/3 (Creemers et al., 1992). SCLC cell lines are divided into classic- (c-SCLC) and 
variant-SCLC (v-SCLC) types. c-SCLC has a relatively long doubling time, grows as a 
dense aggregate, and has high expression of neuroendocrine markers. Conversely, v-
SCLC has a relatively short doubling time, grows as a loose aggregate, and is partially 
or totally devoid of neuroendocrine markers (Gadzar et al., 1985; Weynants et al., 
1990). 
In contrast to SCLC, non-small cell lung cancer (NSCLC) generally lacks markers 
characteristic of a neuroendocrine phenotype (Berendsen et al., 1988). Epidermal 
growth factor (EGF) family members, such as amphiregulin (AR), transforming 
growth factor-α (TGF-a) and heparin binding-EGF (HB-EGF), as well as the EGF 
receptor (EGFR), are found almost exclusively in NSCLC (Hader et al., 1988; Véale 
et al., 1989) where they participate in an autocrine loop (Falco et al., 1990) and in 
the paracrine induction of tumor stroma formation (Bergh, 1988). 
Lung tumors can be admixtures of phenotypes, suggesting that cell type transitions 
take place that may determine the progression of a particular type of lung cancer, as 
well as its resistance to treatment (Carney et al., 1985; Gadzar et al., 1985). 
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Transfection of c-SCLC cells overexpressing either the c-myc or N-myc 
protooncogenes with the viral Harvey ras (v-Ha-ras) gene induces morphological, 
biochemical and growth characteristics consistent with a NSCLC phenotype (Falco et 
al., 1990), giving additional credence to the theory that SCLC progresses to NSCLC. 
This progression is also manifested by the transition of lung tumors from a 
treatment-sensitive state, associated with a neuroendocrine, SCLC phenotype, to a 
treatment-resistant state, typical of tumors with NSCLC characteristics, including 
increased production of EGFR and TGF-a. 
We recently cloned a novel protein from Xenopus hypophysis, referred to as X7365 
(Eib and Martens, 1996), that is structurally similar to the transmembrane precursors 
of EGFR ligands. In addition to being the first transmembrane protein with follistatin 
modules, X7365 has a unique EGF-domain that fails to comply with the consensus 
sequence for EGFR ligands by only the substitution of a tyrosine for a crucial arginine 
(Arg41; numbering refers to mature EGF), essential for EGFR binding (Engler et al., 
1991). The function of X7365 is unknown, but its similarity to EGF family 
precursors and predominantly neuroendocrine distribution in Xenopus, suggested that 
the human homolog would be expressed in lung tumors. Because the neuroendocrine 
traits of lung tumors are related to their position along the SCLC-NSCLC continuum 
(Barr et al., 1996), and because EGF ligands and the EGFR are concentrated at the 
NSCLC end of this continuum, we reasoned that characterization of H7365 
expression in lung tumors could lend insight into its relationship with a 
neuroendocrine phenotype, the EGFR and its ligands, and SCLC progression. To 
achieve these ends, we cloned the human homolog of X7365 (H7365) and examined 
its expression in primary SCLC and NSCLC, SCLC- and NSCLC-derived cell lines, as 
well as in normal organs and cell lines derived from a variety of non-lung 
neuroendocrine tumors, and squamous- and adenocarinomas. 
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MATERIALS AND METHODS 
cDNA libraries and screening 
Approximately 50,000 plaques of a human fetal bram cDNA library (Stratagene, La Jolla, CA), 
constructed in pBluescnpt SK', on duplicate nitrocellulose filters (Schleicher and Schuell, Dassel, 
Germany), were hybridized overnight with a probe synthesized by random pruning an EcoRV-EcoRV 
insert of X7365 (nucleotides 506 to 2003, Eib and Martens, 1996) with [o>32P]dATP according to 
standard procedures (Sambrook et al, 1989) Hybridization was performed overnight at 42° m 6X 
saline-sodium citrate (SSC), 0 5% sodium dodecyl sulfate (SDS), 0 1% pyrophosphate, 40 mM sodium 
phosphate, pH 7 0, 1 mM EDTA, 25% formarmele and 0 1 mg/ml denatured herring sperm DNA Filters 
were washed to a final stringency of 60°C, 0 1 X SSC, 0 1% SDS and 1 mM EDTA and 
autoradiographed for2 days at -70°C A OLC-1 cDNA library constructed m pBluescnpt SK, was 
screened in asimilar manner with a random-pnmed, H7365 2 EcoRl-EcoKl insert (nucleotides 118-
1031), except that that 50% formamide was present during hybridization, and filters were washed to a 
final stringency of 65°C, 0 1 X SSC, 0 1% SDS and 1 mM EDTA 
DNA sequence analysis 
Sequencmg of clones was performed m both directions on single- and double-stranded DNA usmg T? 
DNA polymerase (Pharmacia, Uppsala, Sweden) and the dideoxy chain termination method (Sanger et 
al, 1977) with specific primers Nucleotide sequences and deduced protein sequences were compared 
with those present m the EMBL/GenBank and SwissProt/PIR databases usmg the computer facilities 
of the CAOS/CAMM Center at the University of Nijmegen 
Primary lung tumors and lung carcinoma cell lines 
Lung carcinoma specimens were obtained from the Pathology Department of St Antonius Hospital, 
Nieuwegein, The Netherlands Specimens were processed as described previously (Roebroek et al, 
1989), and classified according to WHO criteria (World Health Organization, 1982) Lung cell lines 
used in this study were all established human SCLC or NSCLC cell lmes The SCLC cell lines GLC-1-
M13 and GLC-1 (de Ley et al, 1985), and SCLC-ІбНс, SCLC-ІбН , SCLC-21H and SCLC-22H 
(Beppler et al, 1987a and 1987b) and have been described previously Other GLC cell lines were 
established by Berendsen et al (1988), and the NL-SCLC3 cell Ime by Broers et al (1991) The 
remaining cell lmes were fiom the National Cancer Institute (NCI), Certified Cell Lme (CCL), Cell 
Repository Lme (CRL) or Human Tumor Bank (НТВ) senes A549 cells are also referred to as CCL-185 
RNA Isolation and Northern Blot analysis 
Total cellular RNA was isolated from primary tumors or cell lmes usmg the lithium-urea procedure 
(AufTxay and Rougeon, 1980) Total RNA (10-15 μg) from each sample was glyoxylated and size-
fractionated on a 1 0% agarose gel and blotted onto Hybond-N (Amersham, UK) as recommended by the 
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manufacturer. Blots were hybridized with 1 X 106 cpm/ml of randomly labeled [a-32P]dATP probe made 
with a template corresponding to nucleotides 118 to 1031 of H7365.2 (see Fig. 1). Hybridization and 
washing were according to Church and Gilbert (1984). Blots were washed to a final stringency of 6S°C, 
0.5 X SSPE and autoradiography for 1 wk at -70°C. To check loading, blots were stripped and 
rehybridized with a hamster ß-actin probe as described previously (van de Velde et al., 1994). 
RESULTS 
Cloning and sequence analysis ofH7365 
Because the highest expression of X7365 is in Xenopus brain, a human fetal brain 
cDNA library was screened with a probe synthesized using a fragment of X7365 
containing the EGF, transmembrane, and cytoplasmic domains. This resulted in the 
isolation of two cDNAs that encoded overlapping, but not identical proteins. The N-
terminal regions of the two deduced proteins, designated H7365.1 and H7365.2. (Fig. 
1), show no similarity from their starting methionines to Glu^/Glu106, located 
between the signal peptide and the first follistatin module. The nucleotide and 
deduced protein sequences, however, converge at GIu66 (block B, Fig. la) and are 
identical throughout the remainder of the protein coding region. 
H736S.1 contains five in-frame stop codons preceding the initiation codon, assigned 
to nucleotides 164-166, which fulfill the requirements for eukaryotic start codons 
(Kozak, 1989), and has a 1140-bp open reading frame (ORF; nucleotides 164-1303; 
Fig. la). A polyadenylation signal (AATAAA) was found 14 bp from the end of the 
sequence, but no poly(A)+-tail was present. As in X7365, the 3'-untranslated region 
of H7365 contains multiple ATTTA motifs, typically found in cytokines, 
lymphokines and protooncogenes, and known to confer instability and a short half-
life to mRNAs (Shaw and Kamen, 1986). The ORF encodes a predicted protein of 
380 amino acids with a calculated Mr of 40,883 Da and potential N-glycosylation 
sites (Asn-X-Ser/Thr; Pless and Lennarz, 1977) at Asn63 and Asn147. The predicted 
full-length polypeptide has a pi of 6.87, compared to 6.38 reported for X7365 (Eib 
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and Martens, 1996). As mentioned above, the H7365.2 protein is identical to 
H7365.1 from Glu106 to the C-terminus, but from the N-terminus to Glu106 there is 
no similarity between the two deduced proteins (Figs, la and b), indicating that they 
are the products of alternative splicing. H7365.2 contains two potential starting 
methionines, with Met47 being the stronger candidate according to Kozak (1989). 
Initiation from Met1, preceded by three in-frame stop codons, and from Met47 would 
result in translational products of 45,735 Daltons and of 40,438 Daltons. Both 
deduced proteins have more neutral pi values (7.93 and 7.32) than either X7365 or 
H7365.1. The N-terminal region (block C, Fig. lb) of H7365.2 contains potential N-
glycosylation sites at Asn17 and Asn97, for a total of three for the entire protein. 
This region also contains a potential signal sequence with reduced hydrophobicity 
relative to the signal peptide of H7365.1 (block A, Fig. 1), suggesting that 7365 
isoforms containing block С may be efficiently translocated into the endoplasmic 
reticulum, owing to the direct correlation of signal peptide efficiency with 
hydrophobicity (Bird et al., 1990). H7365.3, isolated from a GLC-1 cDNA library, is 
comprised of the N-terminal region of H7365.2 (block C) and a short C-terminal 
region (block D) of unrelated sequence. This cDNA encodes a severely truncated 
version of H7365, lacking the cytoplasmic, transmembrane, EGF and follistatin 
domains found in X7365, and H7365.1 and H7365.2. Initiation from Met1 and from 
Met47 in H7365.3 would produce proteins of 14,930 Daltons and of 9,633 Daltons. 
The calculated pi's of these predicted proteins (10.63 and 9.36) are considerably 
more basic than those of the other H7365 isoforms. Of the three cDNAs, H7365.1 
bears the strongest resemblance to X7365 (Fig. 2). The amino acid sequence identity 
between X7365 and H7365.1 is 73% and the similarity is 82%. The identity and 
similarity increase to 98% and to 100%, in the region extending from the N-terminus 
of the EGF domain (Tyr303/313) to the C-terminus (Val370/38°). Notwithstanding the 
exceptionally high degree of conservation in this region, the amino acid at the 
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position equivalent to Arg41 in EGF is a hydrophilic histidine residue (His309) in 
H7365, and a hydrophobic tyrosine residue (Туг299) in X7365. Only slightly less well 
conserved than the EGF, transmembrane and cytoplasmic domains between human 
and Xenopus 7365 are the follistatin modules; the identity over the first and second 
follistatin modules is 85% and 86%, and the similarity is 96% and 88%. As with the 
Database searches with the nucleotide and deduced amino acid sequences of H7365.1 
uncovered no significant homology or similarity with known proteins, other than 
those reported earlier for X7365 (Eib and Martens, 1996). FASTA searches with the 
deduced H7365.3 protein (blocks С and D, Fig. lb), however, identified a number of 
database entries originating from sequencing projects on human tissues other than 
brain. Information on these entries has been summarized (Table 1). EGF domain of 
7365, the cysteines in the follistatin modules are strictly conserved between Xenopus 
and human, indicating that the three-dimensional structure of these modules is of 
functional importance 
Northern Blot analysis ofH7365 in tumors and tumor-derived cell lines 
Using a probe synthesized from a fragment of H7365.2 comprised of nearly the 
entire extracellular domain, we conducted Northern blot analysis on a suite of both 
normal and transformed tissues, as well as primary and immortal tumor-derived cell 
lines (Fig. 3). This probe contained elements of all known differentially spliced forms 
of H7365, and was therefore not selective for a specific H7365 splicing variant. 
Results of this analysis (Fig. 3) have been collated for lung tumor-derived cell lines 
Fig 1 Nucleotide and deduced ammo acid sequence, and of H7365 splicing variants (a) Nucleotide 
and deduced ammo acid sequence of H7365 1 In-frame stop codons preceding the starting methionine 
are overlined Destabilizing ATTTA motifs are underlined A potential polyadenylation signal is 
doubly underlined • indicates potential N-glycosylation site (b) Nucleotide and deduced ammo acid 
sequence of H7365 3 In-frame stop codons preceding the first potential starting methionine are 
overlined 
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Pro Thr Asn Thr Thr Lau Ser Pro Ala Cya Pro Cya 5er Phe Lya Gin Leu Lya Lye Cya Trp Glu Aen H e Lye Ala Arg Thr Lya Lya 4S 
CCC ACG AAT АСА ACT CTC AOC CCA GCG TGT CCC TGC AOT TTC AAA CAG CTG AAG AAG TGC TGC GAG AAC АТС AAG GCT CGG ACC AAA AAA 251 
Ile Set Ala Hia Glu Arg Arg Olu Lya Val Lye Arg Ser Val Ser Pro Leu Leu Ser Tbr Hia val Leu Gly Lye Glu Aan Ile Lya Ala 75 
ATT ATG GCC CAT GAA AGG AGA GAG AAA GTG AAA CGO AGC CCT CTC CTS AGT ACC CAC GTC СТА GGG AAG GAG AAG АТС AAC АТС AAG GCT 341 
Lys Ila Ala Ser Mec Leu Pro Olu Hi e Phe Leu Leu Leu Ala Glu Pro Pro Arg Glu Glu Pro Aen Thr Thr Pro Thr Pro Oln Pro Lye 105 
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Fig 1 (с) Schematic diagram of Н7365 splicing variants H736S 1 is comprised of the sequence shown 
ш blocks A and B, H736S 2 of that in blocks С and B, and H7365 3 of that in blocks С and D In 
H7365 2, Lys 1 0 5 (block C) is immediately followed by Glu6 6 (block B). SP, signal peptide, FS, folli-
statin module, EGF, EGF-like domain, TM, transmembrane domain 
(Table 2). H7365 is expressed in at least four differentially spliced forms, ranging 
from roughly 1.8 kb to 3.0 kb, and with one exception (A549 cells), is confined to c-
and v-SCLC cell lines. Only three of the six primary SCLC samples analyzed, 
however, were positive (Fig. 3 and data not shown). None of the eight primary 
NSCLC samples (five adeno- and three squamous cell; data not shown), and only one 
of ten NSCLC cell lines (Fig. 3 and data not shown) were positive for H7365. Of 
particular interest is the expression of H7365 in the GLC-14, -16 and -19 cell lines. 
These cells, described previously (Berendsen et al., 1988), originate from biopsy 
material removed from a single patient during longitudinal follow-up after the initial 
diagnosis of lung cancer. GLC-14 was established after the cancer was first diagnosed, 
but prior to beginning therapy. GLC-16 was established following five initial cycles of 
CDE chemotherapy (cyclophosphamide, doxorubicin and etoposide), a three month 
remission, during which the patient received no therapy, and four additional cycles of 
CDE following tumor recurrence. After the patient received radiotherapy (10 times, 
30 Gy) and underwent a second three month remission, there was again recurrence of 
the tumor, from which GLC-19 was established. Comparison of the morphological, 
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Fig 2 Sequence alignment of human and Xenopus 7365 Gaps m the N-termmal have been introduced 
to maximize the alignment The asterisk indicates the residue corresponding to Arg41 in mature EGF SP, 
signal peptide, FS, folhstatin module, EGF, EGF-like domain, TM, transmembrane domain 
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"Letters preceding the nucleotide numbers in the center column correspond to the sequence contained 
in blocks С and D (Fig lb) 
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biochemical and immunological properties of theses cell lines showed good matches 
with the biopsies from which they were derived (Berendsen et al., 1988). A 2.7 kb 
H7365 transcript is clearly evident in GLC-14 cells, started from the initial tumor 
and this transcript is markedly reduced in GLC-16 cells, derived from the tumor 
recurring after chemotherapy. Other transcripts, smaller than 1.8 kb and expressed at 
low levels in GLC-14 cells, are absent in GLC-16 cells. The GLC-19 cell line, 
established from the tumor recurring following radiotherapy, expressed two additional 
H7365 gene products, a 3.0 kb and a 1.8 kb transcript, not observed in the GLC-14 
or GLC-
Fig. 3. Northern blot analysis of H7365 expression in tumors, tumor-derived cell lines and normal 
tissues. NIL, neurointermediate lobe; PD, pars distalis. Each lane contains 10-15 μg of total RNA. 
Blots were hybridized with a 0.9 kb, H7365.2 probe and washed as described in Materials and 
Methods. Following a 1 wk exposure, blots were stripped, rehybridized with a hamster ß-actin probe 
and autoradiographed for 12 h. Molecular weight markers in kilobases are indicated at the left of each 
panel. 
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16 cell lines. Moreover, expression of the 2.7 kb band is greatly diminished in GLC-
16 and -19 cells relative to GLC-14 cells. Other positive tumor cell lines, besides 
those derived from lung tumors, include malignant melanoma (G-361), chorion-
Table 2 
Expression of H7365 transcripts in human lung carcinoma cell lines 

























































'Classification of cell types is according to WHO guidelines (World Health Organization, 1982). 
''Bands in auto-radiographs of Northern blots (Figure 3) were awarded a relative intensity ranging from 
1/2+, based on the signal in HTB-172 cells, to ++++, based on the signal in GLC-19 cells. 'Although 
classified as c-SCLC, these cells express neurofilaments and lack some neuroendocrine antigens, and are 
therefore acknowledged to contain a v-SCLC-type component (Berendsen et al., 1988). 
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carcinoma and neuroblastomas (НТВ-11 and CCL-127). Among H7365 positive, 
non-lung cancer cell lines, only BeWo and G-361 cells express small H7365 
transcripts in the vicinity of the 1.8 kb gene product found in the majority of c- or 
v-SCLC cell lines (Fig. 3). A number of neuroendocrine tumor cell lines were negative 
for H7365, including those derived from rat medullary carcinoma (CRL-1607), 
pituitary adenoma (GH-3), pheochromocytoma (PC-12) and glial tumor (CCL-107), 
and from mouse pituitary adenoma (AtT-20) and neuroblastoma (CCL-131 and CCL-
147). Also negative were cell lines derived from human squamous cell carcinomas of 
the larynx (CCL-23), pharynx (CCL-138) and mouth (CCL-17). Additionally, a 
variety of normal tissues, including muscle, uterus, ovary, testis, salivary gland and 
adrenal from mouse, neurointermediate and anterior lobes from rat hypophysis, and 
human lung, thyroid or parathyroid gland, expressed no detectable H7365 (Fig. 3 and 
data not shown). 
DISCUSSION 
The cloning of H7365 and subsequent comparison of its deduced amino acid sequence 
to that of X7365 highlights several interesting facets of this novel protein. Perhaps 
the most striking feature of an alignment of the Xenopus and human homologs 
(Fig. 2) is the degree of conservation, highest in the transmembrane and cytoplasmic 
regions of the protein. This suggests that this portion of 7365 is functionally 
important, possibly participating in signal transduction as has been demonstrated for 
the transmembrane precursor of heparin binding-EGF (Naglich et al, 1992) and 
indicated for the TGF-ct precursor (Shum et al., 1994). A similar level of 
conservation (95%) exists between the cytoplasmic domains of the human and 
Xenopus transmembrane Eph (Erythropoietin producing hepatocellular) ligands 
Lerk-2 and XLerk (Jones et al., 1997), which also transmit signals bi-directionally 
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through the plasma membrane (Bruckner et al., 1997). The strict conservation of 
cysteine residues throughout 7365 is also readily apparent from the sequence 
alignment (Fig. 2), indicating that tertiary protein structure is also highly conserved. 
As with X7365, H7365 contains an EGF-domain that differs from established EGFR 
ligands by a single substitution at the position equivalent to Arg41 in mature EGF (Fig. 
2). The histidine present at this position in H7365 (His309) represents a conservative 
substitution relative to arginine but not relative to the analogous tyrosine (Туг299) in 
X7365. The high degree of conservation between X7365 and H7365 in the region of 
the protein containing the EGF domain makes this non-conservative substitution 
even more remarkable. Previous studies have shown that the analogous arginine to 
histidine point mutation in human EGF reduces its affinity for the EGFR to 0.2% of 
wild type levels (Engler et al., 1990). Although the significance of this substitution is 
unknown, it is striking that the EGF-domain of 7365 has remained so similar to 
functional EGFR ligands for an evolutionary period estimated at 350 million years 
(Bisbee et al., 1977) while in all likelihood remaining non-functional in terms of its 
ability to stimulate the EGFR directly. 
The high degree of conservation found in the 7365 EGF domain also extends to the 
follistatin modules. It has been hypothesized that these modules contain a structural 
fold allowing them to bind TGF-ß superfamily members, possibly for purposes of 
modulating the biological activity of these growth factors (Patthy and Nikolics, 
1993). TGF-ß,.3, platelet derived growth factor (PDGF), and type I-III TGF-ß 
receptors are all expressed in lung cancer, with elevated expression occurring in 
NSCLC and during the transition of lung tumors from SCLC to NSCLC (Soderdahl, 
1988; Damstrup et al., 1993; Jakolew et al., 1995). Although expression of H7365 
occurs chiefly in SCLC, its concomitant presence with members of the TGF-ß family 
in v-SCLC leaves open the possibility that one or both of its follistatin modules are 
involved in mediating the activity of TGF-ß family members in lung cancer. 
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Follistatin also binds to heparan sulfate proteoglycans on cell surfaces and in the 
extracellular matrix (Sugino et al., 1993), and several follistatin module-containing 
proteins, including osteonectin, agrin and SCI, mediate cell adhesion (Murphy-Ullrich 
et al., 1995; Storms et al., 1996; Corbel et al., 1996). Cultured SCLC cells grow in 
floating aggregates, while NSCLC cells form adherent monolayers (Pettingill et al., 
1980), and the down-regulation of cellular adhesion proteins has been linked to the 
transition of SCLC to NSCLC (Doyle et al., 1990). Therefore, the apparent down-
regulation of H7365 transcripts in NSCLC relative to SCLC, together with its 
homology to proteins involved in cell adhesion, suggests that H7365 may have a role 
in maintaining the aggregates observed in cultured SCLC cells. The lack of significant 
similarity of the N-terminal of H7365 to known proteins precludes meaningful 
speculation over functional implications of the various isoforms. The absence of 
multiple transcripts in Northern blots of X7365 (Eib and Martens, 1996) and mouse 
7365 (D.W. Eib and G.J.M. Martens., unpublished results), and the occurrence of 
splicing variants in H7365, suggests that alternative splicing may be a more highly 
evolved mechanism for regulating H7365 activity. It is interesting that the sequence 
in block A (Fig. la), and hence H7365.1 (Fig.lc), was found only in cDNAs isolated 
from the human fetal brain library, while the sequences shown in blocks В and С (Fig. 
lb) were present in cDNAs from both fetal brain and GLC-1 libraries, as well as in 
libraries constructed from a variety of neuroendocrine and non-neuroendocrine 
sources (Table 1). H7365.1 may therefore be a brain- or development-specific 
splicing variant. The sequence shown in block D (Fig. lb) was not found in any of the 
H7365 splicing variants isolated from the fetal brain cDNA library but was 
encountered in cDNAs isolated from libraries constructed from primary neuronal and 
endothelial cultures, and fetal liver, spleen and heart (Table 1). That the sequence 
depicted in blocks С and D was found in cDNAs originating from prenatal tissues, 
together with the presence of H7365.1 in fetal brain, further suggests that expression 
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of H7365.1 is brain- as opposed to development-specific. The occurrence of H7365 
splicing variants that encode transmembrane as well as secreted proteins is 
reminiscent of the glial growth factors (GGFs), which include transmembrane, 
intracellular and secreted proteins that are all products of the same gene (Marchionni 
et al., 1993). As with H7365, however, the functional significance of N-terminal 
splicing variants of the GGF gene is unclear. Further understanding of H7365 splicing 
events and gene products awaits genomic sequence information. 
Of all cells and tissues examined, the expression of H7365 is highest in SCLC cells 
(Fig. 3 and Table 2), most clearly manifested by the 1.8 kb and 3.0 kb transcripts in 
GLC cell lines. Variations of the SCLC phenotype in culture strongly suggest that 
lung tumors progress from a c-SCLC to a NSCLC phenotype via a v-SCLC 
intermediate (Mabry et al., 1991). Initially, SCLC is extremely sensitive to chemo-
and radiation therapy. In contrast, v-SCLC and NSCLC are more refractory to 
treatment, and there is evidence that SCLC tumors with reduced expression of 
neuroendocrine markers are less sensitive to therapy than pure SCLC tumors. GLC-
14 cells reflect the therapy sensitive form of SCLC, and GLC-16 and -19 cells are 
believed to represent the in vitro counterpart of chemo- and radiotherapy resistant 
SCLC tumors in which no admixtures of non-SCLC histology are apparent 
(Berendsen et al., 1988). Nevertheless, GLC-16 and -19 cells express neurofilaments 
and lack some neuroendocrine markers, characteristics indicative of the presence of a 
v-SCLC component. In GLC-19 cells, the induction of the 1.8 kb and 3.0 kb H7365 
transcripts suggests that up-regulation of these H7365 gene products may result from 
SCLC progression toward a variant phenotype, or that H7365 is itself concerned with 
this transition. Therefore, induction of these two H7365 transcripts may prove 
useful as a marker for treatment resistance in SCLC. Transfection studies of c-SCLC 
cell lines with H7365 should help clarify its role, if any, in SCLC progression. 
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The expression of H7365 transcripts in c-SCLC and v-SCLC, and their virtual 
absence in NSCLC is complementary to the expression of TGF-a, amphiregulin (AR) 
and EGFRs, which are largely confined to NSCLC (Soderdahl et al., 1988; Falco et al., 
1990; Hader et al., 1988). EGF itself has not been found in any form of lung cancer 
(Gamou et al., 1987; Soderdahl et al., 1988) and no reports exist concerning the 
expression of the remaining EGFR ligands in lung neoplasms. Of the remaining class I 
growth factor receptors, only erbB2 has been observed in lung cancer, where it too is 
restricted to NSCLC (Tsai et al., 1993). These observations argue against a direct 
functional relationship between 7365 and the EGF family, at least in lung cancer, and 
suggest instead that 7365 is involved with establishing or maintaining a 
neuroendocrine phenotype or the characteristic morphology of SCLC cells. 
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INTRODUCTION 
We recently isolated a cDNA encoding the novel X7365 protein from a Xenopus 
hypophysial library (Eib and Martens, 1996), and subsequently cloned the mouse 
(M7365) and human (H7365) homologs from brain and small cell lung carcinoma 
(SCLC) cDNA libraries (D.W. Eib and G.J.M. Martens, unpublished results). 7365 is 
enriched in neuroendocrine tissues and is remarkably similar to the transmembrane 
precursors which give rise to ligands for the epidermal growth factor receptor 
(EGFR). Analysis of the predicted amino acid sequences of 7365 homologs revealed a 
very high degree of conservation, with nearly complete identity in the trans-
membrane and cytoplasmic regions. The unique EGF-like domain of 7365 meets all 
criteria imposed by the consensus sequence for EGFR ligands (Carpenter and Wahl, 
1990) except that it has a tyrosine (X7365) or a histidine (M7365 and H7365) in 
place of the requisite arginine at position 41 (numbering refers to mature EGF). In 
addition to the EGF-like domain, the extracellular region of 7365 also contains two 
follistatin modules. These modules have been previously found in a number of 
secreted proteins, but 7365 is the sole example of a transmembrane protein with 
follistatin modules. Although the function of 7365 is unknown, we sought to map its 
human chromosomal location to gain insight into possible relationships with other 
genes and genetic disorders. 
MATERIALS AND METHODS 
A random-primed cDNA probe (nucleotides 503-1144 of H7365) was used to screen a PAC library 
spotted onto nylon membranes. This library, which is similar to the previous version (Iannou et al., 
1994), consisted of 147,456 clones with an average insert size of 120 kb, representing six genome 
equivalents. Hybridization was performed as described (Church and Gilbert, 1984) and four positives 
were identified. Southern blot analysis of an £coFU digest of these positives (PAC clones 878, 1055, 
1165 and 1175) confirmed the results obtained from screening the PAC library. A somatic cell hybrid 
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panel, which consists of monochromosomal hybrid cell lines of the NIGMS mapping panel 2 (Coriell 
Cell Repository) was hybridized with the same probe as described above, and a clear signal, not present 
in hamster or mouse DNA, was observed in the cell line containing human chromosome 9 (Fig. 1). PAC 
clone 1055 DNA (1 μ$) was subsequently labeled with biotta-16-dUTP (Biotin-Nick Translation Mix, 
Boerhinger). Hybridization was conducted essentially according to published procedures (Sinke et al., 
1992; Suikerbuijk et al., 1992). Briefly, 250 ng of PAC DNA and a 50-fold excess of Cot-1 DNA 
(Gibco, Life Technologies) were dissolved in 12 μΐ of hybridization mixture (2 X SSC, 10% dextran 
sulfate, 1% Tween-20, 50% formamide). Prior to hybridizing, the probe was heat denatured followed by 
preannealing at 37°C for 30 min. Metaphase spreads were prepared according to standard techniques. 
Following denaturation of the spreads, incubation with the probe was carried out under 20 X20 rrm 
coverslips in a moist chamber for 48 h at 37°C. Immunocytochemical detection of labeled, hybridized 
PAC DNA probe was achieved using fluorescein isothiocyanate (FITC)-conjugated avidin (Vector 
Laboratories), followed by two amplification steps using rabbit-anti-FITC (DAK.O) and mouse-anti-
rabbit-FITC (Jackson Immunoresearch Laboratories). Chromosomes were counter-stained with 4',6 
diamidine-2'-phenylindole dihydrochloride (DAPI). Digital images of hybridized chromosomal spreads 
were obtained with a Zeiss epifluorescence microscope equipped with a high-performance cooled CCD 
camera (Photometries) coupled to a Macintosh Quadra 950 computer. Images were processed using the 
BDS-Image FISH software package (Oncor). 
c o n t r o l 
Chromosome 1 9 15 22 Χ Y hamohu 
Fig 1. Autoradiograph of somatic cell panel hybridized with a random primed H7365 probe and exposed 
for 3d at -80°C. ha, hamster; mo, mouse; hu, human. 
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RESULTS AND DISCUSSION 
Analysis of twenty metaphase spreads showed that 80-90% had a PAC 1055 signal in 
the 9q31 region (Fig. 2). The majority of chromosomal abnormalities reported in 
conjunction with SCLC concern the 3pl4-p23 region, however a novel SCLC tumor 
suppressor locus has recently been assigned to 9q (Merlo et al., 1994). Recurrent 
breakpoints at 9q31 have been reported in cases of extraskeletal myxoid chondro-
sarcoma (Ture-Carel et al., 1988) and deletions with a breakpoint in this region are 
associated with myelodysplastic syndrome (Ringressi et al., 1988). Familial 
Fig. 2. Localization of the H7365 gene to human chromosome 9q31 by FISH, (upper panel) Computer-
enhanced, merged image of fluorescein signals and DAPI-stained chromosomes showing specific 
hybridization (symmetrical double spots) of PAC-clone 1055, containing the H7365 gene, (lower 
panel) Enlargement of two chromosomes 9 from upper panel. For comparison to the cytogenetic banding 
pattern, an idiogram of chromosome 9 is shown. 
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Dysautonomia, an autosomal recessive sensory microneuropathy affecting 1/3700 
individuals of Ashkenazi Jewish ancestry, has been prenatally diagnosed by analysis of 
linked CA-repeat polymorphisms in the 9q31-33 region (Eng et al., 1995), and this is 
a commonly deleted region in non-Hodgkin's lymphoma (Offit et al., 1993). The 
gene responsible for Fukuyama-type muscular dystrophy (Walker-Warburg 
Syndrome), a severe, autosomal recessive muscular dystrophy coupled with complex 
malformations of the eye and brain, also maps to 9q31 (Toda et al., 1993). In 
addition, 9q31 has been frequently identified in connection with Gorlin syndrome 
(Albrecht et al., 1994) which includes medulloblastoma, a primitive neuroectodermal 
tumor of the cerebellum, as a primary symptom. Interestingly, immunohistochemical 
and in situ hybridization studies of mouse brain show that M7365 is highly expressed 
in cerebellum (D. Eib, N. Dewulf, D. Huylebroeck and G. Martens, unpublished 
results). The M7365 gene can be expected to map to mouse chromosome 4 owing to 
its synteny with the 9q31 region of human chromosome 9 (DeBry and Seldin, 1996). 
Using somatic cell hybridization and fluorescence in situ hybridization we have 
localized the H7365 gene to human chromosome 9q31. Refined mapping of this gene 
will allow a more detailed analysis of its possible role in genetic aberrations involving 
the 9q31 region. 
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The EGF module of H7365 does not stimulate 
phosphorylation of erbB receptors 
Chapter 6 
ABSTRACT 
The recently discovered H7365 gene encodes a protein with motif structure and 
sequence homology to the transmembrane precursors giving rise to ligands for erbB 
family receptors. The H7365 protein contains an epidermal growth factor (EGF) 
module that complies with all specifications of the consensus sequence for EGF 
receptor (EGFR) ligands, except for the substitution of a histidine for the arginine 
dictated at position 41. Nonconservative, as well as conservative substitutions of this 
arginine in EGF result in a ligand virtually devoid of EGFR affinity. Recent studies 
have shown that all erbB ligands are capable of stimulating receptors that, when 
expressed alone, are not stimulated, in a process referred to as transmodulation. 
Therefore, although the H7365 EGF module cannot compete with EGF for EGFR 
binding, its potential for weak interactions with the EGFR, or for transmodulation 
among erbB receptors was unknown. To search for such activity, we overexpressed 
the wild type EGF-like module of H7365, as well as a mutant with the endogenous 
histidine 41 altered to an arginine, and tested the ability of the purified, refolded 
peptides to stimulate erbB family receptors expressed singly and in pairwise 
combinations in mouse BaF3 cells, and in MDA-MD-453 mammary carcinoma cells. 
We also tested the ability of these peptides to act as agonists or antagonists in the 
presence of betacellulin (BTC) and neuregulin (NRG). Although we did not exhausti­
vely test for erbB-2 and erbB-3 antagonism, our results indicate that the EGF module 
of H7365 is not an angonist for erbB family receptors, nor does it modulate BTC or 
NRG stimulation of these receptors. 
D W Eib1, D J Riese, И2, D F Stem2, and G J M Martens1 
'Department of Molecular Animal Physiology, University of Nijmegen, Toernooiveld 1, 6525 ED 
Nijmegen, The Netherlands 
2Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, 06520-
8023 
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INTRODUCTION 
The erbB family of receptors is composed of the epidermal growth factor (EGF) 
receptor (EGFR/erbB-1), neu (erbB-2/HER2), erbB-3 (HER3), and erbB-4 (HER4). 
These receptors can be stimulated by at least 15 different agonists, including EGF, 
transforming growth factor-α (TGF-a), amphiregulin (AR), betacellulin (BTC), 
heparin-binding EGF-like growth factor (HB-EGF); the differentially spliced forms of 
neuregulin (NRG), also known as the neu differentiation factors, heregulins, gp30, 
glial growth factors, or acetylcholine receptor inducing activity (ARIA); and 
epiregulin (reviewed by Groenen et al., 1994; Salomon et al., 1995; Lee et al., 1995). 
A single EGF-family hormone can stimulate more than one receptor and a single 
erbB family receptor can bind more than one EGF family ligand (reviewed by 
Groenen et al., 1994; Salomon et al., 1995). Moreover, erbB receptors participate in 
a process referred to as transmodulation, whereby in cells expressing a given erbB 
receptor alone, phosphorylation is not induced by EGF family hormones. However, 
when coexpressed with other erbB family members, the same receptor is 
phosphorylated in response to peptides of the EGF family (reviewed by Hynes et al., 
1994 and by Earp et al., 1995). For example, EGF stimulates neu when expressed in 
cells with the EGFR, but not when neu is expressed by itself (Akiyama et al., 1988; 
King et al., 1988; Stem and Kamps, 1988; Connelly and Stern, 1990). Every EGF-
family hormone tested has the ability to regulate other erbB family members through 
transmodulation (Stern and Kamps, 1988; Johnson et al., 1993; Plowman et al., 
1993; Carraway et al., 1994; Kita et al., 1994; Sliwkowski et al., 1994; Karunagaran 
et al., 1995; Riese et al., 1995), which is believed to occur through receptor 
heterodimerization and receptor cross-phosphorylation (Goldman et al., 1990; Wada 
et al., 1990; Spivak-Kroizman et al., 1992). 
115 
Chapter б 
The recently cloned H7365 protein bears motif structure and sequence homology to 
the immature forms of EGF family hormones (Eib and Martens, 1996; Eib et al., 
1997). These mitogens are cleaved extracellularly from their transmembrane 
precursors to yield soluble ligands for erbB family receptors, however the membrane-
bound form of the EGF family hormones can also stimulate some erbB receptors on 
adjacent cells in a process known as juxtaerine stimulation (Wong et al., 1989; 
Brachmann et al., 1989). The predicted amino acid sequence of H7365 indicates that 
it is a transmembrane protein with two follistatin modules, a unique EGF-like module, 
and transmembrane and cytoplasmic regions. The EGF module meets all criteria 
stipulated by the consensus sequence for EGFR ligands (reviewed by Carpenter and 
Wahl, 1990) except that it contains a histidine at the location corresponding to the 
arginine residue mandated at position 41 (numbering refers to mature EGF). Mutation 
of arginine 41 in EGF to a histidine results in an EGFR ligand with 0.2% of the 
binding affinity of wild type EGF (Hommel et al., 1991). Arginine 41 has been 
implicated in maintaining the structural integrity of EGF by forming a contact across 
the interface of two antiparallel pleated sheets with tyrosine 13 (Cooke et al., 1990), 
as well as in forming a direct contact with the EGFR (Defeo-Jones et al., 1988; 
Defeo-Jones et al., 1989; Engler et al., 1990). 
Although the EGF module of H7365 is unable to compete with EGF for EGFR binding 
(M. v.d. Poll and D. Eib, unpublished results), it has recently been demonstrated that 
EGFR affinity can be uncoupled from receptor stimulation (Van de Poll et al., 1997; 
Puddicombe et al., 1997). Therefore, we undertook the present study to determine if 
the EGF-module of H7365 could stimulate phosphorylation of the EGFR or other 
erbB-family receptors, either directly or via transmodulation, and to examine the 
influence the histidine at position 41 has on receptor stimulation by mutating it to 
the arginine specified in the consensus sequence for EGFR ligands. We also evaluated 
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the potential of both wild type and mutated EGF-like modules to agonize or 
antagonize betacellulin (BTC) stimulation of EGFR and erbB-4, and neuregulin (NRG) 
stimulation of neu via erbB-3. 
MATERIALS AND METHODS 
Cell Lines and Cell Culture 
The human breast cancer cell Ime MDA-MB-453 was obtained from the American Type Culture 
Collection, Rockville, MD Cultures were maintained ш DME F12 11, supplemented with 5% fetal 
bovine serum (Gibco-BRL), 2 mM glutamine and 50 units/ml each of penicillin and streptomycin 
The generation and characterization of the recombinant Ba/F3 cell lines has been described previously 
(Riese et al, 1995) The subset of these cell lines used in the present study were EGFR/3, erbB-3/3, 
neu+erbB-3/7A and erbB-4/7 Cells were grown in RMPI (Gibco/BRL) supplemented with 10% fetal 
calf serum (Sigma) and interleukin-3 (IL-3) supplied as 10% conditioned medium from the WEHI-3B 
mouse myelomonocytic leukemia cell line (Dayley and Baltimore, 1988) Ba/F3 derivatives transformed 
with constructs expressmg erbB family receptors were grown m medium supplemented with 200 μg 
G418 (Gibco/BRL) per ml Production and propagation of the human mammary tumor cell line MDA-
MB-453 has been described previously (Lupu et al, 1990) 
Prokaryotic Expression Constructs 
The EGF-like module of H7365 was amplified by PCR for subcloning into the pQE31 expression 
vector, which expresses proteins as fusion with an N-termmal hexahistidine tag (Diagen) to simplify 
protein purification The 5' pnmer (5'-CACGGATCCAGATGACACTAGTTTGTTGGGAAA-3') and 3' 
pnmer (5,-AGTAAGCTTTTGCCTACTTGGCACTAC-3,) introduced Bamtìl and Hind\\\ restriction 
sites mto the PCR product to facilitate subcloning The PCR reaction consisted of 30 cycles of 1 mm 
each at 94°C (melting), 52°C (annealing) and 72°C (elongation) Following sequencing, the resulting 
construct (pQEH7365EGF) was transformed into competent E coli M-15[pREP4] A second construct 
(PQEH7365EGFDH), encoding the identical region of H7365 2, but with the histidine 313, 
corresponding to arginine 41 m mature EGF, mutated to an arginine, was generated in the same manner 
In this case, however, a different 3' pnmer (5'-TCGAAGCTTTTGCCTACTTGGCACTACATAGAGAA-
TACTAAAGTCTGTCTTTTCACAGCGCTGTCCAGTG-3') was used to introduce the mutation during 
amplification of the EGF-like module from H7365 2 Apart from the mutated codon for histidine 313, the 
inserts for PQEH7365EGF and pQEH7365EGFDH were identical 
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Production of recombinant peptides 
Overexpression of recombinant protein from both H7365 constructs was performed according to the 
following scheme A S ml culture, with 100 mg/ml ampicillm and 25 mg/ml kanamycrn, was inoculated 
and grown overnight at 37°C The following day, 300 ml of the same medium was inoculated with the 
overnight culture and grown to an A«x> value of 0 7-0 8 and expression was induced by the addition of 
2 mM isopropyl-ß-D-thiogalactopyranoside (IPTG) The culture was grown for an additional 3 h 
following induction, at which point cells were cooled on ice for 10 mm and harvested by centnfugation 
at 4000 χ g for 10 mm Cell pellets were «suspended and stirred for 1 h in buffer A (0 01 M Tns/0 1 M 
NaH2P04, pH 8 0, 2 M GuHCl, 150 mM NaCl, and 5 mM ) The resulting lysate was cleared by 
centnfugation at 10,000 χ g for 15 mm at 4°C, and diluted to 50 ml with buffer A without pV 
mercaptoethanol Four ml of a 50% slurry of nickel-nitnlo-tn-acetic acid (Ni-NTA) sepharose (Diagen), 
equilibrated m buffer A without ß-mercaptoethanol was added to the cleared lysate and allowed to bind 
fusion proteins bearing the hexahistidme tag by gentle end-over-end agitation for 1 h at room 
temperature The Ni-NTA sepharose, bearing the fusion protein, was collected by centnfugation at 1000 
χ g for 5 mm at 4°C, washed twice m 50 ml of buffer A, loaded into a 1 cm χ 10 cm column and washed 
for an additional 30 mm in buffer A Flow through the column during this and all subsequent steps was 
1 0 ml/mm The fusion protein was eluted from the column m a 20 ml gradient from buffer A to buffer A + 
500 mM imadazole Peak fractions were identified by fractionation on 12 5% acrylamide-0 15% bis-
acrylamide-0 1% SDS gels (following TCA precipitation to remove GuHCl), and dialyzed against three 
changes of buffer В (0 01 M Tns/0 1 M Na2HP04, pH 7 6, 60 mM GuHCl, 150 mM NaCl, 1 25 mM 
reduced glutathione/0 5 mM oxidized glutathione) at a ratio of 1 250 (dialysate buffer) for 48 h at 4°C 
The refolded fusion protein was then dialyzed against three changes of PBS (2 68 mM KCl, 1 47 mM 
K.HjPO-4, 0 137 M NaCl, 8 06 mM NaîHPCu) at a ratio of 1 250 (dialysate buffer) over 24 h at 4°C The 
punfied, refolded peptides produced by pQE7365HEGF (H7365 wt) and pQEH7365HEGFDH 
(H7365 mut) were indistinguishable when analyzed by reducing, denaturing SDS-PAGE To establish 
that disulfide bonds had been formed in refolded peptides, samples were subjected to non-reducing, 
denaturing SDS-PAGE Protein concentrations were estimated by comparing samples subjected to 
SDS-PAGE and stained with Coomassie blue (BioRad) with standardized markers Production of the 
recombinant betacellulin used in this study has been described elsewhere (Riese et al, 1996), as has the 
production of the chemically synthesized neuregulin 65-mer (Holmes et al, 1992, Barbae» et al, 1995) 
Analysis of stimulation of erbB receptor tyrosine phosphorylation 
2 X 10* recombinant Ba/F3 cells were washed in phosphate buffered salme (PBS) and resuspended m 50 
ml RMP1 medium supplemented with IL-3 The cells were incubated for 6-10 h at 37°C, washed in ice-
cold PBS and resuspended in 1-3 ml ice-cold PBS The remaining steps were performed at 4°C or on ice 
The cells were transferred to 0 5 ml microfuge tubes and recombinant EGF module from human 
betacellulin (BTC), chemically synthesized neuregulin (NRG), H7365 wt and H7365 mut was added 
Following a 10 mm mcubation, cells were lysed m 1 ml of EBC lysis buffer (100 mM Tns, pH 7 4, 120 
mM NaCl and 0 5% NP-40, and the protein content of each sample was assayed using Coomassie blue 
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reagent (Pierce), 2 μg of protein was used in each immunoprecipitation EGFR was unmunoprecipitated 
with 900 ng of anu-EGFR MAb 528 (Gill et al, 1984) and 7 2 μg of rabbit anti-mouse antibody 31188 
(Pierce), neu was immuno-precipitated with 2 μg of anti-neu MAb TA-1 (Langton et al, 1991) and 12 
μg of rabbit anti-mouse antibody or with 1 μg of anti-neu MAb FSP-16 (Harwerth et al, 1992) and 5 μg 
of rabbit anti-mouse antibody, erbB-3 was immunoprecipitated with 200 ng of anti-erbB-3 rabbit 
polyclonal antiserum SC-285 (Santa Cruz Biotechnology), erbB-4 was immunoprecipitated with 1 Hg of 
anti-erbB-4 rabbit polyclonal antiserum SC-283 (Santa Cruz Biotechnology) Antireceptor antibody 
specificity was venfied by testing for cross-reactivity with cell lines expressing heterologous receptors 
All unmunoprecrpitations were performed for 2 h at 4°C after which the immune complexes were 
collected by incubating at 4°C with SO ml of a 10% (vol/vol) suspension of fixed and washed Staphylo­
coccus aureus (IGSL-10, The Enzyme Center) The collected immune complexes were washed three 
times with NET-N (Petti et al, 1991) and were eluted fom S aureus by boiling m 150 μΐ of protein 
sample buffer (Petti et al, 1991) Samples were split, electrophoresed on 7 5% acrylamide-0 17% 
bisacrylamide-01% SDS gels and transferred to nitrocellulose for immunoblottuig with 
antiphosphotyrosine MAb 4G10 (Upstate Biotechnology, Ine) Antibody binding was detected with 
horseradish peroxidase-coupled donkey anti-rabbit antibody NA934 (Amersham) or horseradish 
peroxidase coupled sheep anti-mouse NA931 (Amersham) and enhanced chemiluminescence reagent 
RPN2106 (Amersham) 
RESULTS 
Analysis of the recombinant H7365 wt and H7365 mut peptides by SDS-PAGE 
showed that the single affinity chromatography purification step in the presence of 
2M GuHCl resulted in nearly homogenous preparations. To check that the three 
disulfide bonds had formed in response to the oxidative refolding procedure, samples 
from both preparations were subjected to reducing (5 mM DTT), and non-reducing, 
denaturing PAGE (Fig. 1). Under non-reducing conditions, both the wild type and 
mutant peptides migrated with an apparent molecular mass approximately 2 kDa 
larger than under reducing conditions, indicative of the presence of secondary 
structure resulting from disulfide bonds. 
As an initial screen for stimulation of erbB-family receptors with the EGF-like 
module of H7365 wt and H7365 mut, we first stimulated MDA-MB-453 cells with 













X Fig. 1. Reducing and non-reducing, denatur­
ing PAGE of purified, recombinant H7365 
wt and mut peptides following refolding and fypp 
oxidation of disulfide bonds. Samples were 
loaded in buffer with (+) or without (-) 5 mM 
DTT. 
immunoprecipitated from the lysed cells, and the immune-precipitates were immuno-
blotted using a monoclonal antiphosphotyrosine antibody. While BTC stimulated a 
marked increase in receptor phosphorylation, neither H7365 wt or H7365 mut had 
any discernible effect (Fig. 2). We next repeated the experiment using MDA-MB-453 
cells stimulated with control buffer, BTC, H7365 wt and H7365 mut. Again, 
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Fig. 2. Stimulation of MDA-MB-453 cells with buffer control, BTC (200 ng/ml), H7365 wt (200 ng/ml) 
or H7365 mut (200 ng/ml). Following stimulation, cells were lysed and receptors were immuno­
precipitated with the designated antibody. Immunoprecipitates were then immunoblotted with an 
antiphosphotyrosine antibody. While BTC stimulated EOFR and her-4 (erbB-4) phosphorylation 
(visible only in longer exposures) relative to the buffer control, neither H7365 wt or H7365 mut had 
any discernible effect The high background present in neu immunoprecipitates reflects the high 
endogenous kinase activity of the unliganded receptor. 
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EGFR, neu, and erbB-4 were immunoprecipitated from the stimulated MDA-MD-453 
cells and immunoblotted using the antiphosphotyrosine antibody. This time there 
appeared to be a slight stimulation of EGFR phosphorylation with H7365 mut 
relative to buffer controls (Fig. 3). To further evaluate the possible stimulation of 
EGFR by H7365 mut in a more sensitive system, we stimulated BaF3 cells, stably 
transfected with EGFR (BaF3/EGFR-3), with buffer control, BTC, H7365 wt and 
H7365 mut, however the concentrations of the H7365 protein were increased to 
two- and three-times the levels tested on the MDA-MB-453 cells. The 
phosphorylated EGFR, immuno-precipitated from lysates of the stimulated 
BaF3/EGFR-3 cells, was immunoblotted as described above. This time, both H7365 
wt and H7365 mut appeared to give a slight stimulation of receptor phosphorylation 
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Fig. 3. Stimulation of MDA-MB-453 cells with buffer control, BTC (200 ng/ml), H7365 wt (500 ng/ml) 
or H7365 mut (500 ng/ml). Following stimulation, cells were lysed and the designated receptor was 
immunoprecipitated. Immunoprecipitates were then immunoblotted with an antiphosphotyrosine 
antibody. BTC clearly stimulates phosphorylation of the EGFR and her-4 (erbB-4) and there appears to 
be a small increase in phosphorylation of the EGFR in response to H7365 mut. The high background 




Fig. 4. Stimulation of BaF3/ 
EGFR/3 cells with buffer 
control, BTC (2000 ng/ml), 
H7365 wt (1000 ng/ml and 
5000 ng/ml) and H736S mut 
(1000 ng/ml and 5000 ng/ml). 
The lysed cells were 
immunoprecipitated with anti· 
EGFR antisera and immuno-
blotted with an antiphospho-
tyrosine antibody. BTC gave a 
clear stimulation of the EGFR 
phosphorylation, while both 
H7365 wt and H7365 mut gave 
only a small increase in EGFR 
phosphorylation. 
the EGFR, BaF3/EGFR-3 cells were stimulated with BTC alone, BTC together with 
increasing concentrations of H7365 wt, or H7365 wt alone. EGFR was then 
immunoprecipitated and immunoblotted as described above. H7365 wt had no 
apparent effect on BTC stimulation of EGFR, indicating that it is neither an agonist 
or an antagonist for BTC (Fig. 5). A similar experiment was conducted using 
BaF3/erbB-4/7 cells to evaluate the ability of H7365 wt and H7365 mut to modulate 
the stimulation of erbB-4 by BTC. Again, neither H7365 wt nor H7365 mut had any 
discernible effect on the BTC induced phosphorylation of this receptor (Fig. 6). 
Finally, to test the ability of H7365 to modulate NRG stimulation of neu via erbB-3 
transmodulation, we stimulated BaF3 cells stably transfected with both these 
receptors (BaF3/neu+erbB-3/7A) with H7365 wt and H7365 mut, and to check for an 
antagonistic effect on NRG stimulation of these cells, NRG alone, and NRG together 
with increasing concentrations of H7365 wt. As before, H7365 wt neither stimulated 
phosphorylation of these receptors, nor affected stimulation of phosphorylation by 
NRG (data not shown). 
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Fig. 5. Stimulation of BaF3/EGFR/3 if '*» '*» f 
cells with BTC alone (200 ng/ml) or » $ * I | * 
BTC + H7365 wt (200 ng/ml), BTC+ S S H S S S *> 
H7365 wt (500 ng/ml), BTC+H7365 Р Р * Р Р £ £ 1 
wt (1000 ng/ml), BTC + H7365 mut ί * ^ * * ^ « « 
(200 ng/ml), BTC + H7365 mut (500 3 - ? - 5 ^ . 5 - 5 » , P £ 
ng/ml), BTC + H7365 mut (1000 ΰ § , g ' B g , g , c s î * 
ng/ml), Η7365 wt alone (1000 ng/ml) g g g g g g g g e j i 
or H7365 mut alone (1000 ng/ml). the и S " " " я " и ? » 
_ _ _ _ . . . . , „* * + + + + + + 
EGFR was ìmmunoprecipitated fiom Ο υ υ υ υ υ ο ο α 
lysed cells, and immunoprecipitates Ja « a a S t e m e m S 
were immunoblotted with an anti- 206 kDa-
phosphotyrosine antibody. Addition 
of neither H7365 wt or H7365 mut 
had any effect on the stimulation of 
EGFR phosphorylation resulting 




Fig. 6. Stimulation of BaF3/erbB-4/7 
cells with BTC alone (200 ng/ml) or 
BTC + H7365 wt (200 ng/ml), BTC + 
H7365 wt (500 ng/ml), BTC + H7365 
wt (1000 ng/ml), BTC + H7365 mut 
(200 ng/ml), BTC + H7365 mut (500 
ng/ml), BTC + H7365 mut (1000 
ng/ml), H7365 wt alone (1000 ng/ml) 
or H7365 mut alone (1000 ng/ml). 
erbB-4 was immunoprecipitated fiom 
lysed cells, and immunoprecipitates 
were immunoblotted with an anti-
phosphotyrosine antibody. Addition 
of neither H7365 wt or H7365 mut 
had any effect on the stimulation of 
EGFR phosphorylation resulting 
from BTC alone. 
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We have analyzed the ability of the EGF-like module of H7365 to stimulate tyrosine 
phosphorylation of the four erbB receptors, as well as the ability of these EGF-like 
peptides to modulate receptor stimulation of two established erbB ligands, BTC and 
NRG (Table 1). Our results show that neither the wild type EGF module, nor a 
mutant, with the arginine at position 41 specified by the consensus sequence for 
EGFR ligands present in place of the endogenous histidine, stimulate EGFR, neu or 
erbB-4. Moreover, neither the wild type or mutant EGF homology modules agonize 
or an antagonize BTC stimulation of EGFR or erbB-4, nor NRG-induced trans-
activation of erbB-2 via erbB-3. An apparent omission to these experiments might 
appear to be the analysis of direct erbB-3 stimulation by the two H7365 
preparations, however, this was not feasible due to the catalytic impairment of erbB-
3 (Sliwkowski et al., 1994; Tzahar et al., 1994). A significant argument, however, 
can be made against the possibility that H7365 is an agonist of this receptor: Every 
EGF-family hormone tested to date not only activates receptors directly, but 
stimulates receptors in trans via ligand-induced heterodimerization. Therefore, if 
H7365 were a ligand for erbB-3 it should have stimulated phosphorylation of EGFR, 
neu, or erbB-4 in MDA-MB-453 cells. Although H7365 failed to modulate NRG-
induced erbB-3 transactivation of neu, this does not exclude the possibility that 
H7365 may antagonize heterodimerization of neu with EGFR or erbB-3. Clearly, 
further exploration of the potential antagonistic activity of H7365 is warranted. We 
also did not test the ability of the H7365 wt and H7365 mut to modulate the 
stimulation of erbB receptors by all EGF hormones, therefore it is possible that 
H7365 agonizes or antagonizes erbB receptors only in combination with a particular 
ligand. Also, should ligands be found that can directly activate neu, the agonistic and 
antagonistic potential of H7365 will need re-evaluation. 
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Table 1 Stimulation of erbB family receptors, 
expressed singly and in pairwise combi- EGFR ? 
nations, by BTC and NRG Parentheses егЬВ-з 
indicate binding without stimulation of ESFH+erbB-4 
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The negative results obtained with our overexpressed H7365 wt and H7365 mut EGF 
modules suggests that these preparations may have simply lacked activity. Several 
observations, however, indicate that this was not the case: The N-terminal 
hexahistidine fusion expression system employed in the present study has been 
successfully used to overexpress active NRG-2 (Chang et al., 1997), making it 
doubtful that there are problems inherent to using this expression system in 




Analysis of the recombinant H7365 wt and H7365 mut peptides by reducing and non-
reducing SDS-PAGE showed that disufide bonds had been formed in response to the 
oxidative refolding procedure. Because ß-mercaptoethanol was used in the isolation 
of protein from E. coli inclusion bodies, any disulfide bonds present in the final 
preparations of recombinant protein must have formed during treatment with 
oxidized and reduced glutathione, and not in the bacteria. Although analysis by SDS-
PAGE cannot insure that the correct disulfide bridges had formed, the refolding and 
oxidation procedure used in this study closely mimicked those used to produce active 
BTC (Riese et al., 1996), HB-EGF (Thompson et al., 1994), NRG-2 (Chang et al., 
1997) and TGF-α (Derynck et al., 1984) from E. coli inclusion bodies. Furthermore, 
early overexpression studies with TGF-α in E. coli demonstrated that even when no 
attempt was made to oxidize disulfide bonds, the resulting preparation had 20% to 
30% of the biological activity of correctly folded protein (Derynck et al., 1984). 
Therefore, given the high concentrations of recombinant H7365 wt and H7365 mut 
tested in the present study (Figs. 4 and 5), it is highly unlikely that our negative 
results are the consequence of incorrectly folded or inactive protein. 
Another argument in support of our results, indicating that the EGF module of 
H7365 is not a ligand for erbB-family receptors, can be made on a structural basis. 
Extensive mutagenesis studies on EGF and TGF-α have shown that a number of 
residues in the EGF B-loop, not specified in the consensus sequence for EGFR ligands 
(reviewed by Carpenter and Wahl, 1991), can substantially reduce EGF affinity for 
EGFR when mutated. Analysis of the primary structure of EGF, TGF-α, BTC, 
H7365-a (Eib et al., 1997), H7365-ß (a second H7365 gene elucidated through the 
assembly of expressed sequence tags), X7365, NRG and cripto shows that several of 
these residues are nonconservatively substituted in the EGF module of 7365 relative 
to EGF (Fig. 7). A L26G mutant of EGF decreases EGFR affinity and receptor 
phosphorylation to 5% of wild type levels (Campion et al., 1990), and a double 
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Fig 7 Sequence alignment of mature forms of ligands for егЬВ-1 (EGF, TGF-α, BTC), erbB-3 (NRG) and 
erbB-4 (BTC and NRG) and cnpto with the deduced ammo acid sequence of the α and β H7365 genes, 
and X736S Letters above the consensus sequence refer to the А, В and С loops of the tertiary EGF 
structure Numbers above the consensus sequence refer to mature EGF 
L26A/L47A mutant resulted in a ligand with less than 1% of wild type receptor 
affinity (Campion et al., 1993a) The threonine at position 26 and the phenylalanine 
at position 47 in H7365-a represent equivalent or even greater deviations from the 
wild type EGF sequence. H7365-a also has an alanine in place of the tyrosine present 
at position 29 in EGF, which when mutated to a glycine reduces EGFR affinity of the 
resulting analog to 17% of wild type levels (Campion et al., 1990). Η7365-β contains 
the deviations from EGF found in H7365-ot, and also misses the important isoleucine 
at position 23. A similar I23D EGF mutant decreases receptor affinity to 0.1% of 
wild type levels (Koide et al., 1992), and a I23T mutant had only 3% of the EGFR 
affinity of wild type EGF. 
Analysis of the primary amino acid sequence of several representative erbB receptor 
ligands and the EGF modules of H7365 wt and H7365 mut by means of hydropathy 
plots illustrates the clear differences in hydrophobic character of their B-loops 
compared with erbB ligands. All of the known erbB ligands have two hydrophobic 
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regions in the B-loop ß-sheet; the first lies in the vicinity of residues 13-15, which 
flank the amino terminal cysteine of the B-loop, and the second occurs in the 
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Fig. 8. Hydropathy plots (Kyte and Doolittle, 1982) of representative, mature EGF-family hormones, 
and H7365-0, H736S mut, and H7365-ß constructed with the predicted or known amino-acid sequence 
of the mature EGF modules. 
EGF module of H7365 misses the second of these hydrophobic regions. This 
difference in hydrophobicity is also evident in Connolly surfaces constructed on 
homology models of the EGF module of H7365 wt or H7365 mut, structurally based 
on TGF-ct (D. Eib and J. Leunissen, unpublished results). These models clearly show 
two distinct hydrophobic patches on the surface of TGF-ct, while the H7365 EGF 
module has only one. Moreover, although it may evoke structural alterations, the 
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hydropathy plots show that the single H41R mutation has no discernible effect on 
the hydrophobic profile of H7365 mut. Therefore, a possible explanation for the 
inability of either the wild type or the mutant H7365 EGF module to stimulate 
receptor phosphorylation is the absence of the second hydrophobic region. 
Interestingly, the a - and ß-form of H7365 fails to conserve residues in the B-loop, 
and the entire H7365-ß EGF module is hydrophillic. The EGF-like modules encoded 
by the two NRG genes, NRG-1 and -2, exhibit only 50% similarity, but both gene 
products promote heterodimerization of erbB-3. NRG-2 binding to erbB-3 promotes 
heterodimerization with the EGFR, whereas NRG-1 favors heterodimerization of 
erbB-3 or erbB-4 with neu (Carraway et al., 1997). Similarly, the EGF modules of 
H7365-CX and -β may also stimulate receptors in an complementary manner. 
To date, cripto is the only example of a mitogen bearing structural similarity to erbB 
family ligands that lacks an arginine at the position equivalent to residue 41 in 
mature EGF (Fig. 7; Ciccodicola et al., 1989). Cripto, however, misses not only the 
crucial arginine 41, but the majority of the A loop of the three-dimensional structure 
as well (Lohmeyer et al., 1997). This makes cripto similar to H7365 in that there is 
no aromatic residue available at position 13 to hydrogen bond with arginine 41 and 
stabilize the tertiary structure of the EGF module, while in H7365, the converse 
holds. Despite its truncated Α-loop, cripto has recently been shown to form the three 
essential disulfide bonds and adopt the classical EGF-like fold (Lohmeyer et al., 
1997). Although cripto stimulates MAP-kinase activity in MDA-MB-453 cells 
(Lohmeyer et al., 1997), it does not operate via erbB receptors. The Xenopus 
homolog of cripto, FRL-1, was identified using a functional screen for tyrosine 
phosphorylation of the fibroblast growth factor (FGF; Kinoshita et al., 1995). 
Although this study failed to show that cripto is a ligand for FGF, it implies that the 
cripto variant of the EGF-like fold may confer affinity for an unrelated class of 
receptors. Similarly, the 7365 version of the EGF module could be a ligand for a 
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novel receptor, or one not previously associated with ligands resembling EGF 
hormones. The structural similarity of the H7365 EGF module to erbB ligands, 
together with the observation that all erbB receptors undergo transmodulation, 
suggests that the H7365 receptor could stimulate erbB receptors in trans No 
examples of transmodulation between different classes of receptors, however, have 
been reported. 
The obvious conclusion from these results is that the EGF module of H7365 is not a 
ligand for the known erbB family receptors. Such a sweeping statement clearly wants 
more rigorous proving, particularly in regard to the point of potential antagonism of 
neu, mentioned above. However, given that our results hold, the corollary is that 
there are additional members of this family awaiting discovery, or that there is a 
related group of receptors. As suggested earlier (Lohmeyer et al., 1997), of these two 
possibilities, the later seems more likely as extensive sequencing efforts have thus far 
failed to identify additional candidates for erbB family membership (Adams et al., 
1992; 1993). 
REFERENCES 
Adams, M, Dubnick, M, Kerlavage, A , Moreno, R-, Kelley, J, Utterback, Τ, Nagle, J, Fields, С, and 
Venter, J (1992) Nature 355, 632-634 
Adams, M, Kerverlage, A , Fields, С , and Venter, J (1993) Nat Genet 4, 256-267 
Akryama, Τ, Saito, Τ, Ogawara, Η, Toyoshima, Κ , and Yamamoto, Τ (1988) Mol Cell Biol 8, 1019-1026 
Barbacci, E G, Guarino, В С. Stroh, J G, Singleton, D Η , Rosnack, К J , Moyer, J D , and Andrews, G С (1995) J 
Biol Chem 270,9585-9589 
Brachmann, R, Lindquist, Ρ В, Nagashima, M., Kohr, W, Lipari, Τ, Napier, M, and Derynck, R. (1989) 
Cell 56.495-506 
Campbell. I D , Cooke R M, Baron, M, Harvey, Τ S , and Tappm, M J (1989) J Biol Chem 268,1742-1748 
Campion, S К, Matsunami, R.K , Engler, D A , and Niyogi, S К. (1990) Biochemistry 29,9988-9993 
Campion,SR.,Takadi,DK,andNiyogi,SK (1992)J Cell Blechern 50,35-42 
Campion, S R_, Geek, Μ К, and Niyogi, S К (1993a) J Biol Chem 268,1742-1748 
Campion, S R., Biamonti, С , Montelionc, G Τ, and Niyogi, S К (1993b) Protein Eng 6,651-659 
Carpenter, G and Wahl, ΜI (1991) Epidermal growth factor family, in Handbook of Experimental Pharmacology, Vol 
95(Spoom,MB and Roberts, AB , eds), pp67-171 
130 
H7365 does not stimulate erbB family receptors 
Canaway, К L , III, Sliwkowski, M X, Aiuta, R., Platko, J V, Guy, Ρ M, Nurjens, A, Diamomi, A J, Vandlen, R.L 
(1994) J Biol Chem 269, 14303-14306 
Cantley.LC, and Cenone, R.A (1994) J Biol Chem 269,14303-14306 
Canaway, К L , III, Weber, J L, Unger, M J, Ledesma, J, Yu, N , Gassman, M , and Lai, С (1997) Nature 387, 512-
516 
Chang, H, Riese, D J , II, Gilbert, W, and Stern, D F (1997) Nature 387, 509-512 
Ciccodicola, A , Dono, R. Obici, S , Simeone, A , Zollo, M, and Persico, M G (1989) EMBO J 8,1987-1991 
Conelly.PA and Stem, D F (1990) Proc Natl Acad Sci USA 87,6054-6057 
Cooke, R M, Tappin, M J, Campbell, I D , Kohda, D, Miyake, Τ, Fuwa, Τ, Miyazawa, Τ, and Inagaki, F (1990) Eur 
J Biochem. 193. 807-815 
Dayley.GQ and Baltimore, D (1988) Proc Natl Acd Sci USA 85,9312-9316 
Defeo-Jones, D , Tai, J Y, Wegrzyn, R J, Vuocolo, G A , Baker, A E, Payne, L S, Garsky, V M, Oliff, A , and 
Riemen, M W (1988) Mol Ceil Biol 8,2999-3007 
Defeo-Jones, D , Tai, J Y , Vuocolo, G A, Wegrzyn, R J, Schofield, Τ L . Riemen, M W, and Oliff, A (1989) Mol 
Cell Biol 9,4083-4086 
Derynck, R, Roberts, А В , Winkler, M.E, Chen, E Y, and Goeddel, D V (1984) Cell 38,287-297 
Earp, H S , Dawson, Τ L , Xiong, L , and Hong, Y (1995) Breast Cancer Res Treat 35, 115-132 
Eib,DW and Martens, G J M (1996) J Neurochem 67, 1047-1055 
Eib, D W, Roebroeck, A J M, Van de Ven, W, and Martens, G J M (1997) Oncogene, submitted 
Engler, D A , Montelione, G Τ and Niyogi, S К ( 1990) FEBS Lett 271,47-50 
Gill, G Ν , Kawamoto. Τ, Cochet, С , Le, Α , Sato, J D, Masui. H , McCleod, С . and Mendelsohn, J (1984) J Biol 
Chem 259, 7755-7760 
Goldman, R , Ben Levy, R, Peles, Ε, and Yarden, Y (1990) Biochemistry 29, 11024-11028 
Groenen, L С , Nice, E С, and Burgess, AW ( 1994) Growth Factors 11, 235-257 
Harwerth, I M , Wels, W, Marte, Β M, and Hynes, Ν E (1992) J Biol Chem 267, 15160-15167 
Holmes, W E, Sliwkowski, M X, Akita, R W, Henzel, W J, Lee. L , Park, J W, Yansura, D . Abadi, N . Raab, Η , 
Lewis, G D , Shepard, H M, Kuang, W -J , Wood, WI, Goeddel. D V , and Vandlen, R.L (1992) Science 256, 1205-
1210 
Hommel, U, Dudgeon, Τ J, Fallon, A, Edwards, R M, and Campbell, I D (1991) Biochemistry 30, 8891-8898 
Hynes, Ν E and Stem, D F (1994) Biochim Biophys Acta 1198. 165-184 
Johnson, G R. Kannan, В , Shoyab, M , and Stromberg, К (1993) J Biol Chem 268,2924-2931 
Karunagaran, D , Tzahar. E . Liu, Ν , Wen, D , and Yarden, Y (1995) J Biol Chem 270, 9982-9990 
Kmoshita, Ν , Minshull, J. and Kirschner, M W (1995) Cell 83,621-630 
Kita. Y A, Barff, J, Luo, Y, Wen, D , Brankow, D, Hu, S , Liu. N, Pngent, S A , Gullick, W J, and Nicholson, M 
(1994) FEBS Lett 349,139-143 
Koide, H, Muto, Y, Kasai. Kohn. К . Hoshi, К, Takahashi, S, Tsukomo, К, Sasaki, Τ, Oka, Τ, Miyake, 
Τ, Fuwa, Τ, Kohda, D , Inagaki, F , Miyazawa, Τ, and Yokohama, S (1992) Biochim Biophys 
Acta 1120, 257-261 
Kyle, J and Doolittle, R F (1992) J Mol Biol 157.105-152 
Langton, В С , Crenshaw, Μ С , Chao, L A , Stuart, S G, Akita, R W, and Jackson, J E (1991) Cancer Res. 51,2593-
2598 
Lee,DC,Fenton,SE,Berkowitz,EA,andHissong, MA (1995) Pharm Rev 47,51-58 
Lohmeyer, M, Harrison, Ρ M, Karman, S , DeSanbs, M, O'Reilly, N J, Sternberg, M J E, Salomon, D S , and Gullick, 
W J (1997) Biochemistry 36,3837-3845 




Matsunami, R.K, Campion, S R., Niyogi, S К, and Stevens, A (1990) FEBS Lett 263, 105-108 
Petti, L, Nilson, L A, and DiMaio, D (1991) EMBO J 10,845-855 
Plowman, G D, Green, J M, Culouscou, 1 -M., Carlton, G W, Rothwell, V M, and Buckley, S (1993) Nature 366,473-
475 
Puddicombe, S M, Chamberlin, S G, MacGarvie, J, Richter, A, Drummond, D R, Collins, J , Wood, L , and Davies, 
DE (1997)J Biol Chem 271.15367-15372 
Riese, D J, Π, van Raaij. Τ M . Plowman, G D, Andrews, G С, and Stem, D F (1995) Mol Cell Biol 15,5770-5776 
Riese, D J , IL, Benningham, Y, van Raaij, Τ M. Buckley, S M., Plowman, G D, and Stem, D F (1996) Oncogene 12, 
345-353 
Salomon, D S, Brandt, R., Ciardiello, F , and Normanno, N ( 1995) Cnt Rev Oncol -Hematol 19,183-232 
Suwkowslo, M X., Schaefer, G, Akita, R.W, Lofgren, J A , Fitzpatnck, V D, Nuijens, A , Fendley, Β M , Cenone, 
R.A , Vandlen. R.L , and Carraway, К L ΠΙ (1994) J Biol Chem 269,14661-14665 
Spivak-Kroizman, Τ, Rotin, D , Pinchasi, D, Ullrich, Λ, Schlessinger, J, and Lax, I (1994) J Biol Chem 267, 8056-
8063 
Stem, D F and Kamps. Μ Ρ (1988) EMBO J 7,995-1001 
Thompson, S A , Higashiyama, S, Wood, К, Pollitt, N S, Damm, D, McEnroe, G, Gamck, В, Ashton, Ν, Lau, Κ , 
Hancock, Ν. Klagsbran, Μ, Abraham, J А (1994) J Biol Chem 269,2541-2549 
Tzahar, E, Levkowitz, G, Karunagaran, D, Yi, L , Peles, E, Lavi, S, Chang, D, Liu, J, Yayon, A , Wen, D, and 
Yarden,Y (1994) J Biol Chem 269.25226-25233 
Wada, Τ, Qian, X .and Greene. MI (1990) Cell. 61, 1339-1347 
Wong, S Τ, Winchell, L F, McClune, В К, Еагр, H S , Texido, J, Massagué, J , Herman, В , and Lee, D С (1989) Cell 
58,495-506 






The preceding chapters describe the cloning, sequence analysis, expression and initial 
functional analysis of 7365, a mosaic protein that appears to be related to precursors 
of EGF-family ligands. Owing to the novelty of 7365, the majority of this 
dissertation deals with expression analyses of 7365 gene products, which appear to be 
largely confined to the diffuse neuroendocrine system (DNES). 
Expression of 7365 in the Diffuse Neuroendocrine System 
The DNES is divided into the central division, composed of the hypothalamo-
hypophysial axis and pineal gland, and the peripheral division, whose largest 
component consists of the endocrine cells of the pancreas and gastrointestinal tract 
(Pearse, 1977). The DNES is made up of more than 40 peptide and amine-secreting 
cells of the so-called amine precursor uptake and decarboxylation (APUD) series 
(Pearse, 1968, 1969). APUD cells were originally thought to be of neural crest 
origin, but this was later shown to be true for less than one-fourth of all APUD cells 
(Le Douarin and Teilet, 1973; Pearse and Polak, 1971; Andrew, 1974; Pictet et al, 
1976). The concept, however, of a "neural" origin for these cells has persisted 
because of their invariable expression of neuron-specific enolase (Schmechel et al., 
1978; Pearse et al., 1980; Bishop et al., 1981; Wharton et al., 1981). It has been 
proposed that all APUD cells originate from the embryonal ectoblast and have in 
common an inherent neuroendocrine program (Pearse, 1975; 1977). The presence of 
7365 RNA and protein in cells of both the central (hypothalamus) and peripheral 
(pancreas) DNES divisions therefore suggests that it is either involved with the 
dispatch of this program, or is itself expressed as a consequence of it. This 
connection of 7365 with a neuroendocrine phenotype is also reflected by the 
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expression of H7365 transcripts in SCLC cells, characterized as having a neuroen­
docrine phenotype, while NSCLC cells, which lack the majority of neuroendocrine 
markers, are devoid of 7365 (Chapter 5). 
Homology of 7365 to erbB Ligands 
The organization and motif structure of 7365 are most similar to the transmembrane 
precursors of erbB ligands. The homology of 7365 to these growth factor precursors 
does not limit the possible functions of 7365 to those of a precursor, as the pro-
forms of EGF-family hormones have a variety of roles. In addition to functioning as 
progenitors of mature EGF-family ligands, several such transmembrane precursors 
have been demonstrated to act as receptors, despite having short cytoplasmic 
domains with no homology to proteins involved in signal transduction. ProHB-EGF, 
for example, not only gives rise to mature, soluble HB-EGF, but also acts as a 
receptor for diptheria toxin (Naglich et al., 1992; Mitamura et al., 1995). Similarly, 
proTGF-α associates with a protein kinase complex, suggesting that it too transmits 
signals through the plasma membrane (Shum et al., 1994). Furthermore, transfection 
with a proTGF-ct mutant, unable to undergo proteolytic processing, promotes 
anchorage-independent growth of normal rat kidney (NRK) cells in soft agar and 
causes them to be tumorigenic when injected into nude mice (Blasband et al., 1990). 
ProEGF has also been implicated in similar, receptor-like signal transduction (Pfeiffer 
and Ullrich, 1985). As implied by the name, the EGF module of proHB-EGF binds to 
heparin (Thompson et al., 1994). As might be expected, this property is also 
reflected in the precursor, and, for example, proHB-EGF mediates contact between 
the mouse uterine luminal epithelium and blastocysts during blastocyst implantation 
(Das et al., 1994; Raab et al., 1996). Therefore, the observation that 7365 is 
structurally and organizationally similar to EGF-family precursors leaves open a 
variety of possible functions, ranging from cell adhesion to signal transduction. 
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Despite the deviation at position 41, the conformity of the amino acid sequence of 
the solitary 7365 EGF module with the sequences of established ligands of erbB 
receptors, together with its juxtamembrane position in the molecule, strongly 
suggests that this module is a mitogenic ligand for a yet to be determined receptor. 
Although not as readily apparent as the histidine or tyrosine substitution for arginine 
at position 41, perhaps even more important is the difference in hydrophobicity of 
the 7365 EGF module relative to erbB receptor ligands. Whether or not the 7365 
receptor is related to the erbB family, the overlap in mouse brain expression of 
M7365 and erbB-receptor ligands (Chapter 3) suggests that receptors for both could 
be involved in common processes, such as neurogenesis and cell proliferation. Be-
cause of the probability of juxtacrine stimulation, the question as to whether or not 
the transmembrane form of 7365 undergoes proteolytic processing to release a 
soluble EGF module is at this point moot, the primary issue being to find its recep-
tor(s) and characterize the signaling events that result from 7365-induced 
stimulation. 
Homology of 7365 to Follistatin 
In addition to its unique EGF module, the second novel feature of 7365 is the two 
follistatin modules in its extracellular domain, which, although seen previously in 
secreted proteins, have not been observed earlier in a transmembrane protein. 
Unfortunately, as with the similarity of 7365 to EGF-family precursors, the 
consequence of follistatin modules in 7365 is unclear since there are currently at least 
four characteristics attributed to follistatin modules: binding to epithelial cells and 
disassembly of focal adhesions (Murphy-Ullrich et al., 1995; Sage et al., 1995), 
heparin binding (Esch et al., 1987; Nakamura et al., 1991; Hashimoto et al., 1997), 
angiogenesis (Lane and Sage, 1994; Sage, 1997), and the binding of TGF-ß growth 
factor superfamily members (Raines et al., 1992; Patthy and Nikolics, 1992). 
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Structure-function knowledge of follistatin modules is very limited, and has been 
obtained for only osteonectin and follistatin, the function of other follistatin-module 
containing proteins being unknown. The recent determination of the crystal structure 
of the osteonectin follistatin module allows reliable prediction of the structures of 
follistatin modules in other mosaic proteins (Hohenester et al., 1997) including 
follistatin, agrin, SCI, TSC-36/FRP, and 7365. This means that the likelihood of 
functional similarity between the follistatin modules of 7365, and osteonectin and 
follistatin can be forecast by homology modeling. Through the use of synthetic 
peptides, the region of the osteonectin follistatin module responsible for disassembly 
of focal adhesions and endothelial cell binding has been mapped to residues 72-91 and 
255-274 in mature osteonectin (Lankat-Buttgereit et al., 1988). The first of these 
regions has very low homology to 7365 (Fig. 3, Chapter 2), or any other follistatin 
module. The second region occurs in an EF-hand domain, paired with the follistatin 
modules of osteonectin, SCI, testican, hevin and TSC-36, but not present in 
follistatin, agrin, or 7365. Therefore, it is very unlikely that the 7365 follistatin 
modules will have a role in either of the processes attributed to these domains. 
Synthetic peptides corresponding to residues 133-149 in mature osteonectin, 
containing the mitogenic, copper-binding GHK sequence, stimulate endothelial cell 
proliferation and angiogenesis. Intact osteonectin, however, has no similar effects, 
indicating that the results obtained with synthetic peptides are artefactual, or that 
proteolysis of osteonectin may be required for bioactivity (Funk and Sage, 1993; 
Lane et al., 1994). This region of osteonectin has very poor homology with either 
follistatin module in 7365, indicating that the potential for angiogenesis stimulation 
by 7365 is negligible. 
Follistatin occurs in several isoforms that are the result of alternative splicing (Sugino 
et al., 1993). The carboxy terminal of these splicing variants is truncated to various 
degrees, and the affinity of each isoform for heparan sulfate varies, indicating that at 
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least one of the heparin-binding epitopes lies in the region following the last of the 
three follistatin modules (Sugino et al., 1993). Another heparin-binding epitope has 
been mapped to residues 104-120 in mature follistatin (Fig. 3, Chapter 2), in the 
amino-terminal follistatin module of follistatin. Among the residues of which this 
epitope is comprised, the side chains of six of the seven positively charged residues 
project outwardly from an amino-terminal hairpin, making this a prime candidate for 
a heparin binding site (Esch et al., 1987; Nakamura et al., 1991). Comparison of the 
analogous region of the first follistatin module of 7365 shows that only two 
positively charged residues remain, while five negatively charged residues have been 
introduced. In the second 7365 follistatin module no positively charged residues are 
present in this amino-terminal hairpin region, and four negatively charged residues 
have been introduced. In osteonectin, a low affinity heparin binding site has also been 
tentatively assigned to a carboxy-terminal a helix in the follistatin module 
(Hohenester et al., 1997), which contains five positively charged amino acids over a 
span of six residues (residues 136-141 in mature osteonectin). This helix, however, 
has been lost in all known follistatin modules except that of osteonectin. The first 
follistatin module of H7365 does, however, have a small concentration of positively 
charged residues (residues 126, 130, 131 and 133) that could be a heparin binding site. 
To summarize the information extracted from homology modeling, neither 7365 
follistatin module can bind heparin in the same manner as those of osteonectin or 
follistatin do. There is a remote possibility that the amino-terminal 7365 follistatin 
module is weakly heparin binding, but there is no precedent for such a mode of 
interaction between other follistatin modules and heparin. 
Both osteonectin and follistatin bind TGF-ß superfamily members. Although the 
residues in osteonectin responsible for its interaction with PDGF have not been 
mapped, the follistatin modules have been implicated (Patthy and Nikolics, 1993). 
Somewhat more information is available concerning the interaction of follistatin and 
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activin, and mutagenesis studies indicate that at least one epitope involved with the 
binding of activin by follistatin resides in the amino-terminal domain of follistatin, 
preceding the first follistatin module, while another is comprised of residues 124-141 
in the first follistatin module (Inouye et al., 1991; Sumimoto et al., 1995). The 
activin-binding epitope occurring outside the follistatin module in follistatin has no 
counterpart in 7365, since the corresponding region lies in the signal peptide. In 
contrast, the epitope within the follistatin module has significant homology with the 
corresponding region of the first follistatin module of 7365. Comparison of 
homology models generated for the first follistatin module of follistatin and of 7365 
with the single osteonectin follistatin modules shows that many of the residues in this 
region are involved in hydrogen bonding between two anti-parallel ß-sheets, and that 
for every pair of residues involved in hydrogen bonding in this region of osteonectin, 
an analogous pair can be found in 7365 and follistatin (D.W. Eib and R.M. Knegtel, 
unpublished results). This indicates that this ß-pleated sheet structure is maintained 
despite a number of differences in the primary structure of this region between the 
three proteins. The amino-terminal follistatin module of follistatin and 7365, and 
the single osteonectin follistatin module all have a solvent-exposed hydrophobic 
residue at nearly identical positions in a loop preceding the ß-pleated sheet structure 
mentioned above, indicating that this may also contribute to a ligand binding site 
(D.W. Eib and R.M. Knegtel, unpublished results). Based on the homology between 
7365 and follistatin in this activin-binding epitope, it would appear that both have a 
similar function. It is also tempting to predict that this is the region in osteonectin 
responsible for PDGF binding. The homology of 7365 to osteonectin and follistatin 
in this region does not necessarily restrict the binding partner of 7365 to PDGF or 
activin, but serves only to indicate that a related protein may interact with this 
domain in 7365. 
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The most intriguing aspect of 7365 is the combination of follistatin modules with the 
unique EGF module in a transmembrane protein resembling EGF-family precursors. 
The only comparable proteins are the heregulin splicing variants ARIA, or 
acetylcholine receptor-inducing activity, neu, and glial growth factor (GGF), which all 
contain an immunoglobulin module distal to an EGF homology module in their 
extracellular domains. This immunoglobulin module has a high density of positively 
charged residues and contains a sequence (TKKNRP) which conforms to a consensus 
sequence for heparin binding (XBBXBX), where В is a basic residue and X is a 
hydropathic residue, found in vitronectin, apolipoprotein E and platelet factor 4 
(Cardin and Weintraub, 1989). ARIA is believed to be released from motor nerve 
terminals into the extracellular space, where it binds to the glycosaminoglycan 
portion of proteoglycans in the ECM by its immunoglobulin module. It remains 
stored there until released by extracellular proteases which preferentially degrade the 
immunoglobulin module, releasing the protease-resistant EGF homology module and 
allowing it to diffuse to its receptor (Loeb and Fischbach, 1995). In the discussion of 
Chapter 3, it is put forward that a similar mechanism could also be applied to 7365, 
based on the assumption that the heparin binding amino-teminal follistatin module of 
7365 could fill the role of the heparin binding IgG module of heregulin/ARIA. At the 
time Chapter 3 was written, however, the crystal structure of the osteonectin 
follistatin module had not been published. As discussed above, the potential for 
heparin binding by 7365, based on alignments of its amino acid sequence and 
homology modeling, is less than compelling, and such a mechanism is now clearly 
improbable. A second agrument against an ARIA-like model for 7365 is that such a 
model fails to take into account the predicted propensity of the amino-terminal 
follistatin module for interactions with TGF-ß superfamily members. ProTGF-oc is 
internalized after interaction with monoclonal antibody recognizing its extracellular 
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domain (Shum et al., 1994). Similar experiments conducted with COS-1 cells 
transfected with a construct encoding 7365 and treated with polyclonal antisera 
raised against the follistatin modules failed to show a similar effect (D.W. Eib, 
unpublished results). The nearly complete identity of the cytoplasmic and 
transmembrane domains of the Xenopus, mouse and human 7365 homologs, 
however, strongly suggests that 7365 is involved with bi-directional signal 
transduction through the plasma membrane. The interaction of the extracellular 
domain of 7365 with a TGF-ß superfamily member could trigger cytoplasmic events 
such as internalization or stimulation of extracellular proteolytic processing of the 
transmembrane 7365 by transmembrane proteases. ProTGF-a provides a precedent 
for such a mechanism, in that it is cleaved extracellularly in a PKC mediated event, 
even in the absence of cytosol (Bosenberg et al, 1993). Any binding properties of 
the 7365 follistatin modules would also be expected to persist following cleavage 
from the EGF module, and following release, they could attenuate the availability and 
local concentration of any molecules for which they had affinity. 
Future Directions 
As previously mentioned, the highest priority for future work on 7365 must be given 
to functional analysis, particularly to finding the receptor(s) with which its EGF 
module interacts. The recent proliferation of techniques such as phage display and 
biopanning (Parmley and Smith, 1988; Smith and Scott, 1993), that allow the 
detection of protein-protein interactions, are obvious choices for pursuing this 
objective. 
The need for functional analysis of 7365 applies not only to the EGF module, but 
also to the amino-terminal follistatin module. Functional analysis of this region of 
7365 may prove more difficult than for the EGF module, as evidenced by the paucity 
of biochemical data concerning the interaction of follistatin and activin, and PDGF 
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and osteonectin. The lack of comprehensive mutagenesis studies on a protein as 
important and widely studied as follistatin, despite awareness of its affinity for activin 
for over eight years (Nakamura et al., 1990), points to a binding mechanism more 
complex than a simple 1:1 interaction. Use of the techniques mentioned above could 
at least lead to the identification of prospective ligand(s), even if the exact manner 
in which they interact with 7365 does not lend itself to simple analysis. 
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This dissertation deals with a novel protein, identified by chance, during the evalu-
ation of a subtractive screening procedure designed to isolate cDNAs encoding 
proteins coordinately expressed with proopiomelanocortin in Xenopus melanotropes. 
The advantage of identifying a cDNA in a directed screen is that the mere act of 
identification usually gives some indication of the function of its encoded protein, or 
at least of factors influencing its expression. The coincidental discovery of 7365, the 
subject of this dissertation, during an intermediate step of a screening procedure, 
meant that no insight into its function or the regulation of its expression could be 
gleaned from the isolation process. Consequently, any clues as to the function of 
7365 had to be derived from database comparisons of its primary structure to other 
proteins. Such comparisons showed that 7365 was most similar to the precursors 
giving rise to ligands for the family of four erbB tyrosine-kinase receptors, with two 
notable exceptions: the predicted extracellular domain of 7365 had two follistatin 
modules, never before observed in a transmembrane protein, and the extracellular 
domain contained a unique EGF module. This EGF module, though identical to EGF-
family hormones in the spacing of the characteristic six cysteines, lacked a crucial 
arginine at position 41, common to all erbB-receptor ligands. Therefore, although 
highly homologous to EGF-family hormones, this single deviation from all other 
family members cast serious doubt over the relationship of 7365 with these mitogens. 
And, although homologous to follistatin modules present in several proteins, the 
limited functional knowledge of these modules provided little insight into their 
possible role in 7365. To circumvent the impasse formed by the lack of clear 
indicators of possible functions, the majority of work in this dissertation focuses on 
the cloning of 7365 orthologs and analysis of their expression. In Chapter 2 the 
cloning of a full-length X7365 cDNA, and expression of X7365 gene products in 
Xenopus brain and hypophysis, are described. The discovery of X7365 immuno-
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reactivity in hypothalamic nuclei dedicated to the synthesis of positive effectors of 
hypophysial neurosecretion, indicated that 7365 may fulfill a similar role. The 
cloning of M7365 and its expression in mouse brain is presented in Chapter 3. The 
deduced amino-acid sequence of mouse 73 65 afforded the first look at a mammalian 
version of 7365. Comparison of mouse and Xenopus 7365 showed that these 
orthologs were highly conserved, particularly in their EGF, transmembrane and 
cytoplasmic regions. Furthermore, while the deviation from EGF-family hormones at 
position 41 seen in Xenopus 7365 had been maintained in the mouse ortholog, a 
histidine had replaced the tyrosine found in X7365. That this substitution occurs in a 
region that otherwise survived the evolutionary period between amphibians and 
mammals nearly intact, suggested it had important functional consequences. Analyses 
of mouse brain uncovered peak expression of M7365 in hippocampus, cerebellum, 
and olfactory lobe, while lower levels were observed in the hypothalamo-hypophysial 
axis. Postnatal neurogenesis is largely confined to the hippocampus and olfactory 
organ in the rodent brain, which suggested 7365 might have a role in this process. 
Analysis of M7365 tissue distribution in mouse demonstrated that after brain, 
pancreas was one of the chief sources, and in Chapter 4 the expression of M7365 in 
adult pancreatic islets, as well as in developing pancreas, is reported. This study 
showed that M7365 was coexpressed with glucagon from very early in development 
until maturity and that there was also some coexpression of M7365 with peptide YY. 
The expression of M7365 in embryonic pancreas was found to commence prior to 
innervation by the sympathetic nerve supply, and before the initiation of 
morphogenesis. These results indicated that the role of M7365 in pancreas concerned 
the differentiation of cells constituting the endocrine pancreas from their common 
progenitor. It was further hypothesized that the continued expression of M7365 by 
mature a cells pointed to a potential hormonal role for M7365 in mature pancreas. 
Continuing with mammalian 7365 orthologs, the work leading to the cloning of 
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H7365 is presented in Chapter 5. The difficulty in obtaining properly fixed or 
preserved human material prevented analysis of H736S tissue expression, and 
restricted further studies to human cell lines. Because of the enrichment of X7365 
and M7365 transcripts observed previously in neural and endocrine tissue, the 
expression of H7365 was examined in lung cancer cell lines. Small cell lung cancer 
(SCLC) cell lines express a number of markers characteristic of neuroendocrine cells, 
while these markers are largely absent in non-SCLC (NSCLC). Conversely, levels of 
EGF receptor, neu and TGF-a expression, are elevated in NSCLC, while SCLC is 
virtually devoid of EGF mitogens and their receptors. This suggested that if H7365 
was related to the EGF family, it too might be induced in NSCLC relative to SCLC. 
Expression of H7365, however, was found to be restricted to SCLC, giving the first 
indication that H7365 was not functionally related to erbB ligands. The analysis of 
H736S expression in SCLC cell lines also showed for the first time that the human 
H7365 gene was subject to alternative splicing, which results in at least five different 
transcripts. A number of genes involved with the pathogenesis of lung cancer have 
been mapped to the short arm of human chromosome 3. To discover if the H7365 
gene has a similar location, its chromosomal position was determined by somatic cell 
hybridization and FISH analyses. This work, described in Chapter 6, demonstrated 
that the H736S gene maps to 9q31, a region not previously associated with lung 
cancers. In Chapter 7 an account of the production of recombinant H7365 EGF 
module, and a mutant with the critical arginine reinstated at position 41, is given. 
Following purification and oxidative refolding, these peptides were used in assays of 
erbB receptor phosphorylation. Results of erbB receptor phosphorylation assays with 
these peptides showed that neither the H7365 EGF module, nor a H41R mutant, were 
able to stimulate phosphorylation of any erbB receptor. Finally, in Chapter 8 the 






Het onderwerp van dit proefschrift betreft een nieuw eiwit, genaamd X7365, dat 
geïdentificeerd werd met behulp van een differentiële hybridisatieprocedure. Deze 
procedure werd uitgevoerd om cDNA's te isoleren, coderend voor nieuwe eiwitten die 
samen met het prohormoon proopiomelanocortine tot expressie komen in de 
melanotrope cellen van de hypofyse van de klauwpad Xenopus laevis. Als zodanig 
leverde de ontdekking van X7365 geen directe informatie over de biologische rol 
van dit eiwit. Een mogelijke functie van het transmembraan-eiwit X7365 moest 
derhalve in eerste instantie worden afgeleid uit sequentievergelijkingen met gegevens 
uit computerbestanden. Deze vergelijkende studie liet zien dat X7365 het meest lijkt 
op voorlopereiwitten van liganden voor erbB tyrosine-kinase receptoren. Twee 
karakteristieken van X7365 zijn echter opmerkelijk: het extracellulaire domein 
bevat een nieuw type EGF-module en de twee follistatine-modules zijn nooit eerder 
gevonden in een transmembraan-eiwit. De EGF module van X7365 bevat weliswaar 
de zes cysteine residuen met een karakteristieke positie binnen EGF, maar het tussen 
EGF-familieleden geconserveerde arginine-residu 41 is vervangen door een tyrosine, 
een afwijking die een directe verwantschap tussen X7365 en de EGF-familieleden 
twijfelachtig maakt. Sequentievergelijkingen betreffende de twee X7365 follistatine-
modules gaven aan dat deze overeenkomen met modules die aanwezig zijn in een 
aantal bekende eiwitten. Echter, op basis van de beperkte kennis over follistatine-
modules konden geen sluitende conclusies getrokken worden over mogelijke functies 
van de follistatine-modules in X7365. Om meer informatie over X7365 te 
verkrijgen, zijn de in dit proefschrift beschreven experimenten voornamelijk gericht 
op de klonering, sequentie-analyse en expressie van X7365 en haar homologen. De 
klonering van het complete X7365 cDNA en het expressiepatroon van de X7365-
genproducten in de hersenen en hypofyse van Xenopus zijn beschreven in 
154 
Samenvatting 
Hoofdstuk 2. De ontdekking van X7365-immunoreactiviteit in hypothalamische 
kernen die betrokken zijn bij de productie van hormonen die stimulerend werken op 
hypofysaire neurosecretie, suggereert dat X7365 een vergelijkbare functie zou 
kunnen hebben. De klonering van 7365 (M7365) en haar expressie in de hersenen 
van de muis zijn beschreven in Hoofstuk 3. Door de aminozuurvolgorde afgeleid van 
M7365 cDNA werden de eerste gegevens over 7365 in een zoogdier bekend. 
Vergelijking van muis en Xenopus 7365 liet zien dat dit eiwit, vooral in de EGF-, 
transmembraan- en cytoplasmische domeinen, sterk geconserveerd is. Ondanks deze 
hoge mate van conservering is het tyrosine-residu 41 in X7365 vervangen door een 
histidine in M7365. Uit in situ hybridisatie-analyse van M7365-expressie in de 
hersenen van de muis bleek dat de hoogste expressie aanwezig is in de hippocampus, 
het cerebellum en het reukorgaan, en het mRNA in mindere mate tot expressie komt 
in de hypothalamo-hypofyse-as. Aangezien in de hersenen van muis en rat 
postnatale neurogenese uitsluitend plaats vindt in de hippocampus en het reukorgaan, 
zou 7365 een rol kunnen spelen in dit proces. Verdere analyses van M7365-expressie 
in de muis lieten zien dat dit eiwit ook duidelijk tot expressie komt in de alvleesklier. 
In Hoofdstuk 4 wordt de expressie beschreven van M7365 in de eilandjes van 
Langerhans, zowel tijdens de ontwikkeling als in het volwassen dier. Uit deze studie 
bleek dat M7365 samen met glucagon, en gedeeltelijk ook met het peptide YY, 
vanaf de vroege ontwikkeling tot expressie komt. Het feit dat de expressie van 
M7365 tijdens de ontwikkeling van de alvleesklier plaatsvindt voor de innervatie 
door sympathische zenuwen en het begin van de morfogenese, suggereert dat M7365 
betrokken is bij de differentiatie van de endocriene alvleeskliercellen uit een 
gemeenschappelijke voorlopercel. Het feit dat M7365 ook tot expressie komt in de 
α-cellen van het volwassen dier doet veronderstellen dat M7365 als een hormoon 
zou kunnen fungeren in de volwassen alvleesklier. De klonering van 7365 in de mens 
(H7365) wordt beschreven in Hoofdstuk 5. Omdat het moeilijk is om intact en goed 
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gefixeerd menselijk weefsel te verkrijgen, werd de analyse van de expressie van 
H7365 voornamelijk beperkt tot gekweekte humane cellen. De eerder gevonden 
expressie van X7365 en M7365 in neuronale en endocriene weefsels suggereerde dat 
H7365 in longkankercellijnen gevonden zou kunnen worden, en met name in 
kleincellige longkankercellijnen (SCLC) die een aantal kenmerken bevatten die 
specifiek zijn voor neuroendocriene cellen en die afwezig zijn in niet-kleincellige 
longkankercellen (NSCLC). Daarentegen komen EGF-receptoren, neu en TGF-o 
relatief in hoge mate tot expressie in de NSCLC-cellen terwijl zij grotendeels afwezig 
zijn in de SCLC-cellen. Dit gegeven geeft aanleiding om te veronderstellen dat, 
indien H7365 een lid is van de EGF familie, dit eiwit alleen tot expressie zou komen 
in de NSCLC- en niet in de SCLC-cellen. De expressie van H7365 was echter alleen 
te vinden in de SCLC-cellen. Deze vinding gaf een eerste indicatie dat 7365 geen 
volwaardig lid is van de EGF-familie. De Northern blot analyse van humane 
longkankercellen maakte tevens voor het eerst duidelijk dat minstens vijf 
verschillende vormen van alternatief gesplitst H7365 mRNA voorkomen bij de 
mens. Een aantal genen betrokken bij longkanker is gelokaliseerd op de korte arm 
van het menselijke chromosoom 3. Om de chromosomale ligging van het H7365-
gen te bepalen, werden somatische celhybridisatie- en FISH-analyses uitgevoerd. 
Deze worden beschreven in Hoofstuk 6. Het H7365-gen bleek gelokaliseerd te zijn 
op 9q31, een gebied dat niet in verband is gebracht met longkanker, maar waar 
recent wel een nieuw SCLC tumorsuppressorgen is gevonden. Om functionele 
experimenten uit te kunnen voeren, werd zowel het EGF-domein van H7365 als een 
mutant van dit domein, waarin het histidine 41 vervangen werd door een arginine, 
tot expressie gebracht in E. coli. De resultaten, beschreven in Hoofdstuk 7, toonden 
aan dat de twee recombinante EGF-domeinen niet in staat zijn om erbB receptoren 
te fosforyleren in een receptor fosforyleringsassays. Uit een gedetailleerde sequentie-
analyse bleek dat het EGF-domein van 7365, naast het arginine-41, een van de twee 
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hydrofobe gebieden mist die alle bekende erbB-receptorliganden wel bevatten. 
Tenslotte worden in Hoofdstuk 8 de gegevens van de eerdere hoofdstukken 
bediscussieerd en worden suggesties voor toekomstige studies gegeven. 
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